{
  "experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750
  },
  "results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Based on the provided document pages, Chevron held a **39.2% ownership interest** in Petroboscan as of the 2022 reporting period. The document explicitly states: \"Chevron has a 39.2 percent interest in Petroboscan, a joint stock company which operates the Boscan Field in Venezuela.\" Additionally, the document confirms Chevron had an **outstanding long-term loan to Petroboscan of $560**, which was fully provisioned for at year-end 2021. However, the document does not specify the total outstanding loan amount beyond this $560 figure (which appears to be a separate, smaller loan provision, not the total loan balance). The question asks for the \"total amount of Chevron's outstanding loan to Petroboscan,\" but the document only references the $560 loan provision and does not provide a total outstanding loan figure. Therefore, the ownership percentage (39.2%) is clearly documented, but the total loan amount cannot be determined from the provided information. \n\n**Answer:**  \nChevron held a 39.2% ownership interest in Petroboscan as of the 2022 reporting period. The document does not specify the total outstanding loan amount, only referencing a $560 loan provision that was fully provisioned for at year-end 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59960,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15204,
        "completion_tokens": 305,
        "total_tokens": 15510
      }
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "The sale of Dermstore LLC generated $356 million in cash proceeds and resulted in a $335 million pretax gain, which is the total financial impact of the transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38395,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9814,
        "completion_tokens": 41,
        "total_tokens": 9855
      }
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Based on the collaboration details in the document, Amgen recorded **$125 million** of product sales to BeiGene during the year ended December 31 2023 under their collaboration agreement. (Sales were $64 million in 2022 and $72 million in 2021.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51772,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13156,
        "completion_tokens": 61,
        "total_tokens": 13217
      }
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "The 2007 Omnibus Incentive Plan authorized the issuance of approximately 127 million shares of Danaher common stock, and as of December 31 2021, about 50 million shares remained available for future issuance under that plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 126,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44787,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11420,
        "completion_tokens": 56,
        "total_tokens": 11476
      }
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "Based on the provided document pages, the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm was $1.05 billion received in 2023 and an additional $305.0 million received in 2024, for a total of $1.355 billion. This amount was distributed as $1.05 billion in 2023 and $305.0 million in 2024, as explicitly stated in the \"Divestitures\" section under \"Olanzapine Portfolio (including Zyprexa)\" which notes \"we received $1.05 billion in cash in 2023 and an additional $305.0 million in cash in 2024.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45417,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11577,
        "completion_tokens": 137,
        "total_tokens": 11715
      }
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded $298 million of goodwill as a result of its acquisition of Terran Orbital, and the purchase consideration of $314 million was paid with $231 million in cash (the remaining $83 million was attributed to previously held investments).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56854,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14429,
        "completion_tokens": 64,
        "total_tokens": 14493
      }
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, which represents 50% equity ownership in the company. This carrying value is consistent with the equity method accounting for its 50% stake, as disclosed in Note 15.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59960,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15208,
        "completion_tokens": 68,
        "total_tokens": 15276
      }
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021 (from $1,160 million to $1,357 million). During the same period, the average revenue per car for Forest Products increased by $155 (from $5,269 to $5,424).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39222,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10029,
        "completion_tokens": 59,
        "total_tokens": 10088
      }
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "Based on the provided financial data, Restasis generated total net revenue of $224 million in 2024, representing a 48.7% decline compared to $436 million in 2023 when measured using actual currency rates. This decline aligns with the broader trend of decreasing Humira revenues due to biosimilar competition, though Restasis specifically shows a significant drop from its 2023 level.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55540,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14101,
        "completion_tokens": 95,
        "total_tokens": 14197
      }
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "As of December 31, 2023, Capital One Financial Corp’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %**. The minimum regulatory capital adequacy requirement for CET1 under the Basel III framework is **4.5 %**. Thus, Capital One’s CET1 ratio exceeds the minimum requirement by **8.4 percentage points**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45368,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11559,
        "completion_tokens": 77,
        "total_tokens": 11636
      }
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million, compared with $81 million in 2022 and $56 million in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57071,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14492,
        "completion_tokens": 45,
        "total_tokens": 14537
      }
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of BlackRock's investor/customer relationships decreased by $138 million, from $447 million at December 31 2022 to $309 million at December 31 2023. This reduction is primarily attributable to an increase in accumulated amortization—rising from $338 million to $338 million (the table shows accumulated amortization of $338 million for 2022 and $338 million for 2023, but the net carrying amount fell because the gross carrying amount also declined, reflecting amortization expense that was not offset by new additions).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56660,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14398,
        "completion_tokens": 136,
        "total_tokens": 14534
      }
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023 is $400 million. UPS classifies this debt as long‑term debt on its consolidated balance sheet, even though the notes mature in September 2024, based on its intent and ability to refinance the obligation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35241,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9033,
        "completion_tokens": 73,
        "total_tokens": 9107
      }
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "The available‑for‑sale debt investments fell by **$5.7 billion** (from $15.6 billion to $9.9 billion) in the fiscal year ended July 27 2024. This decline contributed to a **$8.3 billion** reduction in the combined total of cash and cash equivalents, available‑for‑sale debt investments and marketable equity securities, which dropped from $26.1 billion to $17.9 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51712,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13162,
        "completion_tokens": 92,
        "total_tokens": 13254
      }
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long‑Term Incentive Plan, and of those shares, 2,452,443 could be granted as awards other than options or stock appreciation rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38551,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9874,
        "completion_tokens": 58,
        "total_tokens": 9933
      }
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The company received a total of $526 million in cash from the settlement of forward interest‑rate swap contracts tied to the 2023 Notes, March 2022 Notes and September 2022 Notes ($247 million for the 2023 Notes, $143 million for the March 2022 Notes and $136 million for the September 2022 Notes).  These inflows are reflected in the cash‑flow statement as financing cash inflows from the swap settlements, providing a modest positive contribution to the company’s overall cash flow from financing activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44578,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11391,
        "completion_tokens": 127,
        "total_tokens": 11518
      }
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "Based on the 2024 10‑K, NEE’s ownership interest in XPLR is approximately 52.6 % (reflected as a non‑controlling interest). The principal equity‑method investees, including XPLR, primarily own contracted renewable‑energy assets such as wind, solar and battery‑storage projects, as well as a natural‑gas pipeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57322,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14559,
        "completion_tokens": 78,
        "total_tokens": 14637
      }
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The total fair value of Corporate notes and obligations reported in the fair value hierarchy table is $2,978 million, which is $464 million lower than their amortized cost of $3,014 million, resulting in unrealized losses of $45 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15181,
        "completion_tokens": 59,
        "total_tokens": 15241
      }
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "Based on the \"RAIL EQUIPMENT\" section in UNP_10k_2024.pdf (pages 17-21), UNP operated a total of **7,026 locomotives** in 2024, comprised of **6,106 owned** and **920 leased** locomotives. This total includes multiple-purpose locomotives (5,973 owned, 920 leased), switching locomotives (122 owned), and other locomotives (11 owned). The document explicitly states \"Total locomotives | 6,106 | 920 | 7,026\" in the equipment table, confirming the combined figure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35022,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8965,
        "completion_tokens": 115,
        "total_tokens": 9081
      }
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net change in the value of Brands/Tradenames for LIN in 2024 was a decrease of $105 million, driven by a $107 million foreign‑currency translation adjustment and a $36 million amortization expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42008,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10719,
        "completion_tokens": 50,
        "total_tokens": 10769
      }
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities at the end of 2021 was $2,303 million, compared with $2,303 million at the end of 2020, resulting in no dollar change year‑over‑year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52730,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13401,
        "completion_tokens": 51,
        "total_tokens": 13452
      }
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The maximum potential fair value at grant date of the performance‑based LTIP units awarded under the 2023 LTI Program is $42.5 million, as stated in the 2023 LTI Program description. These units are not reflected as a material dilutive effect on net income attributable to common stockholders for 2023 because they are performance‑based awards that will not vest until a future performance period (January 1, 2027), so no expense or dilution is recognized in the current year’s income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47358,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12092,
        "completion_tokens": 121,
        "total_tokens": 12213
      }
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "The amortized cost of Covered Bonds held by CRM at January 31 2024 was $81 million, while their fair value was $78 million, resulting in an unrealized loss of $3 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15171,
        "completion_tokens": 42,
        "total_tokens": 15214
      }
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Based on the \"RAIL EQUIPMENT\" table on page 18, Union Pacific reports **920 leased Multiple Purpose locomotives** out of a total of **6,893** Multiple Purpose locomotives. This represents **13.36%** of the Multiple Purpose fleet (920 ÷ 6,893 = 0.1336).  \n\nFor the \"Switching\" and \"Other\" categories combined:  \n- Switching locomotives: **0 leased** (all 122 owned)  \n- Other locomotives: **0 leased** (all 11 owned)  \n- Combined leased proportion: **0%** (0 ÷ 133 = 0).  \n\nThus, leased locomotives in the Multiple Purpose category (13.36%) are significantly higher than the combined proportion for Switching and Other categories (0%).  \n\n**Answer**: 13.36% of Multiple Purpose locomotives are leased, compared to 0% for the combined Switching and Other categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35022,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8980,
        "completion_tokens": 191,
        "total_tokens": 9171
      }
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined natural gas liquids (NGLs) volume in the Lower 48 increased by **540 million barrels** from the end of 2020 (793 MM bbl) to the end of 2023 (1,333 MM bbl).  \n\nThe total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 were **$5,729 million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 141,
          "pages": [
            139,
            140,
            141,
            142,
            143
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74785,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18935,
        "completion_tokens": 71,
        "total_tokens": 19007
      }
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent $0.4 billion to acquire full ownership of Alert Innovation in fiscal 2023, and subsequently sold and deconsolidated the entity in fiscal 2025. The consolidated financial statements for fiscal 2025 show no remaining carrying amount for Alert Innovation, reflecting its deconsolidation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58743,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14926,
        "completion_tokens": 74,
        "total_tokens": 15001
      }
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "The total revenue generated from Metals & minerals shipments for Union Pacific (UNP) in 2021 was $1,811 million, derived from 697,000 carloads at an average revenue per car of $2,598. This is calculated by multiplying the reported freight revenue for Metals & minerals ($1,811 million) by the revenue per car ($2,598), confirming the total revenue from this commodity group.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39222,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10020,
        "completion_tokens": 93,
        "total_tokens": 10114
      }
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The Company issued $1.3 billion aggregate principal amount of Series 2023‑1A Securities in the 2023 Securitization. This amount is greater than the $1.3 billion of Series 2013‑2A Securities that were repaid in March 2023, as the 2023 issuance matched the outstanding balance of the 2013‑2A securities that were fully retired at that time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57094,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14503,
        "completion_tokens": 84,
        "total_tokens": 14588
      }
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During 2023 the Company borrowed a total of $3.0 billion and repaid $6.1 billion of revolving indebtedness under its 2021 Multicurrency Credit Facility. The facility’s total borrowing capacity was $6.0 billion (including a $3.5 billion sub‑limit for multicurrency borrowings), so the repayments exceeded the amount drawn but remained within the overall $6.0 billion commitment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50773,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12926,
        "completion_tokens": 94,
        "total_tokens": 13020
      }
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "The total Intermodal revenue increased by **$515 million** from 2020 to 2021 (rising from $3,989 million to $4,504 million), a **13 % growth**. During the same period, the average revenue per Intermodal car rose from $1,267 thousand to $1,403 thousand, an **11 % increase**. Thus, the revenue growth outpaced the growth in average revenue per car.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39222,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10028,
        "completion_tokens": 86,
        "total_tokens": 10114
      }
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "The total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021 was $534 million, as shown in the capital‑expenditure table. This amount is lower than the net gain of $1,040 million reported from operations in the same region for 2021, indicating that operating earnings exceeded the capital spend.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 34232,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8791,
        "completion_tokens": 82,
        "total_tokens": 8874
      }
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft positions Copilot Pro as a consumer‑focused subscription that extends the AI‑enhanced capabilities of Microsoft 365, offering faster and more powerful AI assistance within Microsoft 365 apps and on the web. It is classified as part of the “Office Consumer products and cloud services” revenue stream, which falls under the broader “Productivity and Business Processes” segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40290,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10302,
        "completion_tokens": 96,
        "total_tokens": 10399
      }
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan resulting from the 2024 special dividend adjustment was 128,000 shares. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan based on the Nasdaq stock price movement, specifically using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023 (last trading day prior to the ex-dividend date) to the Nasdaq opening price of $662.70 on December 27, 2023 (ex-dividend date), which resulted in a 1.018 multiplier applied to outstanding RSUs and a proportional adjustment to the plan's share reserve.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 25348,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6566,
        "completion_tokens": 163,
        "total_tokens": 6729
      }
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "The Transportation and Electronics segment experienced a 1.4% decline in reported sales for 2024, but when adjusted for the PFAS special item, sales actually rose 3.1%. This growth was partially offset by headwinds from PFAS manufactured products and lower automotive OEM build rates, which negatively impacted organic sales growth despite gains in electronics and new product launches.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37264,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9540,
        "completion_tokens": 96,
        "total_tokens": 9636
      }
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31 2021 was $3 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54830,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13924,
        "completion_tokens": 41,
        "total_tokens": 13965
      }
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott's interest rate hedge contracts with a total notional value of $2.2 billion offset the interest‑rate risk of a portion of its fixed‑rate debt, causing the carrying amount of that debt to be adjusted by the fair‑value changes of the swaps; consequently, the fair value of its $13.7 billion long‑term debt is effectively stabilized and reflected in the balance‑sheet measurement of the hedged debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41786,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10679,
        "completion_tokens": 100,
        "total_tokens": 10780
      }
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "Based on the reserves table in the 2024 10‑K (page 9), the total oil‑equivalent proved reserves for equity companies in Asia are **1,276 million barrels**. This is compared with the total proved reserves for consolidated subsidiaries in Asia, which amount to **2,286 million barrels** (also shown in the same table). Thus, equity‑company reserves in Asia represent roughly 56 % of the reserves held by consolidated subsidiaries in the same region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62098,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15759,
        "completion_tokens": 111,
        "total_tokens": 15870
      }
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss tax reform enacted in September 2019 generated a $767 million tax benefit in 2019, which included a $769 million reduction in deferred‑tax expense from the step‑up of intangible assets for tax purposes. This benefit was recorded in the third quarter of 2019 and was the primary tax‑related impact of the reform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 131,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12406,
        "completion_tokens": 80,
        "total_tokens": 12486
      }
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "The total financial impact on PepsiCo in 2022 from the pension obligation transfer to TBG and the gain from remeasuring its 39% stake in TBG was a $520 million gain on the transaction, partially offset by a $318 million settlement charge, resulting in a net pre‑tax gain of $202 million (or $0.18 per share after tax).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52224,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13280,
        "completion_tokens": 79,
        "total_tokens": 13360
      }
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "The sales‑based milestone payments made by Merck to Eisai for Lenvima in 2021 totaled $200 million, and as of December 31 2021, accrued but unpaid sales‑based milestone payments amounted to $600 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45111,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11507,
        "completion_tokens": 50,
        "total_tokens": 11558
      }
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Tropicana, Naked and other select juice brands to PAI Partners, and it retained a 39 % non‑controlling interest in TBG as part of the transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44872,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11445,
        "completion_tokens": 54,
        "total_tokens": 11500
      }
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities (instead of the prior calculated value approach) results in the market value changes of those securities being recognized immediately in net periodic pension cost, rather than being amortized over five years. This change causes the expected return on plan assets component of net periodic pension cost to reflect current fair value movements for liability-hedging assets, leading to potentially more volatile net periodic pension cost compared to the prior smoothed approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 287,
          "pages": [
            285,
            286,
            287,
            288,
            289
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 287,
          "pages": [
            285,
            286,
            287,
            288,
            289
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43592,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11139,
        "completion_tokens": 140,
        "total_tokens": 11280
      }
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "The total increase in Netflix's content spending from 2019 to 2021 was $3,694 million, calculated as the difference between the 2021 total content expense ($12,230,367 thousand) and the 2019 total content expense ($9,216,247 thousand). Over this period, spending on produced content grew by $2,201 million (from $1,973,448 thousand in 2019 to $4,174,556 thousand in 2021), while licensed content increased by $813 million (from $7,242,799 thousand in 2019 to $8,055,811 thousand in 2021), indicating that growth in produced content significantly outpaced growth in licensed content.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37290,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9539,
        "completion_tokens": 145,
        "total_tokens": 9685
      }
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "The 2023 pre‑tax impairment charge recorded for PepsiCo’s 39 % noncontrolling interest in TBG was $321 million, which is the impairment charge referenced in Note 13 for the year ended December 30, 2023. In contrast, the company recognized a $520 million gain in 2022 from the remeasurement of the same 39 % investment in TBG (the gain recorded when the investment was initially measured at fair value after the juice‑brand divestiture).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45053,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11499,
        "completion_tokens": 109,
        "total_tokens": 11608
      }
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "In 2021, Netflix’s increased investment in original programming led to higher content asset amortization, but because releases were delayed by the pandemic, amortization grew more slowly than revenue. As a result, cost of revenues fell to 58% of total revenue (down from 61% in 2020), indicating that the additional spending on original content did not proportionally increase amortization expenses relative to the revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69347,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17551,
        "completion_tokens": 107,
        "total_tokens": 17658
      }
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million, and its international revenue grew by 10.7% at constant currency rates (compared with a 8.3% increase at actual currency rates).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55540,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14111,
        "completion_tokens": 49,
        "total_tokens": 14161
      }
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target Corporation recognized a $335 million pretax gain from the sale of Dermstore LLC in February 2021, which was included in Net Other Income in the financial statements. This gain was excluded from the consolidated revenues and operating income calculations, as Dermstore represented less than 1 percent of the company's consolidated revenues, operating income, and net assets. The gain was recognized in the fiscal year 2021, not 2023, and was not part of the 2023 financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31949,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8208,
        "completion_tokens": 122,
        "total_tokens": 8330
      }
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "The amortized cost of Salesforce's mortgage-backed obligations was $128 million, while their fair value was $122 million, a $6 million difference. This represents approximately 0.1 % of the total marketable securities at fair value ($5,184 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85864,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21702,
        "completion_tokens": 62,
        "total_tokens": 21764
      }
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "Based on the provided 2023 10-K filing pages, MetLife retrospectively adjusted **specific line items within its consolidated financial statements** as a result of adopting the new LDTI accounting guidance. The adjustments primarily impacted **liabilities and equity accounts**, with the most significant changes being:\n\n1.  **Future Policy Benefits** decreased by **$17,006 million** (from $204,228M to $187,222M), driven by the remeasurement of policyholder liabilities under the new LDTI model.\n2.  **Accumulated Other Comprehensive Income (AOCI)** increased by **$4,462 million** (from $(27,083)M to $(22,621)M), primarily due to the remeasurement of future policy benefits discount rates and other comprehensive income adjustments.\n3.  **Retained Earnings** decreased by **$1,621 million** (from $41,953M to $40,332M), reflecting the cumulative impact of the LDTI adoption on net income and other comprehensive income.\n\nThese adjustments covered the **transition period effective December 31, 2022**, as explicitly stated in the \"Transition Date impacts\" section and reflected in the comparative tables for 2022 and 2021. The adjustments were applied retrospectively to all periods presented, with the cumulative effects recorded in the opening balances of retained earnings and AOCI as of the Transition Date (January 1, 2022). The changes were primarily driven by the reclassification of Market Risk Benefits (MRBs) and the implementation of the full retrospective approach for LDTI, affecting the balance sheet as of December 31, 2022, and the related income statement and comprehensive income for 2022 and 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 164,
          "pages": [
            162,
            163,
            164,
            165,
            166
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 162,
          "pages": [
            160,
            161,
            162,
            163,
            164
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11783,
        "completion_tokens": 404,
        "total_tokens": 12188
      }
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "Based on the provided document pages, Disney has a total potential financing commitment of **$2.2 billion** through its two cruise ship credit facilities. The interest rate structure differs between the facilities: the borrowing for the Disney Treasure has a fixed interest rate of **3.80%**, while the borrowing for the Disney Destiny (if utilized) will have a fixed interest rate of **3.74%**, both payable semi-annually over 12 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41844,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10688,
        "completion_tokens": 109,
        "total_tokens": 10797
      }
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $513 million to its total upstream equity earnings in 2024. This contribution represents a significant portion of Chevron's overall upstream earnings and underscores the company's substantial production involvement in Angola through its 36.4 % stake in the Angola LNG project.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16112,
        "completion_tokens": 85,
        "total_tokens": 16197
      }
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "Based on the provided 10-K pages, Disney had $1.886 billion of foreign currency denominated debt outstanding as of September 28, 2024, which included Canadian dollar-denominated notes. The document states that the Company entered into pay-floating interest rate and cross-currency swaps that effectively convert this Canadian dollar debt into variable-rate U.S. dollar borrowings indexed to SOFR. However, the filing does not disclose the specific total amount of Canadian dollar notes outstanding or the exact portion converted through swaps. The only related figures provided are the individual Canadian note amounts ($0.9 billion and $1.0 billion) and the swap mechanism description, but no quantitative breakdown of conversions is given.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41844,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10689,
        "completion_tokens": 185,
        "total_tokens": 10874
      }
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,265 million for U.S. Plans and $115 million for Non-U.S. Plans, for a combined total of $1,380 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56242,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14271,
        "completion_tokens": 61,
        "total_tokens": 14332
      }
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle recognizes cloud services and license support revenues ratably over the contractual period, while cloud license and on-premise license revenues are recognized up front at the point the software is made available to the customer. This difference in timing and basis of revenue recognition results in a distinct revenue pattern for cloud versus license-based offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50613,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12878,
        "completion_tokens": 93,
        "total_tokens": 12971
      }
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "The worldwide sales growth of ERLEADA from 2021 to 2023 was 26.9% in 2023 (compared with a 45.7% increase in 2022), reflecting strong market adoption and share gains. This growth contributed to the Oncology segment's worldwide sales increasing by 10.5% in 2023 (to $17.661 billion) versus a 9.9% rise in 2022, driven significantly by ERLEADA's performance alongside other key oncology products like DARZALEX and CARVYKTI.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43658,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11140,
        "completion_tokens": 105,
        "total_tokens": 11245
      }
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "As of December 31 2023, MDLZ reported a total notional amount of **$7,456 million** of net‑investment‑hedge derivative contracts and **$7,969 million** of non‑U.S.‑dollar debt designated as net‑investment hedges. The combined notional of these two items therefore equals **$15,425 million**. This total notional amount is disclosed in the “Notional Amount” table under “Net investment hedges” and “Non‑U.S. dollar debt designated as net investment hedges.”  \n\nThe fair value of the derivative assets recorded in “other current assets” and “other assets” on the consolidated balance sheet for the same date is **$1,347 million** for derivative assets (and $1,209 million for derivative liabilities). Consequently, the total fair‑value amount of derivative assets shown on the balance sheet is **$1,347 million**, which is considerably lower than the aggregate notional amount of the hedges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51286,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13082,
        "completion_tokens": 222,
        "total_tokens": 13304
      }
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "Based on the provided document pages, the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. pension plans combined as of December 31, 2023, is **$686 million**. This is derived from the following:  \n- U.S. Plans: $676 million (reported under \"Mortgage/Asset-backed securities\" in the U.S. Plans fair value table for 2023).  \n- Non-U.S. Plans: $10 million (reported under \"Mortgage/Asset-backed securities\" in the Non-U.S. Plans fair value table for 2023).  \nCombined, $676 million + $10 million = **$686 million**. The document explicitly lists these values in the asset category breakdown for both U.S. and Non-U.S. plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56242,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14272,
        "completion_tokens": 167,
        "total_tokens": 14440
      }
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29, 2024, the remaining portion of the Nestlé upfront royalty payment that has not yet been recognized is $5.8 billion of long‑term deferred revenue. This amount reflects the straight‑line recognition over the 40‑year term of the Global Coffee Alliance agreement, under which Nestlé’s prepaid royalty will be amortized ratably throughout the partnership’s life.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44216,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11280,
        "completion_tokens": 94,
        "total_tokens": 11375
      }
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "Based on the provided pages from XOM's 2023 10-K filing, the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations is disclosed in the \"Long-Term Obligations to Equity Companies\" line item within the financial instruments and derivatives section. Specifically, the table shows a fair value of **$1,896 million** for long-term obligations to equity companies at December 31, 2023, which represents the total disclosed amount for these obligations. Additionally, the \"Other Third-Party Obligations\" column under \"Guarantees\" includes $5,945 million, but this pertains to broader third-party guarantees, not specifically equity company obligations. The question asks for the total fair value of **long-term obligations to equity companies and guarantees related to equity company obligations**, which is explicitly stated as **$1,896 million** in the \"Long-term obligations to equity companies\" line (fair value column, Level 3 input). This figure is distinct from the broader guarantee totals and directly corresponds to the equity company obligations disclosed. \n\n**Answer**: The total fair value of long-term obligations to equity companies and guarantees related to equity company obligations, as disclosed in XOM's 2023 10-K, is $1,896 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47167,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12013,
        "completion_tokens": 326,
        "total_tokens": 12339
      }
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "Based on the provided document pages, the total value of Mortgage/Asset-backed securities investments for Honeywell's U.S. and Non-U.S. pension plans as of December 31, 2023, is **$676 million for U.S. Plans** and **$10 million for Non-U.S. Plans**. This allocation reflects a significantly larger exposure in the U.S. plans compared to non-U.S. plans, where the amount is relatively minimal. The U.S. plans hold $676 million in this category, while non-U.S. plans hold only $10 million, indicating a concentrated allocation in U.S. fixed-income securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56242,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14285,
        "completion_tokens": 139,
        "total_tokens": 14424
      }
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "Based on the GAAP to Non-GAAP Reconciliations tables for fiscal years 2022 and 2021, the \"Medical device regulations (4)\" adjustment is explicitly listed as a Non-GAAP adjustment with a pre-tax impact of $102 million for fiscal year 2022 and $83 million for fiscal year 2021. These adjustments represent estimated incremental costs of complying with new European Union medical device regulations for previously registered products, as noted in the footnote (4) of the reconciliation tables. The question asks for the total pre-tax financial impact across fiscal years 2021 and 2022, which sums to $102 million + $83 million = $185 million. This is directly sourced from the provided document pages, specifically in the Non-GAAP Adjustments section of the GAAP to Non-GAAP Reconciliations tables. \n\nThe answer is $185 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44729,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11398,
        "completion_tokens": 206,
        "total_tokens": 11605
      }
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "The total goodwill impairment recognized for the OpenTable and KAYAK reporting unit during 2020 was $573 million, recognized as part of the annual goodwill impairment test as of September 30, 2020. The key factor that led to the continued impairment in the annual test as of September 30, 2020 was the significantly lowered outlook for monetization opportunities in restaurant reservation services and slower-than-expected recovery trends for airline travel, which extended the assumed recovery period to 2019 levels of profitability beyond five years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 46869,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11948,
        "completion_tokens": 138,
        "total_tokens": 12086
      }
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart's ownership stake in Flipkart increased by approximately 10 percentage points, rising from about 75% at the end of fiscal 2023 to approximately 85% at the end of fiscal 2024. This increase was supported by a $3.5 billion transaction in which Walmart purchased shares from certain Flipkart noncontrolling interest holders and settled related liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54406,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13815,
        "completion_tokens": 90,
        "total_tokens": 13906
      }
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounts for 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds a North American market share of over 40% in the paper towel category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13411,
        "completion_tokens": 52,
        "total_tokens": 13464
      }
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "The total pre‑tax charge recorded by RTX in 2024 for resolving Thales‑Raytheon Systems and Related Matters is $364 million, which is part of the combined $918 million pre‑tax charge disclosed in the “Resolution of Certain Legal Matters” note. This resolution is tied to the SEC Administrative Order through the deferred prosecution agreement (DPA‑1) and the SEC order that require RTX and Raytheon Company to retain an independent compliance monitor and to comply with cooperation and disclosure obligations; any breach could result in vacatur of the SEC order and further enforcement action.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54281,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13796,
        "completion_tokens": 148,
        "total_tokens": 13944
      }
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "As of April 2021, Trodelvy had been approved in three specific countries for metastatic triple‑negative breast cancer: the United States, Great Britain, and Switzerland. (The document notes that Canada also approved it later in September 2021, but the question asks for the countries approved by September 2021, which includes the U.S., U.K., Switzerland, and Canada.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62545,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15867,
        "completion_tokens": 92,
        "total_tokens": 15959
      }
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "The total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024 is $11.5 million, and the amount expected to be reclassified from AOCI into earnings within the next 12 months is $9.5 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66244,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16792,
        "completion_tokens": 59,
        "total_tokens": 16852
      }
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "As of the end of fiscal 2024, Starbucks has two Japanese‑yen‑denominated credit facilities: a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. Both facilities bear interest at a variable rate tied to TIBOR plus an applicable margin (0.400% for the ¥5 billion line and 0.300% for the ¥10 billion line), and as of September 29, 2024, no borrowings were outstanding under either facility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44177,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11278,
        "completion_tokens": 119,
        "total_tokens": 11397
      }
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,563 shares. Of these, 2,000,308 shares were bought under the publicly announced open‑market share purchase program, and the remaining 72,255 shares were acquired in transactions unrelated to that program. The average price paid per share for the shares purchased under the open‑market program was $303.05.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35598,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9160,
        "completion_tokens": 105,
        "total_tokens": 9265
      }
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and $74 million of their principal amount was exchanged in the 2020 debt‑exchange transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42300,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10796,
        "completion_tokens": 40,
        "total_tokens": 10837
      }
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "The 10‑K states that Netflix amortizes its content assets on an accelerated basis over the shorter of the title’s contractual window or an estimated period of use, “typically over 90 % of a licensed or produced content asset is expected to be amortized within four years after its month of first availability.” Because the amortization schedule is front‑loaded, a disproportionate share of the expense is recognized in the first four years of a title’s life, with the remainder spread over later years. This accelerated policy therefore front‑loads amortization expense, concentrating the cost in the early years and reducing it thereafter.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56998,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14489,
        "completion_tokens": 160,
        "total_tokens": 14649
      }
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on the Foreign Exchange Rate Risk table in Item 7A, BlackRock’s net exposure to foreign‑exchange‑sensitive investments is $1,125 million, and a hypothetical 10 % adverse movement in the applicable foreign‑exchange rates would result in a $112 million impact. Thus, if all such investments experienced a –10 % exchange‑rate change, the total potential financial impact in 2023 would be approximately $112 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45364,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11562,
        "completion_tokens": 104,
        "total_tokens": 11666
      }
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "The 2022 10‑K filing lists **four amendments** to the Target Corporation Deferred Compensation Trust Agreement, with the following effective dates:\n\n- **January 1, 2009** (original agreement)  \n- **June 8, 2011** (Amendment Q)  \n- **October 25, 2017** (Amendment R)  \n- **December 18, 2020** (Amendment S)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35032,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8969,
        "completion_tokens": 76,
        "total_tokens": 9045
      }
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The total carrying value of the 6.90% 2038 Notes was $254 million, and $37 million of principal of those notes was exchanged in the 2020 debt‑exchange transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42300,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10793,
        "completion_tokens": 40,
        "total_tokens": 10834
      }
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The Fleet Ballistic Missile (FBM) program contributed approximately $940 million to higher product sales at Space in 2023, and drove about $815 million of the $849 million increase in product costs for that segment. The net financial impact was a modest improvement in overall profitability, as the revenue boost from the FBM ramp‑up more than offset the added costs, helping lift consolidated net earnings to $6.9 billion for the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44927,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11463,
        "completion_tokens": 109,
        "total_tokens": 11572
      }
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The 5.375% 2043 Notes have a carrying value of $185 million, which represents 0.55 % of AMGN’s total debt carrying value of $33,309 million reported for 2022. In 2020, $76 million of principal from these notes was exchanged in the debt‑exchange transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42300,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10803,
        "completion_tokens": 64,
        "total_tokens": 10868
      }
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "The total value of securities on loan subject to indemnification was approximately $259 billion as of December 31, 2023, and BlackRock held about $276 billion of cash and securities as collateral to back those indemnities. If significant borrower defaults occurred simultaneously with rapid declines in collateral value, the resulting collateral shortfalls could trigger material liabilities under the indemnification obligations, potentially causing a decline in BlackRock’s revenue and earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63753,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16189,
        "completion_tokens": 124,
        "total_tokens": 16313
      }
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "Based on the provided document pages, the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. has been amended three times. The document specifically references the original agreement dated December 16, 2015 (HH ‡), the First Amendment dated November 30, 2016 (II ‡), and the Second Amendment dated January 9, 2018 (JJ). Therefore, the total number of amendments made to this agreement is 3.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35032,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8972,
        "completion_tokens": 104,
        "total_tokens": 9076
      }
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of Technology‑related finite‑lived intangible assets declined from $180 million at December 31 2022 to $142 million at December 31 2023, a $38 million decrease.  Over the same period, the accumulated amortization for this category increased from $81 million to $118 million, a $37 million increase.  Thus, the decline in net carrying amount is essentially offset by the rise in accumulated amortization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56660,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14402,
        "completion_tokens": 106,
        "total_tokens": 14509
      }
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,559 million (from $657 million in fiscal 2023 to $2,203 million in fiscal 2024), whereas the increase in the Americas region was $7,048 million (from $5,678 million in fiscal 2023 to $12,726 million in fiscal 2024). Thus, the growth in Asia Pacific was significantly smaller than the growth in the Americas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46558,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11860,
        "completion_tokens": 103,
        "total_tokens": 11963
      }
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "Based on the Debt Securities table for December 31, 2023, the total fair value of redeemable preferred securities held by CVS is $20 million, and the unrealized loss recognized on these securities as of that date is $1 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 147,
          "pages": [
            145,
            146,
            147,
            148,
            149
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57257,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14543,
        "completion_tokens": 56,
        "total_tokens": 14599
      }
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022 was **$1.0 billion**, which represents the full outstanding balance under the program. This borrowing is well within the combined capacity of the back‑up credit facilities, which provided up to **$3.0 billion** of available credit at that date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41320,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10551,
        "completion_tokens": 83,
        "total_tokens": 10634
      }
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Based on the provided SEC 10-K filing, Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and the company incurred $40 million in profit and loss sharing expenses related to these products during the same year. These figures are specifically noted in the \"Collaborations\" section under the BeiGene partnership details, which states: \"During the years ended December 31, 2023, 2022 and 2021, product sales from Amgen to BeiGene under the collaboration were $125 million, $64 million and $72 million, respectively... During the years ended December 31, 2023, 2022 and 2021, profit and loss share expenses related to the initial product-specific commercialization period were $40 million, $53 million and $64 million, respectively.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39648,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10133,
        "completion_tokens": 187,
        "total_tokens": 10320
      }
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million (from $1,241 million to $2,886 million). This liability is measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange (Level 2), which corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, also measured at fair value using the same quoted prices on the active exchange.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51575,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13131,
        "completion_tokens": 117,
        "total_tokens": 13248
      }
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "As of December 31 2024, the 2020 Stock Incentive Plan had **48 million shares available for future grants**. The plan documentation explicitly references **non‑qualified stock options, restricted shares (restricted stock units), and performance‑based restricted stock unit awards** as the types of share‑based awards that can be granted.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54900,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13956,
        "completion_tokens": 84,
        "total_tokens": 14040
      }
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "The company expects to recognize approximately $4 billion of remaining contracted revenue from Paxlovid deliveries scheduled between 2025 and 2028. In 2024 it recorded a one‑time sales true‑up settlement that generated about $129 million of revenue, which is a non‑recurring item distinct from the ongoing contracted revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81530,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20626,
        "completion_tokens": 81,
        "total_tokens": 20708
      }
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "Based on the provided SEC 10-K filing information, the parental guarantee from Berkshire Hathaway Inc. covered the ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO for the portion of reserves ceded to NICO. Specifically, the agreement transferred 80% of the reserve risk on substantially all U.S. Commercial long-tail exposures for accident years 2015 and prior, with Berkshire Hathaway providing a parental guarantee to secure NICO's obligations under this agreement. The document confirms that \"Berkshire Hathaway Inc. has provided a parental guarantee to secure NICO's obligations under the agreement\" (page 97), though it does not specify a monetary amount for the guarantee itself. The guarantee was in place as of December 31, 2023, covering the ceded reserves under this specific retroactive reinsurance arrangement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 184,
          "pages": [
            182,
            183,
            184,
            185,
            186
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60118,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15257,
        "completion_tokens": 215,
        "total_tokens": 15473
      }
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "The total amount of credit receivables purchased for PayPal’s merchant finance offerings was approximately **$1.8 billion in both 2021 and 2020**. This purchase volume is consistent with the outstanding balance of merchant loans, advances, and interest and fees receivable, which was **$1.4 billion as of December 31, 2021** (and also $1.4 billion as of December 31, 2020, net of participation interest).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56490,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14373,
        "completion_tokens": 101,
        "total_tokens": 14474
      }
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "Based on the provided document pages, the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023 was approximately $500. By July 2024, the Japanese subsidiary had repaid $77 of these notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32925,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8448,
        "completion_tokens": 57,
        "total_tokens": 8506
      }
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The decrease in the value of available‑for‑sale debt investments from 2021 to 2022 was $3,259 million, while net realized gains on those investments were only $9 million, so the decline exceeded the gains by roughly $3,250 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47657,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12131,
        "completion_tokens": 57,
        "total_tokens": 12189
      }
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "Based on the provided document pages, the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit, is $7.2 billion. This figure reflects the unused portion of the $7.0 billion unsecured revolving credit facility plus the $7.2 billion of unused letters of credit disclosed in Note 7.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54656,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13884,
        "completion_tokens": 101,
        "total_tokens": 13985
      }
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "Based on the document, the total cash outflow for acquisitions made by Thermo Fisher Scientific (TMO) in 2023 was $3.61 billion, which includes $2.70 billion for The Binding Site Group and $0.91 billion for CorEvitas, LLC. Of this total, $2.70 billion was specifically allocated to The Binding Site Group acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46852,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11938,
        "completion_tokens": 79,
        "total_tokens": 12017
      }
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Based on the \"RAIL EQUIPMENT\" table in the document, Union Pacific reports that as of December 31, 2023, its total highway revenue equipment includes 47,439 owned containers and 545 leased containers, for a total of 47,984 containers. This means leased containers represent only 545 / 47,984 ≈ 1.1% of the total container fleet. In contrast, for chassis equipment, the company reports 30,635 owned chassis and 17,705 leased chassis, totaling 48,340 units, with leased units comprising 17,705 / 48,340 ≈ 36.6% of the chassis fleet. Thus, while a small fraction (about 1.1%) of containers are leased, a significantly larger portion (about 36.6%) of chassis units are leased.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34908,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8948,
        "completion_tokens": 168,
        "total_tokens": 9116
      }
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "Based on the exhibits listed in the financial document, there are **12 distinct supplemental indentures** related to Senior Notes that include the 2035 Note. The most recent of these agreements was the **Tenth Supplemental Indenture**, dated **November 20, 2024**, involving **Computershare Trust Company, National Association** (as successor to Wells Fargo Bank, National Association) as trustee.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 83232,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21034,
        "completion_tokens": 99,
        "total_tokens": 21133
      }
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The expensing methodology for non-employee director deferred stock units granted in 2023 differs from those granted prior to 2022 in that prior to 2022, these awards vested immediately and were expensed on the grant date, whereas in 2023 they vest on the earlier of the first anniversary of the grant date or the day preceding the next Annual Meeting of Shareholders and are expensed on a straight-line basis over the requisite service period. The vesting timeline for the 2023 awards is three years from the grant date, subject to acceleration in certain circumstances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40828,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10427,
        "completion_tokens": 142,
        "total_tokens": 10569
      }
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million, representing 6.5 % of the $3,925 million of identifiable assets in that region and business unit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 118,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31324,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8063,
        "completion_tokens": 56,
        "total_tokens": 8120
      }
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "The ATMP JV purchases and resales to AMD totaled $1.7 billion in fiscal year 2024, and AMD provided a $100 million term loan to the JV during the same year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41618,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10626,
        "completion_tokens": 39,
        "total_tokens": 10665
      }
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021 was $2,620 million in 2021 (up from $2,464 million in 2020 and $2,443 million in 2019), while the Research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021—a $11,290 million increase over the same period. Thus, the Analytical and physical instrumentation line saw a $177 million rise from 2019 to 2021, which is far smaller than the $11,290 million growth recorded by the Research and medical products segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47000,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11980,
        "completion_tokens": 140,
        "total_tokens": 12120
      }
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "Microsoft's Intelligent Cloud segment, which includes Azure and other cloud services, SQL Server, Windows Server, and related products, directly contributes to the segment's financial performance through strong revenue growth driven by cloud consumption and infrastructure services. In fiscal 2022, the segment generated $75.3 billion in revenue and $32.7 billion in operating income, reflecting growth in Azure and server products that are powered by SQL Server and other database technologies. This growth is fueled by increased adoption of cloud-based solutions, infrastructure-as-a-service, and platform-as-a-service offerings, which are key revenue drivers for the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9750,
        "completion_tokens": 169,
        "total_tokens": 9920
      }
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The total change in the fair value of Insurance Buy‑in Contracts from 31 Dec 2022 to 31 Dec 2024 is an increase of $440 million (from $950 million to $1,390 million). This change is reflected in the year‑end balances as $1,605 million at 31 Dec 2023 and $1,390 million at 31 Dec 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57054,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14482,
        "completion_tokens": 71,
        "total_tokens": 14553
      }
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "Based on the document, as of December 31 2024 the TI common stock held in the U.S. and non‑U.S. defined‑contribution plans was valued at $852 million in the United States and $34 million internationally. Dividends paid on those shares during 2024 were $26 million in the United States and were not material for the non‑U.S. plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56180,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14265,
        "completion_tokens": 82,
        "total_tokens": 14348
      }
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in the 2022 10-K was $1,250 million. This amount is greater than the combined principal of the 3.900%, 4.450%, and 5.200% Senior Notes, which totaled $2,250 million ($1,000 million + $750 million + $500 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 170,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 33968,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8727,
        "completion_tokens": 70,
        "total_tokens": 8797
      }
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "Based on the provided pages, the total weighted-average grant-date fair value of all Service-Based RSUs that were outstanding at the beginning of the year (1,827 thousand shares at Dec 31 2023) and remained outstanding at the end of 2024 (1,807 thousand shares) is $183.41 per share. This figure reflects the weighted‑average grant‑date fair value for the Service‑Based RSUs as reported in Table 10.1.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 135,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 135,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36902,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9457,
        "completion_tokens": 100,
        "total_tokens": 9558
      }
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS evaluates uncertain tax positions through a two-step process: first, it determines whether a tax position is more likely than not to be sustained upon audit; second, if it meets this threshold, it measures the largest tax benefit that is more likely than not to be realized upon settlement. This assessment, detailed in the Income Taxes note, requires judgment about the probability of various outcomes and is reevaluated quarterly based on changes in facts, tax law, or audit activity, which could result in recognizing a tax benefit or an additional charge to the tax provision. The measurement of these benefits depends on the likelihood of ultimate settlement and is inherently subjective.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36147,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9296,
        "completion_tokens": 174,
        "total_tokens": 9470
      }
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0 % during the same year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 22103,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 5742,
        "completion_tokens": 36,
        "total_tokens": 5778
      }
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "The increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021 was 14.9%, rising from $2,994 million to $3,440 million. This growth contributed to the overall Vision segment sales increase of 19.6% during the same period, as Vision total sales rose from $3,919 million in 2020 to $4,688 million in 2021, with Contact Lenses/Other representing a key component of this growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37852,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9684,
        "completion_tokens": 98,
        "total_tokens": 9782
      }
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "The consolidation of AspenTech into Emerson’s financial statements contributed to a significant rise in the Control Systems & Software segment’s earnings and margin in 2023 versus 2022, with segment earnings rising 21% to $529 million and margin expanding 2.9 percentage points to 20.3% (reflecting favorable pricing, volume leverage and mix, partially offset by higher intangibles amortization). However, in the subsequent 2024 fiscal year, after the full integration of AspenTech and the acquisition of Test & Measurement, the segment’s earnings fell 33% to $282 million and its margin dropped 6.4 percentage points to 5.2%, driven primarily by $560 million of incremental intangibles amortization related to the Test & Measurement acquisition and the lower-margin nature of that business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43873,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11192,
        "completion_tokens": 197,
        "total_tokens": 11389
      }
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "Visa recorded a total monetary liability of $1,441 million for U.S. covered litigation in fiscal 2022. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of the company’s class B preferred stock into class A common stock, which reduces the amount of preferred stock that must be issued to settle the covered claims.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61943,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15708,
        "completion_tokens": 98,
        "total_tokens": 15807
      }
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "Based on the provided document pages, the total financial impact of Pfizer's historical ownership of Meridian in 2021 was an after-tax loss of $167 million related to the sale of Meridian, as noted in the Selected Quarterly Financial Data (Unaudited) section for the fourth quarter of 2021. This loss is explicitly stated as part of the post-closing adjustments directly related to the discontinued Meridian business, which was sold on December 31, 2021. The document also references a pre-tax charge of $345 million in the second quarter of 2021 to resolve a legal matter related to Meridian, but the primary financial impact from the sale itself was the $167 million after-tax loss recorded in Q4 2021. No additional operational results or adjustments beyond this sale-related loss are detailed in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49833,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12673,
        "completion_tokens": 204,
        "total_tokens": 12878
      }
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "The minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, is 5.0 % (the regulatory minimum SLR of 5 % plus the required leverage buffer of 2 %).  \n\nFor its insured depository institution subsidiaries, the required SLR is higher – 6.0 % – which is the minimum SLR needed to be deemed “well‑capitalized” under the Prompt Corrective Action framework. Thus, the parent‑company SLR minimum is 5 % while its bank subsidiaries must hold at least 6 % SLR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74774,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18937,
        "completion_tokens": 132,
        "total_tokens": 19069
      }
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "The adoption of the credit loss guidance on January 1, 2020 required MetLife to recognize an allowance for credit losses (ACL) at acquisition for mortgage loans and other financing receivables, rather than waiting for an incurred loss. Consequently, credit losses are recorded in earnings within net investment gains (losses) as soon as the expected lifetime credit loss can be estimated, and the loan balances are presented net of that ACL. Prior to that date, the company used an incurred‑loss model, recognizing credit losses only when it was probable that all amounts due would not be collected.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 172,
          "pages": [
            170,
            171,
            172,
            173,
            174
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51345,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13071,
        "completion_tokens": 149,
        "total_tokens": 13221
      }
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The Company adopted the new credit‑loss guidance on January 1 2020, which required it to record an allowance for expected lifetime credit losses on leveraged‑lease receivables and mortgage‑loan portfolios rather than using the prior incurred‑loss model. Under the new methodology, expected losses are estimated using a probability‑of‑default and loss‑given‑default model for leveraged leases (incorporating third‑party credit ratings and historical default data) and a methodology comparable to that used for commercial mortgage loans for direct‑financing leases. The allowance is based on pooled leases with similar risk characteristics, the contractual term (adjusted for expected prepayments and extensions), and current and forecasted economic conditions. Consequently, the timing of loss recognition shifted from recognizing impairments only when a loss was incurred to recording an ACL up front, and the methodology moved from a simple incurred‑loss test to a forward‑looking, model‑based estimate of lifetime credit loss.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 233,
          "pages": [
            231,
            232,
            233,
            234,
            235
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57794,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14690,
        "completion_tokens": 257,
        "total_tokens": 14947
      }
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments' structural cost advantage stems from its strategic investment in 300-millimeter wafer manufacturing, which reduces production costs by approximately 40% per chip compared to older 200-millimeter technology. This manufacturing efficiency, combined with its focus on analog and embedded processing products, enables the company to generate strong cash flow from operations—$8.76 billion in 2021—providing the financial foundation to return significant capital to shareholders through dividends and stock repurchases totaling $4.41 billion. The company explicitly links this manufacturing advantage to its ability to sustain long-term free cash flow growth and maintain its competitive edge in the semiconductor market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32476,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8361,
        "completion_tokens": 183,
        "total_tokens": 8544
      }
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "The 1.5‑Year Floating Rate (SOFR + 0.35%) Senior Notes issued by Thermo Fisher Scientific had a principal amount of **$1,000 million** as of December 31, 2021. This compares with the **$500 million** principal amount of the Floating Rate (SOFR + 0.39%) 2‑Year Senior Notes due October 18, 2023 that were outstanding on the same date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49594,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12636,
        "completion_tokens": 83,
        "total_tokens": 12719
      }
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "As of December 31, 2023, the 2020 Stock Incentive Plan had 53 million shares remaining available for future issuance, while the 1993 Employee Stock Purchase Plan had 17 million shares available. Combined, these plans provide 70 million shares for future issuance, with the 2020 Stock Incentive Plan offering the larger remaining allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54939,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13970,
        "completion_tokens": 85,
        "total_tokens": 14055
      }
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "Based on the provided document pages, the total liability for postemployment benefits reported by CAT in 2023 was **$701 million** (non-current liability for postemployment benefits). This figure represents the liability recognized in Statement 3 for postemployment benefits, which includes both pension and other postretirement benefit obligations.  \n\nThe pension benefits freeze (effective December 31, 2019) impacted financial reporting by eliminating service cost and certain assumptions (e.g., rate of compensation increase) for U.S. pension plans. This freeze caused actuarial gains/losses to primarily reflect changes in discount rates and other assumptions rather than service cost, as noted in the \"Postretirement Benefit Plans\" section and \"Actuarial Assumptions\" tables. Specifically, the freeze led to a shift in how actuarial losses/gains were calculated—focusing on discount rate changes and asset return differences rather than service cost—resulting in mark-to-market adjustments that directly affected earnings in other income (expense). This is evident in the 2023 mark-to-market gain of $97 million, driven by higher actual returns on plan assets and favorable claims experience, partially offset by lower discount rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57957,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14711,
        "completion_tokens": 310,
        "total_tokens": 15021
      }
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "The total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans was $2,555 million, compared with $2,797 million in the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67300,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17052,
        "completion_tokens": 55,
        "total_tokens": 17108
      }
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "Based on the provided document pages, specifically the \"Stock-Based Compensation\" section under Note 18, the 2007 Omnibus Incentive Plan authorized approximately 135 million shares for issuance since its inception. As of December 31, 2024, approximately 47 million shares remain available for issuance under the plan (excluding shares underlying outstanding awards). This includes shares available for future stock options, RSUs, and PSUs under the plan's terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58188,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14811,
        "completion_tokens": 115,
        "total_tokens": 14926
      }
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The growth in Google Play's contribution to non-advertising revenue can pressure overall profit margins because non-advertising revenues (such as Google Play, hardware, and YouTube subscriptions) typically carry lower margins than Google's core advertising business. As these non-advertising streams expand, they dilute the company's revenue mix toward lower-margin categories, potentially reducing aggregate profitability unless offset by higher-margin growth elsewhere.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40920,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10466,
        "completion_tokens": 117,
        "total_tokens": 10584
      }
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS does not use specific financial instruments to hedge credit‑quality risk; instead, it manages credit‑quality exposure through maintaining high average credit‑quality ratings and diversified sector exposure in its debt‑securities portfolio, and it expects the use of derivative instruments (e.g., interest‑rate swaps, credit‑default swaps) to reduce overall risk when employed for hedging purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30976,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7960,
        "completion_tokens": 100,
        "total_tokens": 8061
      }
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $682 million for U.S. pension assets and $38 million for non‑U.S. pension assets, with no additional hedge‑fund exposure reported for other postretirement benefit plans. Consequently, the combined investment in hedge funds/limited partnerships for the two plan types totals **$720 million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54823,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13918,
        "completion_tokens": 108,
        "total_tokens": 14027
      }
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "As of December 31 2024, Union Pacific reports owning 33,704 freight cars and leasing 22,472, for a total of 56,176 freight cars.  The company’s 2024 capital plan calls for roughly $3.4 billion in spending, which includes about $143 million of lease‑buyout purchases of freight cars.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42376,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10819,
        "completion_tokens": 70,
        "total_tokens": 10890
      }
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The changes in non‑marketable equity securities contributed $9.8 billion of unrealized gains to other income (expense), net, in 2021, which drove the overall increase in other income (expense) from $6.9 billion in 2020 to $12.0 billion in 2021. This net gain of roughly $9.8 billion reflects the $12.4 billion cumulative gain on non‑marketable equity securities held at year‑end 2021, offset by $122 million of unrealized losses (including impairment). Consequently, the net contribution of these investments to the rise in other income (expense) between 2020 and 2021 is approximately $9.8 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50680,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12900,
        "completion_tokens": 149,
        "total_tokens": 13050
      }
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The Company's forward contracts associated with its ASR transactions executed in 2022 and 2023 were classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40777,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10426,
        "completion_tokens": 68,
        "total_tokens": 10494
      }
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, addresses restrictions under the Internal Revenue Code of 1986 by providing eligible employees with supplemental retirement benefits that exceed the limits imposed by the Code. Specifically, the plan offers salary deferrals and employer matching contributions to participants whose 401(k) Plan benefits are constrained by IRS regulations, ensuring they can save additional pre-tax amounts while maintaining compliance with tax code limitations on contribution caps and eligibility. This structure allows the Company to enhance retirement savings opportunities for employees without violating IRS contribution restrictions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46717,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11920,
        "completion_tokens": 180,
        "total_tokens": 12100
      }
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31 2023 was $700 million, which represents the balance on TDAC’s secured uncommitted lines of credit. This amount is well below the total borrowing capacity of $1.8 billion available under CSC and CS&Co’s uncommitted external bank lines (no amounts outstanding) and below the $63.1 billion additional capacity provided by pledged collateral under the FHLB facilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34530,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8860,
        "completion_tokens": 113,
        "total_tokens": 8973
      }
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "Based on the provided document pages, the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was **$850 million** (as shown in the pension plan assets table under \"Mutual, pooled and commingled funds\" with a total of $850 million for 2021). The combined total value of hedge funds/limited partnerships and real estate investments was **$1,109 million** ($720 million for hedge funds/limited partnerships + $389 million for real estate). Therefore, the total value of these investments combined ($1,109 million) is **$259 million higher** than the mutual, pooled, and commingled funds investment ($850 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53764,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13682,
        "completion_tokens": 164,
        "total_tokens": 13846
      }
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "LTIP units are treated as participating securities for earnings‑per‑share calculations because they receive distributions equal to 10 % of the regular quarterly distributions on Operating Partnership units. Consequently, the two‑class method must allocate earnings to these LTIP units, which reduces the amount of earnings attributable to common stock per share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49463,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12610,
        "completion_tokens": 90,
        "total_tokens": 12700
      }
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "Based on the provided document pages, the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, is not explicitly stated. However, the document indicates that NEE holds an approximately 52.6% noncontrolling interest in X PLR, primarily through its limited partner interest in X PLR OpCo, and accounts for this ownership interest as an equity method investment. The document also references that NEE's investment in principal entities (including X PLR) totaled approximately $6,118 million at December 31, 2024, but this represents the total equity method investment across multiple entities, not specifically the noncontrolling interest in XPLR OpCo. The noncontrolling interest related to XPLR OpCo is not quantified in the provided text. Regarding classification, the entity is classified as a variable interest entity (VIE) in NEE's financial reporting structure, as noted in Note 9, where NEE consolidates certain VIEs within the NEER segment but does not consolidate X PLR OpCo due to not having a controlling financial interest, and accounts for its ownership interest as an equity method investment. \n\n(Note: The document does not provide the specific dollar amount for NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024; it only describes the ownership structure and classification.)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55238,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14043,
        "completion_tokens": 339,
        "total_tokens": 14383
      }
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde uses three primary distribution methods to supply process gases: on‑site (tonnage), merchant (bulk liquid), and packaged (cylinder) gases. The on‑site method differs from the other two in that its contracts are typically long‑term (often 10‑20 years) and require customers to meet minimum purchase volumes, whereas merchant and packaged contracts are usually shorter (3‑7 years) and do not impose such minimum purchase requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62834,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15943,
        "completion_tokens": 109,
        "total_tokens": 16052
      }
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The February 2022 20‑for‑one stock split was contingent on stockholder approval of an amendment to the company’s charter to increase the authorized share count, and it could proceed only after that approval was obtained. The split was authorized by the Board of Directors, which had previously (in April 2021) authorized a $50 billion repurchase program for Class C stock, but the split itself required the separate shareholder vote to increase authorized shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50813,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12952,
        "completion_tokens": 115,
        "total_tokens": 13068
      }
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "Based on the provided document pages, GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to Ultium Cells Holdings LLC as of December 31, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80228,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20286,
        "completion_tokens": 64,
        "total_tokens": 20350
      }
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "The Coca‑Cola Company reported total investments in hedge funds and limited partnerships of $720 million within its pension plan assets and $9 million within other post‑retirement benefit plan assets, for a combined total of $729 million. This dual reporting reflects the company’s broader exposure to alternative‑investment vehicles, showing that such investments are held both directly in the pension fund portfolio and indirectly through other post‑retirement benefit trusts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53526,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13641,
        "completion_tokens": 119,
        "total_tokens": 13760
      }
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The risk factor notes that “the increasing use of the Internet by retailers and consumers” and “the shift of market share from shopping at physical stores to web‑based shopping” could reduce demand for retail space and force Simon Property Group to re‑lease space at lower rates or on less favorable terms. This makes it harder for the company to lease spaces and maintain its rental rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49289,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12552,
        "completion_tokens": 97,
        "total_tokens": 12650
      }
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The corporate income tax legislation enacted in Arkansas reduced UNP’s deferred tax expense by $34 million in 2024 (and $114 million in 2023), while the 2022 impact from Arkansas legislation was $95 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47438,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12083,
        "completion_tokens": 51,
        "total_tokens": 12135
      }
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE’s limited‑partner interest in XPLR OpCo could become a material financial strain if XPLR cannot obtain capital on commercially reasonable terms—such a shortfall would impair XPLR’s ability to fund acquisitions or growth projects, reduce the cash distributions that flow to NEE, and force NEE to either provide additional financing or absorb losses, thereby weakening NEE’s overall liquidity and potentially increasing its borrowing costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54914,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13953,
        "completion_tokens": 110,
        "total_tokens": 14063
      }
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "The fair value of mortgage‑backed obligations reported in the “Marketable securities” section ($236 million) differs from the “Fair Value” column of the marketable securities table ($236 million) only in that the table presents the fair‑value amount directly, whereas the section lists it alongside amortized cost and unrealized gains/losses as part of the overall securities breakdown. In other words, the $236 million figure appears in both places, but the table’s “Fair Value” column is the designated fair‑value column for that line item.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15181,
        "completion_tokens": 135,
        "total_tokens": 15316
      }
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "The revenue recognition method for Google Play requires that we report app sales and in‑app purchases on a **net basis** because our performance obligation is to facilitate a transaction between app developers and end users, and we earn only a service fee. This net‑basis treatment reduces the amount of revenue we record for these transactions, thereby lowering the reported non‑advertising revenue figure and, consequently, affecting overall margins. As the share of non‑advertising revenues—driven by Google Play, hardware, YouTube subscriptions, and Google Cloud—continues to grow, the lower‑margin nature of these revenues increasingly drags down the company’s overall profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41607,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10627,
        "completion_tokens": 172,
        "total_tokens": 10799
      }
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "The total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023 was $0.8 billion, compared with $1.4 billion committed in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50466,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12833,
        "completion_tokens": 43,
        "total_tokens": 12876
      }
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "Based on Note 2 (Acquisitions), Mastercard paid a total cash consideration of **$2.8 billion in 2024** for all acquisitions, of which **$2.7 billion** was the cash paid for the Recorded Future acquisition. The purchase price allocation shows **$1.736 billion of goodwill** recorded as part of the 2024 acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13246,
        "completion_tokens": 78,
        "total_tokens": 13325
      }
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "The UNP 10‑K does not disclose a specific dollar amount for freight‑car lease buyouts over the 2022‑2024 period, nor does it provide a quantitative link between any such buyouts and the 2025 capital plan. Consequently, the requested total spend and its relationship to the 2025 acquisition strategy cannot be determined from the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11931,
        "completion_tokens": 86,
        "total_tokens": 12017
      }
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "Based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023, the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $1.5 billion (the 2022 ASR) plus $2.0 billion (the 2023 ASR) plus $3.0 billion (the 2024 ASR), totaling $6.5 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9560,
        "completion_tokens": 92,
        "total_tokens": 9652
      }
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM's near-term profitability relies heavily on high-margin full-size ICE trucks and SUVs, which fund its EV transition. However, this dependency creates a structural risk: as global regulations, consumer shifts toward fuel efficiency, and EV adoption accelerate, demand for these profitable ICE vehicles could decline faster than anticipated, undermining the cash flow needed to subsidize EV development and potentially triggering losses on EV inventory and battery investments. This creates a critical tension between short-term financial stability and long-term strategic EV goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61795,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15699,
        "completion_tokens": 145,
        "total_tokens": 15845
      }
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "The uncertainty surrounding the pace of the energy transition—driven by volatile commodity prices and evolving regulatory frameworks—directly influences Chevron’s asset impairment assessments and upstream investment decisions. Management evaluates potential impairments when downward revisions to reserves or price outlooks occur, and prolonged low commodity prices can trigger write‑downs of upstream assets, while also prompting a more cautious approach to new upstream projects and capital allocations toward lower‑carbon initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50179,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12776,
        "completion_tokens": 134,
        "total_tokens": 12911
      }
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard’s Consumer Engagement Services—part of its broader payment solutions—enhance the company’s global payments network by driving higher transaction volume and value through increased consumer interaction, engagement, and usage of its brands. This expanded engagement fuels growth in gross dollar volume and cross‑border activity, directly boosting net revenue and overall financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52421,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13326,
        "completion_tokens": 100,
        "total_tokens": 13426
      }
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "The total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025 was $0.4 billion, calculated as the $0.4 billion acquisition cost in fiscal 2023 offset by $0.7 billion in proceeds from the deconsolidation sale in fiscal 2025. This resulted in a net cash outflow of $0.4 billion over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59564,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15120,
        "completion_tokens": 93,
        "total_tokens": 15213
      }
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023 is zero, as the disclosures state that “no securities had a material dilutive effect” for 2023 (and prior years). Consequently, no adjustment was made to net income attributable to common stockholders because the potentially dilutive securities (LTIP units) would not have altered earnings per share or diluted earnings per share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47549,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12126,
        "completion_tokens": 105,
        "total_tokens": 12231
      }
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ is $4,432 million (pension) and $5 million (health‑care and life), for a combined total of $4,437 million. This NAV‑measured amount is significantly smaller than the total investments at fair value, which are $13,536 million for pension assets and $466 million for health‑care and life assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55472,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14092,
        "completion_tokens": 102,
        "total_tokens": 14194
      }
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "In 2023, GM reported equity earnings of **$293 million** from its investment in Ultium Cells Holdings LLC. These earnings were disclosed in the consolidated financial statements under “Equity in net assets of nonconsolidated affiliates” within the notes to the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81008,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20468,
        "completion_tokens": 70,
        "total_tokens": 20538
      }
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "The change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) fell from 0.8 % in 2023 to 0.7 % in 2024, reflecting a modest reduction in their share of the total equity. This shift indicates a slight re‑balancing of ownership toward public investors and the Mastercard Foundation, with Class B holders now representing a smaller portion of both equity ownership and voting power in Mastercard’s overall capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54628,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13879,
        "completion_tokens": 115,
        "total_tokens": 13994
      }
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "Based on the provided document pages, the total financial impact on Walmart (WMT) related to Alert Innovation during fiscal 2023 was a $0.4 billion acquisition cost (recorded as part of the purchase of the entity, which was later sold and deconsolidated in fiscal 2025). This entity was acquired in fiscal 2023 as part of the Company's consolidation of its ownership from a variable interest entity to 100% ownership. In the following fiscal year (fiscal 2025), this entity was subsequently sold and deconsolidated, meaning it no longer contributed to Walmart's financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58743,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14910,
        "completion_tokens": 145,
        "total_tokens": 15055
      }
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "Based on the provided document pages, the total principal repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024 was $1.5 billion (comprising $500 million repaid on January 12, 2024 for the 0.600% senior notes and $1.0 billion repaid on February 14, 2024 for the 5.00% senior notes). As of December 31, 2023, this repayment reduced the facility’s remaining borrowing capacity to approximately $4.5 billion (down from the $6.0 billion maximum, after accounting for the $3.0 billion drawn and $6.1 billion repaid during 2023).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 136,
          "pages": [
            132,
            133,
            134,
            135,
            136
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42250,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10792,
        "completion_tokens": 137,
        "total_tokens": 10930
      }
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel's use of EUV in Intel 4 and Intel 3 nodes is a critical step in its advanced transistor architecture roadmap, enabling smaller, more efficient features for upcoming products like Meteor Lake. The progression continues toward Intel 20A, which will introduce Ribbon FET and PowerVia technologies, followed by Intel 18A, which will incorporate High Numerical Aperture (High-NA) EUV as a key advancement in its process technology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 54406,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13840,
        "completion_tokens": 108,
        "total_tokens": 13948
      }
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "Based on the provided 2023 10-K filing data, the total combined value of investments in U.S. Treasuries and agencies across both disclosed asset categories (pension and postretirement benefit plans) is **$1,412 million** for the pension plans (as shown in the \"Pension Plans\" table under \"Fair values for the pension plans by asset category at December 31, 2023\"). This figure represents the total fair value of U.S. Treasuries and agencies held within the pension plan assets, which is the only disclosed category containing this investment type. \n\nThe total cash and cash equivalents reported across both disclosed asset categories (pension and postretirement benefit plans) is **$1,956 million** for the pension plans (as shown in the same table under \"Cash and cash equivalents\" for 2023), plus **$27 million** for the postretirement benefit plans (as shown in the \"Health Care and Life Plans\" table), totaling **$1,983 million**. \n\nHowever, the question specifically asks for the comparison to \"total cash and cash equivalents\" as reported in the filing. The filing explicitly states \"Cash and cash equivalents\" as a distinct asset category within the pension plans ($1,956 million) and separately for postretirement plans ($27 million), but the total cash and cash equivalents across all plans is **$1,983 million**. The U.S. Treasuries and agencies investment ($1,412 million) is **not** part of cash and cash equivalents, as it is classified under \"Fixed income securities\" (specifically \"U.S. Treasuries and agencies\" as a separate line item). Therefore, the total combined value of U.S. Treasuries and agencies ($1,412 million) is **less than** the total cash and cash equivalents ($1,983 million), but the question does not require a comparative statement—only the total value of the U.S. Treasuries and agencies investments. \n\n**Answer:** The total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories is $1,412 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55472,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14096,
        "completion_tokens": 497,
        "total_tokens": 14593
      }
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "Based on the provided document pages, the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021 was **$10,901 million** (as shown in the \"Net cash consideration\" row of the table summarizing 2021 acquisitions). Of the total goodwill from these acquisitions, **$6,149 million was specifically attributed to Aldevron** (as shown in the \"Goodwill\" row of the same table, where Aldevron's goodwill is listed as $6,149 million within the \"Aldevron | Other | Total\" column). \n\n**Answer**:  \nThe total net cash consideration paid for Aldevron and the other 11 businesses acquired in 2021 was $10,901 million, and $6,149 million of the total goodwill was attributed specifically to Aldevron.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52167,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13268,
        "completion_tokens": 182,
        "total_tokens": 13450
      }
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "As of December 31, 2023, GM’s total committed capital contribution to Ultium Cells Holdings LLC was $800 million, which matches the $800 million carrying amount of its investment in Ultium Cells Holdings LLC reflected on the balance sheet for that date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13047,
        "completion_tokens": 63,
        "total_tokens": 13111
      }
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million, which exceeds the net book value of proved and unproved properties in that region ($74,014 million) by a relatively small amount—approximately 7.7% of the net book value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 157,
          "pages": [
            155,
            156,
            157,
            158,
            159
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65727,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16670,
        "completion_tokens": 71,
        "total_tokens": 16742
      }
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "Based on the document, the company repaid an aggregate of $500 million of its 0.600 % senior unsecured notes due 2024 on January 12 2024 using borrowings under the 2021 Multicurrency Credit Facility. This repayment reduced the outstanding revolving indebtedness under that facility, contributing to the overall reduction of borrowings that occurred during 2023 (e.g., the company borrowed $3.0 billion and repaid $6.1 billion of revolving debt under the 2021 Multicurrency Credit Facility). Consequently, the repayment activity lowered the total revolving indebtedness outstanding under the facility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50324,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12814,
        "completion_tokens": 150,
        "total_tokens": 12964
      }
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 requires the company to submit and obtain approval for site-specific coal ash impoundment remediation and closure plans from state authorities before excavation can begin. This regulatory process, which includes costly excavation, transportation, and disposal of coal ash to engineered landfills or beneficial reuse sites, has been integrated into Duke Energy's rate cases, allowing recovery of these compliance costs through retail rates. As a result, the company has incurred significant operational expenses related to ash basin closure activities, particularly at high-priority sites in North Carolina, where excavation began in 2015 and has since expanded to other jurisdictions. These costs are recovered via rate mechanisms approved by the NCUC, PSCSC, and FPSC, ensuring that compliance does not directly depress earnings but adds to long-term operational expenditures tied to environmental remediation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 55649,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14145,
        "completion_tokens": 248,
        "total_tokens": 14393
      }
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel’s Agilex FPGA family provides the programmable fabric and high‑performance transceiver capabilities that are integrated into Intel’s IPU platforms (e.g., the Oak Springs Canyon reference platform) to accelerate networking, storage and AI workloads in cloud and edge environments.  The Intel eASIC N5X structured‑ASIC device, built on the same 10 nm SuperFin process, is used alongside the Agilex FPGAs to deliver lower‑cost, lower‑power, faster‑time‑to‑market acceleration for 5G and other latency‑sensitive applications, thereby extending the performance and efficiency benefits of Intel’s IPU architecture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41087,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10490,
        "completion_tokens": 153,
        "total_tokens": 10643
      }
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher reports approximately 24,000 employees in North America and 3,000 employees in other developed markets (Japan, Australia, New Zealand), collectively representing about 43% of its total global workforce of roughly 63,000 employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48213,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12275,
        "completion_tokens": 59,
        "total_tokens": 12335
      }
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "The total fair value of Nike's foreign exchange forwards and options designated as hedging instruments was $313 million as of May 31, 2023, which represented the aggregate of the $269 million recorded in prepaid expenses and other current assets and the $44 million recorded in deferred income taxes and other assets. This $313 million of derivative assets is the amount shown for \"Total derivatives formally designated as hedging instruments\" in the balance‑sheet table, and it matches the total derivative assets reported on the balance sheet for the same year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12346,
        "completion_tokens": 140,
        "total_tokens": 12487
      }
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased from $5,729 million in 2022 to $5,729 million in 2023 (i.e., it remained unchanged), while the number of productive wells in the Lower 48 rose from 118 gross (124 net) in 2022 to 14,251 gross (6,954 net) in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56913,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14467,
        "completion_tokens": 78,
        "total_tokens": 14545
      }
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "Based on the provided pages from Verizon's 2023 10-K filing, the total combined value of investments in U.S. Treasuries and agencies reported across both tables is **$1,412 million** (as shown in the \"Pension Plans\" fair value table for 2023 under \"U.S. Treasuries and agencies\"). This allocation represents a significant portion of the fixed income securities, where U.S. Treasuries and agencies constitute **$1,412 million** of the total $9,104 million in total investments at fair value for pension plans. The allocation between the two categorizations (Level 1 and Level 2/3) shows that U.S. Treasuries and agencies are primarily classified as Level 1 ($1,274 million) with a smaller Level 2 component ($138 million), indicating a high degree of market transparency and liquidity in this segment of the portfolio. This allocation reflects a strategic emphasis on low-risk, high-quality fixed income assets to support pension liability matching.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57856,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14698,
        "completion_tokens": 237,
        "total_tokens": 14935
      }
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Based on the provided pages from Nike's 2024 Form 10-K, the company's \"timed deposits classified as cash and equivalents\" decreased from $1,002 million as of May 31, 2023, to $720 million as of May 31, 2024. This represents a decrease of $282 million over the fiscal year. The decrease is reflected in the \"Short-term investments\" section of the fair value measurements table in Note 4, where the total cash and equivalents (including timed deposits) declined from $7,441 million in 2023 to $9,860 million in 2024, but the specific timed deposits within short-term investments (which include the $720 million figure) show the reduction from the prior year's $1,002 million. \n\nThe exact decrease is $282 million (calculated as $1,002 million - $720 million). \n\n(Word count: 149)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36766,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9391,
        "completion_tokens": 194,
        "total_tokens": 9586
      }
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled **$6,790 million in 2023** (Alaska $1,061 M + Lower 48 $5,729 M). In 2022, the combined total was **$5,795 million** (Alaska $941 M + Lower 48 $4,854 M), representing an increase of about $995 million year‑over‑year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 139,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66419,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16831,
        "completion_tokens": 81,
        "total_tokens": 16913
      }
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "The total fair value of the crypto asset safeguarding liability and the corresponding safeguarding asset reported by PayPal as of December 31 2022 is $1,241 million for each, as shown in the “Financial assets and liabilities measured and recorded at fair value on a recurring basis” table in Note 9. This amount is reflected in the fair‑value measurement disclosures as a Level 2 financial liability and asset, valued using quoted prices in an active market for the underlying crypto assets (significant other observable inputs).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56478,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14356,
        "completion_tokens": 132,
        "total_tokens": 14488
      }
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "Based on the provided document pages, the net financial impact of Walmart's ownership changes in PhonePe during fiscal 2024 was a cash outflow of $3.5 billion to acquire shares from Flipkart non‑controlling interest holders and a cash inflow of $0.7 billion from new equity funding for PhonePe. This resulted in a net cash impact of approximately $2.8 billion for the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13930,
        "completion_tokens": 93,
        "total_tokens": 14023
      }
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $77 million (41 %). This growth was driven largely by higher volumes of KWH sales and additional capacity under wholesale contracts, partially offset by lower average prices. The IIC‑approved affiliate sales mechanism, which governs sales between the system’s generating subsidiaries, ensured that affiliate wholesale transactions were conducted at marginal cost and therefore did not materially affect earnings, while still contributing to the overall rise in reported wholesale revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43760,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11171,
        "completion_tokens": 149,
        "total_tokens": 11320
      }
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Based on the disclosed investments for Arizona ($20 billion for two new fabs), Ohio (more than $20 billion for two leading‑edge fabs), and advanced packaging sites ($10.5 billion), Intel plans to invest roughly **$50 billion** in manufacturing expansion under its IDM 2.0 strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 37299,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9544,
        "completion_tokens": 70,
        "total_tokens": 9615
      }
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher recorded approximately $3.9 billion of goodwill related to its acquisition of Abcam. The Veralto separation generated roughly $2.6 billion of net cash distributions to Danaher prior to the distribution date, which the company used (in part) to redeem about $1 billion of commercial paper and to fund bond maturities and dividend payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46548,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11859,
        "completion_tokens": 86,
        "total_tokens": 11946
      }
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal 2024 was $24 million, which is reflected in \"Other (income) expense, net\" on the consolidated statements of income. This gain is part of the $270 million total gain recognized in income from all derivatives for the year, and it is recorded at fair value on the balance sheet, where the related derivative assets and liabilities totaled $343 million in assets and $151 million in liabilities at year‑end.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48125,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12264,
        "completion_tokens": 124,
        "total_tokens": 12388
      }
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations ($55,912 million) and equity affiliates ($13,272 million) is $69,184 million. This exceeds the 2022 depreciation, depletion, amortization, and impairments for the Lower 48 region ($36,446 million) by $22,738 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 159,
          "pages": [
            157,
            158,
            159,
            160,
            161
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61117,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15525,
        "completion_tokens": 84,
        "total_tokens": 15610
      }
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "The total value of Loans and Interest Receivable, Held for Sale reported by PayPal as of December 31 2023 was $563 million. This amount is classified as Level 3 in the fair‑value hierarchy, meaning its fair value is determined using significant unobservable inputs—specifically, the price at which the Company expects to sell the loans based on its agreement with a global investment firm.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53445,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13593,
        "completion_tokens": 97,
        "total_tokens": 13690
      }
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During the year ended December 31 2023, the company borrowed **$3.0 billion** and repaid **$6.1 billion** of revolving indebtedness under the 2021 Multicurrency Credit Facility. By contrast, under the 2021 Credit Facility it borrowed **$3.1 billion** and repaid **$2.6 billion** of revolving indebtedness over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47273,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12060,
        "completion_tokens": 81,
        "total_tokens": 12141
      }
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "The audit procedures applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs involved testing management’s controls over the likelihood of recovery of incurred costs, refunds, and future rate reductions, and evaluating regulatory orders to assess the probability of cost recovery. These procedures highlighted the subjectivity in assessing future regulatory orders, as they required management to make significant judgments about the likelihood of cost recovery or refunds based on precedents and regulatory decisions, which inherently involve uncertainty and could impact the accounting for regulatory assets and liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 140,
          "pages": [
            138,
            139,
            140,
            141,
            142
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50027,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12750,
        "completion_tokens": 172,
        "total_tokens": 12923
      }
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The decline in Comirnaty revenue in 2023—driven by lower contracted deliveries, transition to new variant vaccines, and the shift to traditional U.S. commercial market sales—directly reduced Pfizer’s total revenue and gross margins, contributing to a $9.4 billion drop in cost of sales and a $1.1 billion increase in SG&A expenses. The collaboration agreement with BioNTech, which includes shared development costs, royalty sharing, and milestone payments, created ongoing financial obligations such as the $225 million upfront payment and potential $200 million sales milestones, while also generating alliance revenue that partially offset the revenue loss; however, the reduced sales of Comirnaty also triggered a $3.5 billion non‑cash revenue reversal and lowered net periodic benefit costs, further affecting Pfizer’s operational results and future cash‑flow commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85025,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21478,
        "completion_tokens": 219,
        "total_tokens": 21697
      }
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "Based on the provided financial statements, specifically Note 4 (Fair Value Measurements) and the accompanying tables showing short-term investments, the value of U.S. Agency securities held as short-term investments was $35 million as of May 31, 2024, compared to $46 million as of May 31, 2023. This represents a year-over-year decrease of $11 million. Therefore, the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023, is a decrease of $11 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36766,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9402,
        "completion_tokens": 136,
        "total_tokens": 9538
      }
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was a decrease of $77, resulting from the repayment of $77 of notes during the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33363,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8562,
        "completion_tokens": 50,
        "total_tokens": 8612
      }
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "The total value of 3M's stand‑alone letters of credit, bank guarantees and similar instruments is $0.5 billion. This amount is modest compared with the $7.7 billion of cash, cash equivalents and marketable securities the company held as of December 31 2024 (about $4.2 billion of which was in the United States).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15983,
        "completion_tokens": 78,
        "total_tokens": 16061
      }
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "In Q4 2023, Meta estimated that duplicate accounts represented roughly 10 % of its worldwide MAUs, while false (violating) accounts accounted for about 4 % of worldwide MAUs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56324,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14298,
        "completion_tokens": 43,
        "total_tokens": 14341
      }
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Pfizer paid BioNTech a $75 million upfront cash payment (plus a $150 million equity investment) for the shingles mRNA vaccine collaboration, whereas the upfront payment to Biohaven for migraine‑treatment rights outside the U.S. was $150 million. Thus, the BioNTech upfront amount ($75 million) is roughly half of the Biohaven upfront amount ($150 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 77109,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19506,
        "completion_tokens": 89,
        "total_tokens": 19595
      }
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "Based on the provided document pages, the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024 is $120 million when considering both hedging and non‑hedging instruments. This figure is derived from the “DERIVATIVELIABILITIES” column in the table that lists fair‑value measurements of derivative assets and liabilities, which shows $115 million in accrued liabilities and $5 million in other long‑term liabilities for the hedging instruments, plus an additional $5 million in accrued liabilities for non‑hedging foreign‑exchange forwards, totaling $120 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48475,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12340,
        "completion_tokens": 150,
        "total_tokens": 12491
      }
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal’s crypto‑asset safeguarding liability reflects its obligation to protect customer‑held digital assets, which is disclosed as a specific liability alongside a corresponding safeguarding asset. This liability is included in the company’s risk‑concentration disclosures, highlighting that a significant portion of its exposure stems from customer‑held crypto balances that must be fully backed by high‑quality, liquid assets. Consequently, the company’s credit‑risk exposure is tied to the credit quality of the institutions that hold these customer funds and the potential for losses if those assets become impaired or uninsured.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51976,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13227,
        "completion_tokens": 158,
        "total_tokens": 13386
      }
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "The 2019 LTIP plan issued 871,680 restricted shares of Simon common stock and 689,202 LTIP units, net of forfeitures.  These LTIP units do not create new dilution for the year ended December 31, 2024 because they are exchangeable into common stock only upon vesting and were not reflected as dilutive securities in the earnings‑per‑share calculations.  Consequently, the LTIP units had no material impact on potential stock dilution for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49417,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12576,
        "completion_tokens": 110,
        "total_tokens": 12686
      }
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "Based on the provided document pages, the total financial impact on 3M's earnings per diluted share from manufactured PFAS products was **$0.28 in 2024** and **$0.90 in 2022**. This represents a significant decrease in the PFAS-related impact on diluted earnings per share from $0.90 in 2022 to $0.28 in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84064,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21232,
        "completion_tokens": 77,
        "total_tokens": 21309
      }
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "The 2024 volume declines in wholesale KWH sales to non-affiliates (a 30.8% drop driven by ended power sales agreements) and the 165.5% surge in sales to affiliates (due to higher affiliated energy needs) under the IIC directly shaped Southern Company’s wholesale revenue performance, with non-affiliate wholesale revenues falling $87 million (20.5%) and affiliate wholesale revenues rising $79 million (131.7%) year‑over‑year. These volume shifts, combined with pricing changes, resulted in a net $47 million increase in wholesale revenue for the Southern Company system in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65670,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16648,
        "completion_tokens": 144,
        "total_tokens": 16793
      }
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission imposed a €1.2 billion administrative fine on Meta Platforms Ireland and issued corrective orders requiring Meta to suspend unlawful data transfers and bring its processing into GDPR compliance. Compliance with these orders will likely increase Meta’s operating costs in Europe by necessitating additional legal, technical and administrative measures to ensure lawful cross‑border data flows and to avoid further penalties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58062,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14751,
        "completion_tokens": 115,
        "total_tokens": 14866
      }
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "The Home Depot’s focus on offering deep product assortments and the ability to sell large job‑lot quantities gives it a distinct advantage in serving professional customers (Pros), who need specialized items, consistent supply and bulk pricing to manage complex projects. If the company fails to maintain this depth and job‑lot capability, it risks losing Pros to competitors, eroding market share and weakening its overall competitiveness.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53820,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13699,
        "completion_tokens": 110,
        "total_tokens": 13809
      }
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $83 million (as reported at December 31, 2021). This exclusion reflects the complexity of valuing the annuity’s underlying debt securities and the actuarial present‑value calculation of the accumulated benefit obligation, which together require a Level 3 valuation approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54024,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13743,
        "completion_tokens": 99,
        "total_tokens": 13842
      }
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal estimates credit losses for merchant receivables using loss curves combined with macroeconomic forecasts that incorporate factors such as unemployment rates and retail e‑commerce sales trends, applying these inputs over a 2.5‑ to 3.5‑year forecast horizon. For consumer receivables (excluding those classified as held‑for‑sale), the allowance is driven primarily by loss curves applied by geography, delinquency and origination period, and also incorporates macroeconomic forecasts—specifically trends in household disposable income and retail e‑commerce sales—over a projected period of roughly 5 to 7 months for revolving products and 3.5 years for installment products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53410,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13583,
        "completion_tokens": 169,
        "total_tokens": 13752
      }
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco’s heavy reliance on Kirkland Signature—through significant investments in its development and protection—means that any erosion of the brand’s reputation or member trust could directly damage loyalty and reduce the high‑margin private‑label sales that differentiate Costco. At the same time, the company’s dependence on its own manufacturing and distribution facilities creates supply‑chain vulnerabilities; disruptions or cost increases in these operations can squeeze margins and force price changes that may alienate members, thereby threatening both brand loyalty and gross‑margin performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34328,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8825,
        "completion_tokens": 151,
        "total_tokens": 8976
      }
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The total grant date fair value of performance-based LTIP units awarded under the 2021 and 2022 LTI Programs is $18.4 million for 2021 and $20.6 million for 2022, for a combined total of $39.0 million. This exceeds the grant date fair value of the time‑based restricted stock units awarded in those same years, which totaled $6.9 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53593,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13625,
        "completion_tokens": 84,
        "total_tokens": 13710
      }
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "As of December 31 2024, 3M held U.S. municipal securities with a fair value of **$20 million**, and these securities are classified as **Level 3** in the fair‑value hierarchy because they are valued using a method that references the carrying value of the related finance‑lease obligation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58273,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14796,
        "completion_tokens": 72,
        "total_tokens": 14868
      }
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "Based on the provided document pages, Meta estimated that approximately **3% of its worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts** (e.g., bots and spam). This estimation was derived from an internal review of a limited sample of accounts, using machine learning models calibrated against user survey data, and required significant judgment due to inherent challenges in measurement.  \n\nThe process reflects key challenges in identifying such accounts across encrypted platforms like WhatsApp, as Meta explicitly states it has **\"limited visibility into WhatsApp user activity due to encryption\"**. This lack of access to detailed behavioral data (e.g., relying only on phone numbers and device information for matching accounts) severely restricts the ability to detect violating accounts within encrypted ecosystems, making the estimation inherently uncertain and prone to potential undercounting or error margins beyond the reported 3%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49020,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12492,
        "completion_tokens": 245,
        "total_tokens": 12737
      }
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Based on the provided document pages, specifically the \"Collaboration with BioNTech\" section under \"Notes to Consolidated Financial Statements\" (Note 2), the total amount of upfront payments and equity investments made by Pfizer in its collaboration with BioNTech for the Comirnaty (COVID-19 vaccine) program is $225 million, which includes a $75 million upfront cash payment and a $150 million equity investment. However, the document does not provide specific details about upfront payments or equity investments made by Pfizer for a shingles vaccine program. The collaboration with BioNTech for shingles vaccine development is mentioned as a separate agreement (dated December 30, 2021) where Pfizer agreed to pay BioNTech $225 million (including $75 million upfront cash and $150 million equity investment), but this is for the shingles vaccine program specifically, not for both the shingles vaccine and Comirnaty programs combined. The document does not indicate any separate upfront payment or equity investment for the Comirnaty program beyond the $225 million total for the shingles vaccine collaboration, and the Comirnaty program was established under a separate April 2020 agreement. Therefore, the total amount for both programs as of December 31, 2023, cannot be determined from the provided information, as the shingles vaccine collaboration is distinct from the Comirnaty program and the document does not specify separate amounts for each program in the context of the question. The $225 million figure refers specifically to the shingles vaccine collaboration agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74187,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18778,
        "completion_tokens": 397,
        "total_tokens": 19175
      }
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "The total net income contribution from ConocoPhillips' operations in Europe, Middle East and North Africa (EMENA) over the 2019–2021 period was $674 million (comprising $695 million of impairment expense in 2021, $6 million in 2020 and $1 million in 2019), which represented a credit relative to the Lower 48 region’s net loss of $804 million in 2020 and $402 million in 2019.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 31566,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8128,
        "completion_tokens": 94,
        "total_tokens": 8222
      }
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The dollar amount decrease in \"Other noncontrolling redeemable interests\" from 2023 to 2024 is $3.72 million (from $172,912 thousand to $169,192 thousand). This reduction contributed to the overall decline in \"Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties\" of $11.22 million, decreasing from $195,949 thousand in 2023 to $184,729 thousand in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51500,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13120,
        "completion_tokens": 100,
        "total_tokens": 13220
      }
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "As of December 31 2024, the combined fair value of foreign corporate debt and asset‑backed securities held by 3M was **$31 million** ( $31 million for foreign corporate debt + $24 million for asset‑backed securities ). This represents an increase from the prior year, when the combined fair value of these two categories was **$0 million** (the prior‑year tables show $0 for both foreign corporate debt and asset‑backed securities).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14225,
        "completion_tokens": 108,
        "total_tokens": 14333
      }
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "Technical errors and data limitations in Meta's Family metrics estimation process can cause inaccuracies in its monthly active people (MAP) and average revenue per person (ARPP) metrics, leading to potential variations of approximately 3% in MAP estimates. These inaccuracies arise from challenges in measuring usage across large global populations, reliance on complex machine learning models with inherent statistical uncertainties, and limitations in data signals—particularly for encrypted products like WhatsApp—resulting in possible discrepancies between reported metrics and actual user numbers or trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49069,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12511,
        "completion_tokens": 153,
        "total_tokens": 12664
      }
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot’s BOPIS program is a core element of its “interconnected retail” strategy, allowing customers who shop online to pick up their orders at any store location. By using BOPIS (Buy Online, Pickup In Store), the company can fulfill roughly half of its U.S. online orders directly from stores, leveraging its extensive store footprint to provide faster, more convenient delivery and to drive additional in‑store traffic and sales. This integrated fulfillment model supports the company’s goal of offering the fastest, most reliable delivery options while maintaining a competitive cost structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46064,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11739,
        "completion_tokens": 151,
        "total_tokens": 11890
      }
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley recognizes compensation expense for Deferred Cash-Based Compensation (DCP) awards based on the notional value of the award adjusted for changes in the fair value of the referenced investments, with expense recognized over the vesting period of each separately vesting portion. In contrast, carried interest compensation expense is recognized for any portion of carried interest (both realized and unrealized) allocated to employees, with no specific timing detail provided beyond the general recognition of such expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 138,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 78572,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19882,
        "completion_tokens": 133,
        "total_tokens": 20016
      }
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024 is $184,729 thousand (approximately $184.7 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49553,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12619,
        "completion_tokens": 59,
        "total_tokens": 12678
      }
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The combined estimated fair value of NEE’s nuclear decommissioning fund assets and FPL’s storm fund assets as of December 31, 2021 is **$8,922 million** ($8,846 million for the nuclear decommissioning fund plus $76 million for the storm fund). This exceeds the carrying amount of NEE’s special‑use funds on its consolidated balance sheet—**$7,703 million** for the nuclear decommissioning fund and **$76 million** for the storm fund, for a total of **$7,779 million**—by roughly **$1,143 million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15896,
        "completion_tokens": 124,
        "total_tokens": 16021
      }
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC serves as both a geographic operating segment and a reporting region in Cisco’s consolidated financial statements, with its revenue and performance measured separately from the Americas and EMEA segments. This dual role means Cisco tracks APJC-specific revenue, gross margin, and asset allocation to evaluate regional performance, but excludes segment-specific operating expenses like R&D or SG&A from its internal performance metrics, which are allocated only at the corporate level. Consequently, APJC’s results directly influence Cisco’s overall financial reporting while its operational efficiency is assessed independently to guide regional resource allocation and strategic decisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51869,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13203,
        "completion_tokens": 173,
        "total_tokens": 13377
      }
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "Verizon Business Group contributed $29.5 billion in total operating revenue in 2024, of which $13.1 billion (about 44 % of the segment’s revenue) came from the “Business Markets and Other” category. This segment incorporates FWA broadband by offering fixed‑wireless access service through its 5G and 4G LTE networks, providing an alternative to traditional land‑line internet access for both Consumer and Business customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51870,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13191,
        "completion_tokens": 106,
        "total_tokens": 13297
      }
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "The fair value of Abbott’s interest rate hedge contracts at the end of 2024 was approximately $391 million, which is far smaller than the total notional amount of its foreign‑currency forward contracts—about $16.2 billion—held at that same date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54041,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13739,
        "completion_tokens": 61,
        "total_tokens": 13801
      }
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "The analysis of proved undeveloped reserves versus net acreage in Asia indicates that ExxonMobil holds substantial undeveloped acreage (e.g., 1,186 k acres undeveloped in Asia for consolidated subsidiaries and 272 k acres undeveloped for equity companies) while maintaining a relatively modest number of development wells (e.g., 0.9 net development wells in Indonesia, 1 net well in Kazakhstan, and 1.5 net wells in Malaysia). This suggests that the company’s development potential in the region is constrained by the scale of its undeveloped land base, requiring significant capital investment to convert acreage into producing reserves. Compared with its consolidated subsidiaries, which demonstrate higher efficiency in land utilization—evidenced by a larger developed acreage base (12,234 k net acres) and a more robust track record of converting undeveloped reserves to developed status (e.g., 1.1 GOEB transferred in 2024)—the equity‑company operations appear less efficient, relying on fewer wells and smaller acreage increments to advance development. Consequently, while the region offers considerable upside through its expansive undeveloped holdings, the current development pace and land‑use efficiency lag behind the company’s broader consolidated performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53898,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13716,
        "completion_tokens": 318,
        "total_tokens": 14034
      }
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company’s unconditional guarantee of Morgan Stanley Finance LLC’s securities is a key component of its broader resolution‑planning framework. Under the amended and restated support agreement, the Parent is required to contribute all of its contributable assets to supported entities (including the Funding IHC) in a resolution scenario, with those contributions secured by the Parent’s assets and the Funding IHC’s assets. This guarantee therefore ensures that, if a resolution event occurs, the Parent’s obligation to fund its subsidiaries is backed by its full asset base, reinforcing the firm’s overall recovery plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 147,
          "pages": [
            145,
            146,
            147,
            148,
            149
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 86201,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21800,
        "completion_tokens": 157,
        "total_tokens": 21958
      }
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The Bipartisan Budget Act of 2015 shifts partnership tax‑audit adjustments to the partnership level, meaning that if a joint‑venture partnership (such as those with Klépierre, The Taubman Realty Group, LLC, or other entities) incurs an IRS audit adjustment, the partnership itself must pay the additional tax, interest and penalties. Because Simon Property Group holds its joint‑venture interests through the Operating Partnership, it could be required to bear a share of those taxes even though the REITs themselves would not face the same corporate‑level tax consequences. This exposure could increase the overall tax burden on Simon’s investments and affect the cash available for debt service and distributions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58610,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14893,
        "completion_tokens": 178,
        "total_tokens": 15072
      }
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "The 2020 impairment of the AMMROC investment – a $128 million non‑cash charge recorded in “Other, net” – reduced net earnings from continuing operations by roughly $96 million (about $0.34 per share after tax). In 2021, RMS incurred $36 million of severance and restructuring charges ($28 million, or $0.10 per share after tax) related to facility closures and workforce reductions. Together, these items lowered net earnings and diluted earnings‑per‑share in their respective years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35392,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9072,
        "completion_tokens": 120,
        "total_tokens": 9193
      }
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The year‑over‑year change in the balance of channel‑partner financing subject to guarantees was a decrease of $0.5 billion (from $1.7 billion as of July 29 2023 to $1.2 billion as of July 27 2024).  This reduction lessens the cash‑flow risk associated with those guarantees and therefore improves Cisco’s overall liquidity and capital‑resource position, as noted in the MD&A discussion of financing guarantees and the related deferred‑revenue offsets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48841,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12442,
        "completion_tokens": 112,
        "total_tokens": 12555
      }
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The total value of “Investments measured at NAV” is $2,656 million for the pension‑plan asset category and $3 million for the other postretirement‑benefit‑plan asset category. Therefore, the pension‑plan category has the higher NAV‑measured investment value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49411,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12573,
        "completion_tokens": 64,
        "total_tokens": 12637
      }
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott’s Diabetes Care business generated an 18.1% revenue increase in 2024, driven by strong growth in continuous glucose monitoring (CGM) systems and related sales, as reflected in the “Diabetes Care” line showing a 18.1% total change (19.7% excluding foreign‑exchange impact). This revenue is recognized under the **Revenue Recognition** accounting policy described in Note 1, which records product sales when control transfers—generally upon shipment or delivery—while also allocating the transaction price to multiple performance obligations (e.g., instruments, reagents, service agreements) based on estimated standalone selling prices. The policy permits the use of a returns reserve and requires allocation of the transaction price to each performance obligation, ensuring that Diabetes Care revenue is recorded when the promised goods or services are delivered.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49816,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12689,
        "completion_tokens": 217,
        "total_tokens": 12906
      }
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "The Home Depot’s 2024 10‑K emphasizes that Pros expect “project planning tools, dedicated sales support, competitive credit and pricing options, product depth and job‑lot quantities, and differentiated fulfillment options” (p. 9).  By investing in tools that streamline project planning and fulfillment—such as the Pro Xtra loyalty program, expanded credit offerings, and an enhanced order‑management system—the company creates a differentiated, tech‑enabled experience that directly addresses these expectations.  This focus on project‑planning capabilities strengthens Home Depot’s competitive positioning against other Pros‑focused retailers, allowing it to win more complex, high‑value contracts and capture greater market share in the professional segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53820,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13682,
        "completion_tokens": 190,
        "total_tokens": 13872
      }
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "Based on the provided document pages, the total number of shares available for award as of the end of 2024 is explicitly stated in the \"Equity Compensation Plan Information\" table under Item 12. The note clarifies that available shares include 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan. Summing these values gives 47,088,821 + 238,700 + 9,362,383 = 56,689,904 shares. This total represents the number of shares remaining available for future issuance under these plans, as confirmed in the document. \n\n**Answer:**  \nThe total number of shares available for award under the specified plans as of the end of 2024 is 56,689,904.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41474,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10611,
        "completion_tokens": 206,
        "total_tokens": 10818
      }
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The reclassification of Customer receivables in 2023 reduced interest income by $4,432 million and increased interest expense by the same amount, with the entire impact recorded within the Institutional Securities segment. This adjustment is explicitly tied to a $4,432 million financial adjustment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 136,
          "pages": [
            134,
            135,
            136,
            137,
            138
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 108601,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27390,
        "completion_tokens": 74,
        "total_tokens": 27465
      }
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined are $133 million (2019) plus $75 million (2021), which equals **$208 million**.  \n\nNet investment hedge derivatives, as disclosed, consist of **cross‑currency interest rate swaps and forward contracts** that are used to hedge a portion of the company’s net investments in its non‑U.S. operations. These instruments are designated as accounting hedges for net investment risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47879,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12209,
        "completion_tokens": 124,
        "total_tokens": 12333
      }
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their 2021 amendments was $5.8 billion, and the maximum aggregate outstanding balance observed during the year ended December 31, 2021 was $2.1 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49052,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12505,
        "completion_tokens": 66,
        "total_tokens": 12571
      }
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The increase in risk retirements on the Black Hawk and CH‑53K programs in 2021 contributed approximately $80 million of operating profit to RMS, as disclosed in the RMS performance‑segment discussion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48423,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12337,
        "completion_tokens": 50,
        "total_tokens": 12387
      }
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "Based on the provided document pages, the total financial impact of energy-related derivatives on Southern Company's natural gas revenues and cost of natural gas in 2021 was a **$144 million pre-tax loss** (as shown in the \"Non-Designated Hedging Relationships\" table under \"Energy-related derivatives\" with a total of **$ (144)** for 2021). This $144 million loss comprised **$ (117) million** deducted from natural gas revenues and **$ (27) million** deducted from the cost of natural gas. \n\nFor 2019, the combined impact was a **$233 million pre-tax gain** (as shown in the same table with a total of **$ 233** for 2019), which included **$ 223 million** added to natural gas revenues and **$ 10 million** added to the cost of natural gas. \n\nThus, the 2021 impact ($144 million loss) was the opposite of the 2019 impact ($233 million gain), representing a significant reversal in the financial effect of these derivatives on Southern Company's natural gas-related income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52442,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13334,
        "completion_tokens": 243,
        "total_tokens": 13578
      }
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "The change in Cisco's losses from privately held investments between 2023 and 2024 was a decrease of $29 million (from a $193 million loss in 2023 to a $164 million loss in 2024). This reduction contributed to a net improvement of $11 million in the overall “Net gains (losses) on investments” figure, which moved from a $177 million loss in 2023 to a $166 million loss in 2024. Consequently, the overall net gains (losses) on investments were lower (i.e., less negative) by roughly $11 million, partially offset by higher losses in available‑for‑sale debt investments and other items.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52698,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13387,
        "completion_tokens": 146,
        "total_tokens": 13534
      }
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "Based on the provided document pages, the total principal repayment made by Verizon in connection with anticipated redemptions of ABS Notes in 2024 was $4.5 billion. This is explicitly stated in the \"ABS Notes\" section under \"Under the terms of each series of ABS Notes outstanding as of December 31, 2024...\" where it notes: \"During the years ended December 31, 2024 and 2023, we made aggregate principal repayments of $4.5 billion and $3.7 billion, respectively, in connection with anticipated redemptions of ABS Notes...\" \n\nRegarding the comparison to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, the document states: \"The aggregate outstanding balance under the 2021 ABS Financing Facility was $8.0 billion as of December 31, 2024\" and \"The aggregate outstanding balance under the 2022 ABS Financing Facility was $5.0 billion as of December 31, 2024.\" Therefore, the combined aggregate outstanding balance of both facilities is $8.0 billion + $5.0 billion = $13.0 billion. \n\nThe $4.5 billion principal repayment made in 2024 is thus compared to an aggregate outstanding balance of $13.0 billion for the 2021 and 2022 ABS Financing Facilities as of December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51950,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13222,
        "completion_tokens": 307,
        "total_tokens": 13530
      }
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL capital transition provisions require that the remaining $720 million CECL benefit be reflected in CET1 capital, and that the phased‑out CECL provisions affect Tier 2 capital, adjusted average assets, total leverage exposure and RWA. Consequently, when calculating the Tier 1 leverage ratio and applying the Standardized approach to First Republic‑related assets, the Firm must use the adjusted‑asset figures and the RWA estimates that incorporate the transition‑rule allowances (e.g., the $43.3 billion of Standardized RWA and $52.4 billion of Advanced RWA for First Republic assets). This ensures the leverage ratio and risk‑weighted calculations reflect the reduced capital benefit and the regulatory transition adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 303,
          "pages": [
            301,
            302,
            303,
            304,
            305
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61778,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15673,
        "completion_tokens": 184,
        "total_tokens": 15857
      }
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon maintains board independence and ethical conduct through governance principles, independent director requirements, and a Code of Business Conduct and Ethics that applies to all officers, directors, and employees. At least a majority of its Board members qualify as independent under NYSE listing standards, with Audit and Compensation Committees composed entirely of independent members meeting NYSE independence and financial expert requirements. These policies align with NYSE rules mandating independent directors and ethical oversight for listed companies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51888,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13181,
        "completion_tokens": 141,
        "total_tokens": 13322
      }
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "The percentage‑of‑completion cost‑to‑cost method requires Lockheed Martin to estimate total contract costs at completion; when estimates are revised, the profit‑booking rate is adjusted and the resulting change in profit is recognized in the period the estimate is updated. Consequently, any increase or decrease in the estimated total cost (or variable consideration) directly impacts the amount of profit recognized, and those adjustments are recorded in the same reporting period in which the revised estimates are determined.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41350,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10578,
        "completion_tokens": 132,
        "total_tokens": 10710
      }
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The combined increase in Services Revenue for the APJC region from 2023 to 2024 was $89 million (a 4 % rise), while the APJC Total Balance grew by $89 million (also a 4 % increase). Thus, both figures rose by the same 4 % amount.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42287,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10800,
        "completion_tokens": 57,
        "total_tokens": 10857
      }
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "Based on the provided document pages, Abbott's total notional value of interest rate hedge contracts was $2.2 billion and foreign currency forward exchange contracts totaled $23.2 billion as of December 31, 2024. These financial instruments are part of Abbott's strategy to manage market risk by hedging exposure to interest rate fluctuations and foreign currency exchange rate movements, respectively, thereby mitigating potential adverse impacts on cash flows and earnings from these market variables. The combined exposure reflects a proactive approach to risk management within Abbott's overall financial strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33664,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8651,
        "completion_tokens": 154,
        "total_tokens": 8806
      }
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "The 2024 10‑K confirms that McDonald’s consolidates only entities in which it has a controlling financial interest; most franchisees are not consolidated because they qualify for the variable‑interest‑entity scope exception. Consequently, the company’s consolidated balance sheet reflects only its own assets and liabilities, and the franchisees’ operations are presented separately as part of “revenues from restaurants operated by franchisees” and related fees. This consolidation policy means that the materiality of franchisee‑related transactions is assessed only for their impact on the company’s own cash flows, working‑capital changes and equity‑related items (e.g., treasury‑stock purchases, dividend payments) rather than for inclusion in the consolidated income‑statement totals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64436,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16335,
        "completion_tokens": 197,
        "total_tokens": 16532
      }
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "The SLR is calculated using adjusted average assets that are reduced by deductions such as goodwill and other intangibles, and it adds off‑balance‑sheet exposures to the denominator; this adjusted‑asset base, together with the firm’s Tier 1 capital, determines the leverage ratio. If the SLR falls below the required 5 % (or the 5 % minimum plus any applicable buffers), the firm would be restricted from paying dividends, repurchasing shares, or making discretionary bonus payments to executives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52038,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13244,
        "completion_tokens": 124,
        "total_tokens": 13368
      }
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31 2021, the borrowings under the Credit Facilities totaled $125.0 million under the revolving Credit Facility and $1.05 billion under the Supplemental Facility. The Supplemental Facility’s maximum borrowing capacity, as set by its amended terms, is $3.5 billion (with a possible increase to $4.5 billion).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49444,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12588,
        "completion_tokens": 80,
        "total_tokens": 12668
      }
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "The total notional amount of outstanding interest rate swaps at the end of 2021 was $500 million, compared with $572 million at the end of 2020—a decrease of about 12.6 %.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38191,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9774,
        "completion_tokens": 42,
        "total_tokens": 9816
      }
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The disagreement between Georgia Power and the other Vogtle Owners over cost‑sharing provisions means that any additional capital‑cost increases above the agreed thresholds will not be recovered from retail customers; instead, those costs will be absorbed as pre‑tax charges to income. This is illustrated by the $440 million pre‑tax charge recorded in the fourth quarter of 2021 (and potential further $460 million charges) that reflects the cost‑sharing and tender provisions of the joint ownership agreements, which are not recoverable from customers. Consequently, Georgia Power’s financial exposure is heightened because it must bear these unrecoverable cost escalations while still being responsible for its proportionate share of the project’s financing and construction expenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 52379,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13319,
        "completion_tokens": 196,
        "total_tokens": 13516
      }
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media ARR of **$12.24 billion** at the end of fiscal 2021. The Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence for businesses is **Adobe Experience Platform**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45889,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11717,
        "completion_tokens": 58,
        "total_tokens": 11776
      }
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "Based on the provided pages from Abbott's 2024 10-K filing, the total fair value of interest rate hedge contracts reported as of December 31, 2024 is $765 million (liability position), compared to $745 million (liability position) as of December 31, 2023. This information is specifically shown in the table summarizing derivative financial instruments on page 40 of the document, which lists \"Fair Value -Liabilities\" for interest rate swaps at $51 million (2024) and $95 million (2023), but the total liability position for all interest rate hedge contracts is reflected in the consolidated summary of $765 million (2024) versus $745 million (2023) in the \"Fair value of hedged long-term debt\" disclosure on page 63. The contracts are designated as fair value hedges for fixed-rate debt, with the liability position representing the fair value of the hedge instruments themselves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45919,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11715,
        "completion_tokens": 220,
        "total_tokens": 11936
      }
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "The combined total of discounted future net cash flows from equity companies in Asia is $60,780 million, which represents approximately 0.30 percent of the total proved reserves (oil‑equivalent) for equity companies in Asia (about 13,006 million barrels).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 134,
          "pages": [
            132,
            133,
            134,
            135,
            136
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75053,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18996,
        "completion_tokens": 63,
        "total_tokens": 19060
      }
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate using Basel III Standardized RWA and the GSIB surcharge, which together determine the firm’s required capital buffers. This allocation ensures compliance with the leverage‑based regulatory framework, specifically meeting the 3.0 % supplementary leverage ratio (SLR) and the additional 2.0 % leverage buffer mandated by the Basel III SLR requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52038,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13268,
        "completion_tokens": 105,
        "total_tokens": 13373
      }
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "Based on the provided document pages, the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post-amendments in 2021 is $5.8 billion. The interest rate structure for Daily SOFR Loans under both facilities is identical: SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49052,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12510,
        "completion_tokens": 103,
        "total_tokens": 12613
      }
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The increase in Sikorsky helicopter program production volume in 2021 drove higher net sales and product costs for RMS, with both metrics rising by approximately $794 million in net sales and $560 million in product costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43095,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11005,
        "completion_tokens": 55,
        "total_tokens": 11060
      }
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "Gains and losses from restaurant business sales are recorded in operating income as part of the Company's recurring transactions with franchisees, driven by its franchise arrangements that allocate consideration between lease (rental income) and non‑lease components (royalties and initial fees). These transactions, disclosed in the “Gains on sales of restaurant businesses” line within Other operating (income) expense, net, are reflected in the financial statements as part of operating income, with related gains or losses recognized when the Company sells restaurants to franchisees or acquires restaurants from them.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55956,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14218,
        "completion_tokens": 155,
        "total_tokens": 14374
      }
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "The 2023 financial impact of Chevron’s derivative commodity instruments was limited, with net gains/losses from derivatives affecting income by only $‑505 million (a $33 million reclassification from AOCL to revenue) and fair‑value assets of $159 million versus liabilities of $262 million. These instruments are integral to Chevron’s risk‑management program, monitored daily by its internal Risk Control group, and are recorded at fair value for balance‑sheet reporting while gains/losses flow through the income statement. The company’s fair‑value hierarchy places most commodity derivatives in Level 1 or Level 2, reflecting observable market prices and third‑party broker quotes, supporting consistent valuation and effective hedging of commodity price risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56912,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14470,
        "completion_tokens": 190,
        "total_tokens": 14660
      }
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "Based on the provided capital components table (page 102), the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital, is $720 million. This $720 million benefit is explicitly stated in note (b) of the capital components table as part of the CET1 capital adjustments, reflecting the remaining CECL capital transition provision benefit that was fully phased in as of January 1, 2025. The allowance for credit losses included in Tier 2 capital ($20,992 million as of December 31, 2024) is accounted for separately in the Tier 2 capital reconciliation but does not directly alter the $720 million CECL benefit figure for CET1 capital. The $720 million represents the net impact of the CECL transition provisions on CET1 capital, distinct from the credit loss allowance component.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58362,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14824,
        "completion_tokens": 236,
        "total_tokens": 15060
      }
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "Based on the provided document pages, the total financial impact of GE's AerCap-related transactions in 2023 was a net gain of $38 million from the AerCap investment. This includes $129 million of realized and unrealized gains reported in Note 19 for the AerCap investment during 2023, which contributed to the overall $5,778 million gain (including other items) reported in that note. The document indicates that the AerCap-related gains were part of the $5,778 million total other income (loss) for 2023, but the specific net impact attributable solely to AerCap transactions is $38 million (as shown in the \"Investment in and note with AerCap realized and unrealized gain (loss)\" line item).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59178,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15020,
        "completion_tokens": 173,
        "total_tokens": 15193
      }
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Based on the provided document pages, Merck transferred a total consideration of **$2.7 billion** to acquire Immune Design (as detailed in the ArQule acquisition context, where Immune Design was acquired for $301 million in cash, with additional intangible assets and goodwill recorded). Of this total consideration, **$20 million** was allocated to goodwill, as explicitly stated in the Immune Design acquisition description: \"The excess of the consideration transferred over the fair value of net assets acquired of $20 million was recorded as goodwill.\" This allocation reflects the portion of the $301 million transaction price attributed to goodwill after fair value adjustments to identifiable net assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46763,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11915,
        "completion_tokens": 177,
        "total_tokens": 12093
      }
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees contribute to McDonald's revenue primarily through rent and royalties based on a percentage of sales, with specified minimum rent payments, and initial fees paid upon opening new restaurants. Additionally, co-investment by McDonald's in franchisee restaurant improvements—where the Company shares capital costs for modernization—impacts depreciation expense by allowing the Company to allocate a portion of those costs to property and equipment, which is then depreciated over the useful life of the improvements (typically 3–10 years for capitalized software or up to 40 years for buildings), resulting in accelerated depreciation expense when such investments are capitalized and depreciated.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62340,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15816,
        "completion_tokens": 176,
        "total_tokens": 15992
      }
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "The value of Goldman Sachs’ securities backed by real estate decreased by $9 million, from $207 million at December 2023 to $208 million at December 2024. The primary cause of the unrealized losses on Level 3 investments in 2023 related to this category was the ongoing weakness in the commercial real‑estate market, which drove losses on securities backed by real estate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 174,
          "pages": [
            172,
            173,
            174,
            175,
            176
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57444,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14597,
        "completion_tokens": 93,
        "total_tokens": 14690
      }
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "The document does not provide specific information about the additional cost incurred beyond the principal amount when repaying the CoreSite Debt, nor does it disclose the previously reported outstanding balance of the CoreSite Debt as of December 31, 2021. Consequently, the requested cost comparison cannot be determined from the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59160,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15021,
        "completion_tokens": 86,
        "total_tokens": 15108
      }
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "Based on the document, GE's collections from CFM International contributed to a $0.9 billion decrease in cash impacts from current receivables in 2024, driven by higher volume and improved collections. This financial interaction stems from GE's long‑term services agreements with CFM International, under which GE supplies parts and services and receives payments tied to engine utilization and usage‑based fees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64399,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16338,
        "completion_tokens": 103,
        "total_tokens": 16441
      }
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments, was $145 million. This increase reflects revenue growth driven by the Ohio tax reform deferrals and the Ohio electric rate case, partially offset by lower volumes and other factors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51554,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13122,
        "completion_tokens": 100,
        "total_tokens": 13223
      }
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe's Digital Media segment generated **$11.52 billion in total revenue for fiscal 2021**. Within that segment, **Creative Cloud contributed approximately $9.55 billion** (about 83 % of the segment’s revenue), while **Document Cloud contributed roughly $1.97 billion** (about 17 % of the segment’s revenue).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45413,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11588,
        "completion_tokens": 77,
        "total_tokens": 11665
      }
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments, was $316,784 thousand. This figure represents the net increase in marketing expenses ($316,784 thousand) as reported in the \"Marketing\" section of the financial statements, which explicitly includes advertising expenses and personnel-related costs for marketing activities. The breakdown shows a $222 million increase in advertising expenses and a $116 million increase in personnel-related costs, both contributing to the total marketing expense growth of $316,784 thousand year-over-year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 76200,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19275,
        "completion_tokens": 173,
        "total_tokens": 19449
      }
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "General Motors' equity earnings from Ultium Cells Holdings LLC are recorded in \"Automotive and other cost of sales\" and totaled $975 million in 2024, $293 million in 2023 and $8 million in 2022. This treatment reflects that Ultium Cells is a key strategic partner for GM’s electric‑vehicle battery supply chain, so the earnings are presented as a cost of sales rather than as separate investment income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 70169,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17783,
        "completion_tokens": 100,
        "total_tokens": 17883
      }
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average price of U.S. Henry Hub natural gas fell 59.7% in 2023 versus 2022 (from $6.36/Mcf to $2.56/Mcf). This decline was driven by high storage and production, with the price dropping further to $1.73/Mcf by mid-February 2024. In contrast, Chevron's international natural gas realizations averaged $7.69/Mcf in 2023 (down from $9.75/Mcf in 2022), reflecting lower LNG prices but still significantly higher than U.S. Henry Hub prices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45256,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11541,
        "completion_tokens": 109,
        "total_tokens": 11651
      }
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "The sensitivity of fair‑value measurements to credit‑spread movements is reflected in the Level 3 credit‑derivative balances, where a change in credit spreads directly affects the valuation of those instruments. As shown in the “Significant Unobservable Inputs” table, credit spreads range from 8 bps to 1,328 bps (average 134 bps/median 91 bps) and are a key driver of the Level 3 credit‑derivative asset of $1.218 bn (and liability of $1.650 bn in 2023). Consequently, variations in these spreads—particularly at the higher end of the range—produce material shifts in the fair‑value measurements of Goldman Sachs’ Level 3 credit derivatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64642,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16394,
        "completion_tokens": 160,
        "total_tokens": 16554
      }
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The repayment of the $955.1 million CoreSite Debt in January 2022 removed that liability from AMT’s balance sheet, reducing total long‑term obligations and the current portion of debt (which included the $955.1 million CoreSite Debt). The repayment amount matched the carrying value of the debt ($955.1 million), indicating that the debt was recorded at its fair value with no unamortized discount or premium, confirming that the balance‑sheet valuation was accurate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47839,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12202,
        "completion_tokens": 116,
        "total_tokens": 12318
      }
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "The ongoing tax examinations, which are expected to focus on intercompany transfer‑pricing practices, could require adjustments to Adobe’s unrecognized tax benefits. The company has reserved for potential decreases in those benefits, estimating a possible reduction of $0‑$5 million over the next 12 months, and believes such adjustments could materially affect its financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43768,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11187,
        "completion_tokens": 96,
        "total_tokens": 11283
      }
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "The combined growth percentage of alliance revenue related to Lenvima was 21% in 2021 and 44% in 2020, reflecting strong demand in the U.S. and China. This growth supports Merck's broader oncology strategy of leveraging combination therapies, exemplified by Keytruda's partnerships with Lenvima (e.g., in endometrial carcinoma and RCC) and other agents like Lynparza, to expand its targeted cancer portfolio and drive franchise growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47812,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12183,
        "completion_tokens": 108,
        "total_tokens": 12292
      }
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "Based on the provided document pages, GM's investment in Ultium Cells Holdings LLC in 2024 directly contributed to EBIT-adjusted performance through an increase of $0.7 billion in equity earnings related to Ultium Cells Holdings LLC, as explicitly stated in the \"Factors that most significantly influence a region's profitability\" section of the GM North America (GMNA) analysis. This contribution was quantified as part of the EBIT-adjusted improvement, where the $0.7 billion equity earnings from Ultium Cells was cited as a key positive factor offsetting other cost increases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56603,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14367,
        "completion_tokens": 144,
        "total_tokens": 14511
      }
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "The SEC’s new monthly short‑position reporting rule for institutional managers (effective January 2025) obligates Goldman Sachs’ registered security‑based swap dealers—such as GS Bank USA, GSBE and GSI—to incorporate that short‑position data into their existing SEC‑mandated reporting and disclosure obligations for derivatives. Because these entities are already subject to SEC rules on capital, margin, record‑keeping and public trade reporting for security‑based swaps, the new short‑position requirement extends their reporting scope, requiring additional disclosures about equity short positions alongside their regular security‑based swap reports. Consequently, Goldman Sachs must adjust its derivatives reporting practices to capture, aggregate and file the monthly short‑position data in compliance with the SEC’s new threshold‑based filing schedule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56578,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14384,
        "completion_tokens": 214,
        "total_tokens": 14598
      }
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "The remeasurement of PepsiCo’s 39% noncontrolling interest in TBG to fair value following the sale of its juice brands resulted in a $520 million gain recorded in 2022, driven by a combination of the transaction price, discounted cash‑flow and option‑pricing models that reflected PepsiCo’s liquidation preference in TBG. This gain was recognized in the PBNA and Europe divisions and contributed to the overall $3.26 billion net impact of the Juice Transaction, illustrating that the deal was structured as a cash sale to PAI Partners with PepsiCo retaining a 39% equity stake and significant influence over the newly formed joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43641,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11152,
        "completion_tokens": 159,
        "total_tokens": 11312
      }
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "In 2024, GE’s retained ownership interests—including its stake in Baker Hughes—generated $518 million of gains (losses) on retained and sold ownership interests, which contributed to total other income of $2.264 billion. This compares with $5.778 billion of such gains in 2023, indicating a substantial decline in the contribution from these retained interests year‑over‑year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58633,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14884,
        "completion_tokens": 94,
        "total_tokens": 14978
      }
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, is $236 million, and this amount represents approximately 0.004% of the total assets measured at fair value ($5,722 million) as of that date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85516,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21612,
        "completion_tokens": 59,
        "total_tokens": 21671
      }
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix’s varied membership plans across countries allowed it to tailor pricing and features to local market conditions, which drove a 7% rise in average monthly revenue per paying member in 2021. This increase, combined with an 11% growth in the number of paying members, produced a 19% overall revenue increase for the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57708,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14664,
        "completion_tokens": 81,
        "total_tokens": 14746
      }
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck's collaboration with Eisai on Lenvima, particularly through the LEAP clinical program, is expected to drive growth in its pharmaceutical segment revenue, especially via alliance revenue from Lenvima sales. While the LEAP-007 and LEAP-011 trials were discontinued due to futility, the ongoing LEAP-002 Phase 3 trial for first-line advanced HCC and other LEAP studies (e.g., in endometrial cancer and NSCLC) remain active, with Lenvima generating $704 million in alliance revenue in 2021. However, the FDA's Complete Response Letter for the HCC indication (based on KEYNOTE-524/Study 116) indicates that the combination with Keytruda did not meet accelerated approval criteria, meaning future revenue from this specific indication depends on the outcome of the LEAP-002 trial and potential regulatory approvals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46396,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11829,
        "completion_tokens": 203,
        "total_tokens": 12033
      }
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Based on the provided financial data, Chevron's total cost incurred by consolidated companies in 2023 was $24,559 million. This amount exceeds the combined total of expensed exploration costs ($0.5 million) and the PDC Energy acquisition cost ($6.52 billion) by $17.53 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56294,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14295,
        "completion_tokens": 69,
        "total_tokens": 14365
      }
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower determines the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component using a Monte Carlo simulation model, which calculates the probability of satisfying the market condition requirements based on multiple input variables. The specific market metric used is relative total shareholder return measured against the S&P 500 REIT Index constituents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56710,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14409,
        "completion_tokens": 104,
        "total_tokens": 14514
      }
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "Based on the provided pages from CAT_10k_2024.pdf, **four amendments** to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the filings. The **fourth amendment** became effective on **July 1, 2022**, as stated in the filing for \"Fourth Amendment to the Caterpillar Inc. Supplemental Employees' Investment Plan, effective as of July 1, 2022\" (referenced in Exhibit 10.14 of the Annual Report on Form 10-K for the year ended December 31, 2021, and further detailed in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2022).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75896,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19193,
        "completion_tokens": 143,
        "total_tokens": 19337
      }
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "The amortized cost of Corporate Notes and Obligations held by CRM was $2,574 million, while their fair value was $2,557 million, a difference of $17 million. This fair value is classified as Level 2 in the fair‑value hierarchy, meaning it is derived from observable market inputs but not from quoted prices in an active market for identical assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85864,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21700,
        "completion_tokens": 87,
        "total_tokens": 21787
      }
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Based on the provided document, Disney has secured financing for its new cruise ships through dedicated credit facilities. Specifically, it borrowed $1.1 billion under one facility for the Disney Treasure (delivered in October 2024) with a fixed interest rate of 3.80%, and has a second $1.1 billion facility available for the Disney Destiny (scheduled for fiscal 2026 delivery) with a fixed rate of 3.74%. The interest rates on these cruise ship facilities are fixed at 3.80% and 3.74%, respectively, and are payable semi-annually over 12 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41844,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10687,
        "completion_tokens": 136,
        "total_tokens": 10823
      }
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron’s 50 % equity stake in the Tengizchevroil joint venture represents roughly 3 % of its total equity‑method investment portfolio (about $3 billion of the $46.6 billion total equity‑method investments). This stake is a key component of its Kazakhstan operations, contributing significantly to the joint‑venture’s production volumes that help drive Chevron’s overall upstream output.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16108,
        "completion_tokens": 96,
        "total_tokens": 16205
      }
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A change in credit spreads or upfront credit points directly affects the fair value of Goldman Sachs' level 3 credit derivatives, with higher spreads or larger upfront points generally reducing the value of purchased credit protection (and increasing the value of written protection). The firm determines the fair value of these derivatives using valuation techniques that incorporate significant unobservable inputs—including credit spreads, upfront credit points, recovery rates, and correlation—typically applied through option‑pricing, correlation and discounted‑cash‑flow models. These inputs are derived from market‑based assumptions and are reflected in the level 3 rollforward tables and sensitivity analyses provided in the 2024 and 2023 fair‑value disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64642,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16386,
        "completion_tokens": 192,
        "total_tokens": 16578
      }
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "The potential failure to meet the Minimum DSCR under the 2015 Securitization and Trust Securitizations could trigger a cash‑trap, restricting excess cash flow from the securitized assets and preventing its distribution to AMT. This would limit the cash available to fund capital expenditures, acquisitions and other growth initiatives, thereby constraining AMT’s ability to finance the construction of communications sites globally as planned in its 2024 10‑K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57452,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14583,
        "completion_tokens": 116,
        "total_tokens": 14700
      }
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "The critical audit matter identified by PwC relates to Caterpillar’s product warranty liability, which is estimated by applying historical claim rates to the current field population and dealer inventory. This involves significant management judgment and actuarial assumptions, requiring auditors to perform independent actuarial analysis and evaluate the reasonableness of the historical claim rate assumptions. Based on the disclosed reconciliation of the warranty liability, the balance as of December 31, 2024, was $1,700 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38637,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9903,
        "completion_tokens": 133,
        "total_tokens": 10037
      }
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "The difference between Disney's stated interest rate on Asia Theme Parks borrowings (7.93%) and the effective interest rate applied to those borrowings (5.75%) reflects a lower actual cost of capital for the Asia Theme Parks debt, driven by favorable market conditions and the impact of interest rate swaps that reduce the effective borrowing cost below the nominal stated rate. This disparity indicates that the effective rate—accounting for swaps, hedges, and other adjustments—represents the true economic cost of capital for this debt category, which is notably lower than the higher nominal rate initially reported.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44288,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11305,
        "completion_tokens": 155,
        "total_tokens": 11460
      }
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $21 billion, and this acquisition was primarily responsible for contributing 2.2 trillion cubic feet (TCF) of purchases in the DJ basin.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 73427,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18583,
        "completion_tokens": 52,
        "total_tokens": 18636
      }
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "The adoption of the new LDTI accounting guidance required MetLife to retrospectively adjust its previously reported financial statements, primarily resulting in the reclassification of $7.4 billion of FPBs to PABs at the transition date and adjustments to additional insurance liabilities, DAC, and related balances. These adjustments were reflected in the consolidated balance sheet, income statement, comprehensive income, equity, and cash‑flow statements, with the net effect of a $3.5 billion reduction in total assets and a $6.4 billion reduction in total liabilities, leading to a $2.8 billion increase in total equity after the LDTI adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 163,
          "pages": [
            161,
            162,
            163,
            164,
            165
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 164,
          "pages": [
            162,
            163,
            164,
            165,
            166
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48514,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12369,
        "completion_tokens": 162,
        "total_tokens": 12532
      }
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "The Solar Turbines Incorporated Managerial Retirement Objective Plan has been amended twice, as documented in the filing. The most recent amendment was the Second Amendment, which became effective on January 1, 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 79924,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20206,
        "completion_tokens": 54,
        "total_tokens": 20260
      }
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina Rate Case Order impacted Duke Energy’s impairment of assets and other charges by reducing the charge by $13 million in 2024 (from $44 million in 2023), as noted in the “Impairment of assets and other charges” line item for Duke Energy Carolinas. This reduction was reflected in the consolidated statements of operations, contributing to a $525 million increase in operating income for Duke Energy Carolinas in 2024, which helped drive the overall net income rise to $1.883 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68253,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17307,
        "completion_tokens": 125,
        "total_tokens": 17432
      }
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "The licensed store model generates a modest but strategically important 12 % of Starbucks’ total net revenue. Although licensed locations deliver lower gross margins than company‑operated stores, they provide higher operating margins because the company earns both a margin on the branded products and supplies it sells to the licensee and collects ongoing royalties and license fees, while the licensees bear most operating costs and capital investments. This structure allows Starbucks to expand its global footprint with limited capital outlay and to leverage local partners’ market knowledge, offsetting the lower revenue per store with the cumulative financial benefit of these margin‑enhancing and cash‑flow contributions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52970,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13471,
        "completion_tokens": 182,
        "total_tokens": 13653
      }
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "Target’s owned and exclusive brands generate roughly one‑third of sales and deliver higher margins than national brands, but they require longer lead times and involve heightened responsible‑sourcing risks. If Target cannot successfully develop, source, and market these brands—especially amid supply‑chain disruptions, trade‑policy shifts, and sustainability expectations—the resulting inventory imbalances, higher markdowns, and reputational damage could erode profitability and weaken its competitive position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39644,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10173,
        "completion_tokens": 128,
        "total_tokens": 10301
      }
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "The Caterpillar Inc. Deferred Employees' Investment Plan has been amended four times, with the most recent two amendments incorporated by reference from the 2021 Annual Report (Form 10‑K) and the 2022 Quarterly Report (Form 10‑Q). Specifically, the Third Amendment (effective January 1, 2022) appears in the 2021 Form 10‑K (Exhibit 10.22), and the Fourth Amendment (effective July 1, 2022) is referenced in the 2022 Form 10‑Q (Exhibit 10.6).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 75896,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19205,
        "completion_tokens": 110,
        "total_tokens": 19316
      }
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "Based on the 2024 10-K filing (pages 82-89), **73 million shares remain available for future grant or issuance under the 2013 Equity Incentive Plan**, and **outstanding equity awards related to this plan include stock options (8 million outstanding, with 6 million exercisable) and restricted stock units/performance-based awards (26 million outstanding, with 23 million expected to vest)**. The plan also includes shares available under the 2014 Inducement Plan (1 million) and the ESPP (13 million), but the question specifically references the 2013 Equity Incentive Plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53896,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13700,
        "completion_tokens": 143,
        "total_tokens": 13843
      }
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Based on the provided document, the majority of Starbucks' Channel Development revenues are derived from the Global Coffee Alliance with Nestlé, specifically through product sales and royalties from this partnership. The document states that \"Most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.\" While the exact percentage of fiscal 2024 Channel Development revenues attributable to this alliance is not explicitly stated, the context confirms that the Global Coffee Alliance is the primary source of these revenues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39104,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10009,
        "completion_tokens": 150,
        "total_tokens": 10159
      }
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "Based on the provided pages from MetLife's 2023 10-K filing, the specific financial statements retrospectively adjusted due to the adoption of the new LDTI accounting guidance were the **consolidated balance sheet**, **consolidated statement of operations**, **consolidated statement of comprehensive income**, **consolidated statement of equity**, and **consolidated statement of cash flows**. The effects of these adjustments are illustrated in the tables presented as of **December 31, 2022** (and for comparative periods ending December 31, 2021), which detail the retrospective application of the LDTI guidance to previously reported financial statements. These tables show line-by-line impacts across assets, liabilities, equity, revenues, expenses, and cash flows, reflecting adjustments such as reclassification of additional insurance liabilities, changes to deferred policy acquisition costs, and impacts on retained earnings and accumulated other comprehensive income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 163,
          "pages": [
            161,
            162,
            163,
            164,
            165
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 166,
          "pages": [
            164,
            165,
            166,
            167,
            168
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13900,
        "completion_tokens": 244,
        "total_tokens": 14145
      }
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "Based on the provided document pages, the value of equity method investment contracts was not disclosed in the financial statements, but the document explicitly states that these contracts were included in the total derivative fair value reporting under \"Note 10. Financial Instruments\" as part of \"Derivatives not designated as accounting hedges.\" Specifically, the table on page 95 shows \"Equity method investment contracts (2)\" under \"Derivatives not designated as accounting hedges\" with a fair value of $3 million as of December 31, 2022 (and $3 million as of December 31, 2023, though the 2023 figure is not directly tabulated in the main table—only referenced in the footnote). The total fair value of all derivatives was $1,597 million as of December 31, 2023, and $790 million as of December 31, 2022. \n\nThe equity method investment contracts represented a negligible portion of the total derivative portfolio, accounting for approximately 0.2% of the total derivative fair value in 2022 ($3 million / $790 million) and an even smaller fraction in 2023 (as the $3 million figure is not included in the 2023 total derivative fair value table, but the document confirms it was part of the portfolio). This indicates that equity method investment contracts were not a significant component of MDLZ's derivative portfolio, which was dominated by currency exchange contracts, commodity contracts, and interest rate swaps. The document further clarifies that these contracts were \"economic hedges not designated as accounting hedges,\" reinforcing their minor role relative to the broader derivative portfolio. \n\n**Answer**: The equity method investment contracts had a fair value of $3 million in 2022, representing a negligible portion (approximately 0.2%) of the total derivative portfolio's fair value of $790 million. This indicates they were not material to MDLZ's overall derivative portfolio, which was primarily composed of currency, commodity, and interest rate derivatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47394,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12069,
        "completion_tokens": 496,
        "total_tokens": 12565
      }
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The freezing of U.S. pension benefits as of December 31 2019 eliminated the “rate of compensation increase” assumption for the U.S. pension plans, so that assumption no longer influences the actuarial calculations of benefit obligations or net periodic pension cost. Consequently, the post‑retirement benefit accounting for the frozen U.S. plans now relies only on the remaining assumptions (discount rate, expected return on assets, health‑care trend, mortality, etc.), and any changes to those inputs affect the measured benefit obligation and expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60902,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15441,
        "completion_tokens": 138,
        "total_tokens": 15580
      }
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems is reflected in its hardware revenue structure, where hardware revenues (including Engineered Systems) are recognized upfront at delivery and supported by ongoing hardware support contracts priced as a percentage of net hardware fees. This structure, combined with the company's reliance on a complex supply chain for hardware components and manufacturing, creates vulnerability to disruptions—such as those caused by the COVID-19 pandemic, component shortages, or logistics delays—that can delay production, increase costs, and force inventory buildup. These supply chain challenges, coupled with declining hardware profitability and the need to invest heavily in data center capacity and infrastructure, can pressure margins and make it difficult to maintain consistent profitability in the hardware business, especially when competing with lower-cost alternatives or facing delays in market adoption of new systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50312,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12810,
        "completion_tokens": 243,
        "total_tokens": 13053
      }
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area was $3,555 million, reflecting a 19.7% year‑over‑year increase for UPTRAVI and a 10.6% increase for OPSUMIT. This total growth outpaces the overall Pulmonary Hypertension category’s 11.6% sales growth for 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43658,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11151,
        "completion_tokens": 80,
        "total_tokens": 11231
      }
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full‑year contribution from the legacy PDC Energy assets added roughly **$3.5 billion** to Chevron’s 2024 U.S. upstream earnings and lifted net oil‑equivalent production by about **250,000 barrels per day** (a 19 % increase), driven primarily by the PDC assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 117851,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 29687,
        "completion_tokens": 66,
        "total_tokens": 29753
      }
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "The retrospective application of the new LDTI accounting guidance required adjustments to **multiple financial statements**, including the consolidated statements of operations, comprehensive income, equity, and cash flows. Specifically, the adjustments impacted revenue recognition (e.g., premiums, universal life fees), expenses (e.g., policyholder benefits, market risk benefit remeasurements), and comprehensive income components (e.g., unrealized investment gains/losses, foreign currency translation adjustments). These changes reflect the scope of the guidance’s impact, which extended beyond the income statement to materially affect the balance sheet (e.g., future policy benefits, accumulated other comprehensive income) and equity balances, demonstrating a comprehensive transformation in how MetLife reports its financial position and performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 165,
          "pages": [
            163,
            164,
            165,
            166,
            167
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 164,
          "pages": [
            162,
            163,
            164,
            165,
            166
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55932,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14217,
        "completion_tokens": 214,
        "total_tokens": 14432
      }
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "The total fair value of equity method investment contracts disclosed in the derivatives fair value table as of December 31, 2022 was $3 million. This is substantially lower than the total fair value of net investment hedge contracts, which was $24 million at the same date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47790,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12182,
        "completion_tokens": 68,
        "total_tokens": 12250
      }
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "The net assets of Universal Beijing Resort increased by $117 million from December 31 2023 to December 31 2024, reflecting the $3.4 billion of debt and $7.3 billion of assets reported on Comcast’s consolidated balance sheet for 2024 versus $3.5 billion of debt and $7.8 billion of assets for 2023. This change is captured in the consolidated balance sheets where Universal Beijing Resort’s assets and liabilities are included, illustrating how the VIE’s financial activity is reflected in Comcast’s reported totals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54186,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13770,
        "completion_tokens": 128,
        "total_tokens": 13899
      }
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "As of September 29 2024, Starbucks’ Japanese‑yen‑denominated credit facilities total **$103.6 million** in capacity (a ¥5 billion facility maturing December 30 2024 at $34.5 million and a ¥10 billion facility maturing March 27 2025 at $69.1 million).  \n\nThe 2021 Revolving Credit Agreement backs the commercial‑paper program by providing a **$3 billion backstop commitment** that can be drawn to fund any outstanding commercial‑paper issuances, ensuring the program’s borrowing capacity and usage for working‑capital, capital expenditures, acquisitions, share repurchases, and dividend payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40936,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10469,
        "completion_tokens": 148,
        "total_tokens": 10618
      }
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems and its broader hardware portfolio is reflected in its infrastructure technologies revenue, which represented 58‑60 % of total cloud services and license support revenue in fiscal 2022‑2020, indicating that hardware sales remain a material contributor to the company's overall infrastructure earnings. However, this reliance on hardware exposes Oracle to supply‑chain vulnerabilities—particularly for single‑source components and manufacturing partners—so any delays, shortages, or disruptions (e.g., those caused by COVID‑19, geopolitical shifts, or logistics bottlenecks) can constrain production, increase costs, and negatively affect both hardware profitability and the company's ability to meet customer demand for its engineered systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50122,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12754,
        "completion_tokens": 199,
        "total_tokens": 12954
      }
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "The debt of Universal Beijing Resort fell slightly from $3.5 billion in 2023 to $3.4 billion in 2024, and this modest reduction contributed to a small decline in the overall “Debt Not Guaranteed” category, which dropped from $4.8 billion to $4.8 billion (essentially unchanged, with the $0.1 billion decrease in the Universal Beijing Resort portion being offset by other changes).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53066,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13474,
        "completion_tokens": 95,
        "total_tokens": 13569
      }
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell’s use of the cost‑to‑cost input method for long‑term contracts creates significant estimation uncertainty for contract costs and revenue timing, requiring auditors to perform extensive testing of management’s assumptions, controls over cost estimates, and analytical procedures to assess the propriety of revenue recognition over time. This complexity is highlighted in the Critical Audit Matter discussion, which notes that auditors evaluated the appropriateness of methods and assumptions used to recognize revenue and costs on long‑term contracts and tested recorded revenue against underlying contract data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52979,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13481,
        "completion_tokens": 155,
        "total_tokens": 13637
      }
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The difference in magnitude between NEER's $1,729 million of non‑qualifying hedge gains included in net income and FPL's $300 million of gains included in net income is $1,429 million. This disparity illustrates that NEER records such hedge gains directly in earnings, whereas FPL treats comparable gains as regulatory assets or liabilities that are passed through to customers, reflecting the distinct accounting treatment of derivative transactions between the two business units.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50281,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12834,
        "completion_tokens": 120,
        "total_tokens": 12955
      }
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast’s 30% ownership stake in Universal Beijing Resort is reflected in its consolidated balance sheet as part of the Theme Parks segment’s assets and liabilities, with the resort’s $7.3 billion of assets and $7.0 billion of liabilities (primarily debt) included in the totals reported for 2024. Because the resort is a variable‑interest entity that Comcast consolidates, the company’s maximum financial exposure is limited to its 30% equity interest, which represents the portion of the resort’s debt financing that Comcast could lose. This 30% equity stake therefore constitutes the proportion of total debt financing that reflects Comcast’s maximum risk of financial loss.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61019,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15500,
        "completion_tokens": 169,
        "total_tokens": 15670
      }
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "The cumulative goodwill impairment charges recognized for OpenTable in 2020 totaled $1.053 billion ($489 million in the March 31, 2020 interim test plus $573 million in the September 30, 2020 annual test). This amount is substantially lower than the contribution of OpenTable to Booking Holdings’ advertising and other segment revenue, which generated $388 million in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51695,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13144,
        "completion_tokens": 93,
        "total_tokens": 13237
      }
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil incorporates estimated greenhouse‑gas emission costs—including the projected costs to meet its 2030 net‑zero Scope 1 and 2 emission‑reduction goal—into the cash‑flow assumptions used for recoverability testing of asset groups. These emission‑cost estimates are part of the future cash‑flow projections developed under the Corporate Plan and are used to assess whether the carrying amounts of long‑lived assets are recoverable.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50813,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12935,
        "completion_tokens": 109,
        "total_tokens": 13045
      }
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "As of December 31 2023, Capital One has phased in 50 % of the $2.4 billion CECL transition capital add‑back, leaving $1.2 billion to be phased in over 2024‑2025 ($600 million each year). Consequently, the remaining $1.2 billion will be added to regulatory capital in 2024 and 2025, and this amount will be reflected in the CET1, Tier 1 and total capital ratios for the reporting period October 1 2023 – September 30 2024, raising the Company’s CET1 ratio from 12.6 % (on a fully‑phased‑in basis) to the 12.9 % ratio reported when the transition election is applied. This phased‑in addition is part of the capital conservation buffer that determines the minimum capital requirements for that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 192,
          "pages": [
            190,
            191,
            192,
            193,
            194
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51105,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13024,
        "completion_tokens": 174,
        "total_tokens": 13199
      }
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million (down from $11,275 million to $9,562 million), while Euro notes increased slightly by $250 million (up from $7,666 million to $7,916 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45360,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11558,
        "completion_tokens": 60,
        "total_tokens": 11618
      }
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The Resideo subsidiary is obligated to make cash payments to Honeywell equal to 90% of Honeywell’s annual net spending on environmental matters at certain sites, subject to a $140 million cap per year and continuing until the earlier of December 31, 2043, or the third consecutive year in which the payment falls below $25 million. This indemnification agreement therefore ties the payment amount directly to Honeywell’s net environmental spending, with the maximum annual payment capped at $140 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 91788,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 23174,
        "completion_tokens": 126,
        "total_tokens": 23300
      }
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "The changes in non‑qualifying hedges and FPL cost‑recovery clauses shifted the fair‑value of NEE’s mark‑to‑market energy contracts from a net liability of $2,728 million at 12/31/2022 to a net liability of $128 million at 12/31/2023, reducing the overall liability by roughly $2.6 billion. This reduction lowered the total accrued asset‑removal and decommissioning liabilities reported in the “Accrued decommissioning, dismantlement and other accrued asset removal costs” line from $5,774 million (2022) to $5,450 million (2023), improving NEE’s total financial position for both the FPL and NEER segments by about $324 million over the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62368,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15813,
        "completion_tokens": 160,
        "total_tokens": 15974
      }
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "The net assets of Universal Beijing Resort declined slightly from $3.5 billion in 2023 to $3.4 billion in 2024, a decrease of about $0.1 billion.  Over the same period, the company’s debt obligations fell from $3.5 billion to $3.4 billion, also a reduction of roughly $0.1 billion.  Thus, both net assets and debt obligations decreased by a comparable small amount.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53626,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13625,
        "completion_tokens": 91,
        "total_tokens": 13716
      }
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) became eligible for treatment of pediatric patients aged 2 to 12 years with HIV, and the company targeted regulatory filings for this indication in both the United States and the European Union.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40762,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10417,
        "completion_tokens": 63,
        "total_tokens": 10480
      }
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com’s merchant‑based transaction model adds payment‑processing, fraud‑related chargebacks and other personnel costs that directly erode operating margins, even though it generates incremental “merchant” revenues. At the same time, ongoing regulatory investigations in Switzerland (e.g., the Price Surveillance Office probe of Booking.com commissions) and across the EU—particularly the EU’s Digital Markets Act, Digital Services Act and competition‑law scrutiny of parity contracts—pose potential fines, forced changes to business practices and heightened compliance costs. Together, these pressures compel Booking Holdings to balance margin‑squeezing investments in the merchant model and the Connected Trip against the risk of costly regulatory penalties and the need to adapt its strategy in a tightening legal environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 51348,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13066,
        "completion_tokens": 208,
        "total_tokens": 13275
      }
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, as specified in the Oil and Gas Act for such licenses, which may be extended at the Minister's discretion up to the full 15-year maximum. This regulatory framework, which allows for long-term retention rights but requires periodic renewal and ministerial approval, supports ExxonMobil's long-term LNG development strategy in the region by providing the necessary security for investments in projects like the Papua New Guinea LNG development, as highlighted in the 2022 10-K filing's discussion of Upstream operations and project timelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 32353,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8342,
        "completion_tokens": 158,
        "total_tokens": 8500
      }
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "The year‑over‑year change in Coca‑Cola’s Level 2 investments in mutual, pooled and commingled funds was a decrease of $15 million (from $778 million at the end of 2022 to $763 million at the end of 2023).  In contrast, the Company’s Hedge funds/limited‑partnership investments remained essentially unchanged, with no reported Level 2 balance in either 2023 or 2022, indicating no year‑over‑year change for that category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52748,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13418,
        "completion_tokens": 105,
        "total_tokens": 13523
      }
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was an $88 million estimated loss recorded in \"Estimated loss on regulatory disallowance,\" which directly reduced net income. This $88 million charge was partially offset by approximately $24 million in higher earnings related to the disallowances, resulting in a net negative impact on net income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45695,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11668,
        "completion_tokens": 103,
        "total_tokens": 11772
      }
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T classified WarnerMedia, Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift to streamline its portfolio and focus on core telecom businesses. This classification allowed AT&T to separate these non-core assets (including WarnerMedia's spin-off to Discovery) from its ongoing operations, reflecting a broader restructuring effort to simplify its business model and redirect capital toward its core Communications and Latin America segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45958,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11724,
        "completion_tokens": 119,
        "total_tokens": 11843
      }
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair value of Medtronic's auction rate securities declined by $3 million (from $33 million at April 30 2021 to $33 million at April 29 2022, reflecting a $3 million unrealized loss), and this $3 million change contributed to a $245 million total unrealized loss on available‑for‑sale debt securities over the same period. Consequently, the overall fair‑value decline of $245 million for the debt‑security portfolio includes the $3 million impact from the auction rate securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56186,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14273,
        "completion_tokens": 120,
        "total_tokens": 14394
      }
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The $489 million goodwill impairment charge recorded in March 2020 (related to OpenTable and KAYAK) reduced the carrying value of that goodwill to $1.5 billion, and the subsequent $573 million impairment recognized in September 2020 further lowered it to $1.0 billion as of September 30, 2020. Together, these two impairment charges represented the cumulative impact of $1.062 billion in goodwill write‑downs for the OpenTable and KAYAK reporting units.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50196,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12778,
        "completion_tokens": 113,
        "total_tokens": 12891
      }
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Southern Company Gas's 2023 net income increased by $43 million (7.5%) to $615 million, primarily due to the absence of a $131 million pre-tax impairment charge recorded in 2022 related to the sale of natural gas storage facilities, partially offset by $88 million in estimated regulatory disallowance charges at Nicor Gas and higher depreciation from infrastructure investments. Operating revenues decreased by $1.26 billion (21.1%) to $4.7 billion in 2023, driven by lower gas cost recovery due to reduced natural gas prices and volumes, as well as regulatory disallowances at Nicor Gas, though these impacts were partially mitigated by infrastructure replacement program rate increases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40584,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10352,
        "completion_tokens": 172,
        "total_tokens": 10524
      }
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, which represented approximately 5.7% of the total 283 million shares authorized under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38148,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9762,
        "completion_tokens": 55,
        "total_tokens": 9817
      }
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T’s 2023 10‑K notes that it is partnering with Ericsson to accelerate commercial‑scale Open RAN deployments, targeting roughly 70 % of wireless traffic on open‑capable platforms by late 2026 and fully integrated Open RAN sites beginning in 2024. This initiative is part of its broader cost‑transformation and efficiency push, and the company expects the associated capital spending and accelerated depreciation to put upward pressure on 2024 operating expenses while positioning the network for longer‑term operational efficiencies and lower network‑related costs as 5G and fiber investments scale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48651,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12387,
        "completion_tokens": 150,
        "total_tokens": 12537
      }
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "The total proved developed bitumen reserves for XOM's consolidated subsidiaries in Canada/Other Americas as of December 31 2021 were $23,596 million.  This figure is reflected in the “Results of producing activities for consolidated subsidiaries” table under the Canada/Other Americas column, where the net result of producing activities for consolidated subsidiaries in that region equals $2,783 million, and the accompanying note on capitalized costs shows net capitalized costs of $40,786 million for Other Americas (which includes the proved developed bitumen reserves).  Consequently, the discounted future net cash flows attributable to these reserves in 2021 amount to $2,783 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 137,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 142,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 82878,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20952,
        "completion_tokens": 172,
        "total_tokens": 21125
      }
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022-02 eliminated the previous accounting guidance for troubled debt restructurings (TDRs) and replaced it with a new framework for identifying financial difficulty modifications (FDMs), which are now reported separately from TDRs. This change impacted Capital One's allowance for credit losses by requiring the company to assess all loan modifications—including FDMs—when estimating expected credit losses, resulting in a $2.1 billion increase in the allowance for credit losses and a corresponding increase in the allowance coverage ratio to 4.77% as of December 31, 2023. Additionally, the ASU mandated new disclosure requirements for certain loan refinancings and restructurings, which Capital One implemented beginning January 1, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 139,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52023,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13223,
        "completion_tokens": 191,
        "total_tokens": 13415
      }
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could require additional capital contributions to GE's insurance subsidiaries and may lead to higher loss estimates that would need to be recognized, potentially stressing GE's liquidity position as reported in its 2023 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65173,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16512,
        "completion_tokens": 81,
        "total_tokens": 16594
      }
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "Based on the table in the provided 10-K pages (Item 12, Securities Authorized for Issuance under Equity Compensation Plans), the Amended and Restated 2010 Share Incentive Plan had **27,381,461 shares remaining available for future issuance** as of August 31, 2022. This figure is explicitly listed in the \"Number of Shares Remaining Available for Future Issuance Under Equity Compensation Plans\" column for that specific plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37711,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9654,
        "completion_tokens": 106,
        "total_tokens": 9761
      }
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "Based on the provided disclosures, AT&T paid off the full $2,500 principal amount of its 2025 Term Loan during 2023, and the loan was terminated on **March 30, 2023**, as explicitly stated in the \"Credit Facilities\" section of the document. This termination occurred in the first quarter of 2023, as noted in the timeline of loan repayments and terminations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49459,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12578,
        "completion_tokens": 89,
        "total_tokens": 12667
      }
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "The change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023 was a decrease of $61 million (from $304 million in 2022 to $243 million in 2023). Of the $243 million reported for 2023, $257 million was classified under Level 2 valuation inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51104,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13000,
        "completion_tokens": 67,
        "total_tokens": 13067
      }
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million, as disclosed in the \"Earnings (loss) of discontinued operations before income taxes\" line item for Bank BPH within the Results of Discontinued Operations table. Net cash paid to AerCap related to continuing involvement during the same period was $203 million, as stated in the \"GECAS/AerCap\" section of the document.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66700,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16904,
        "completion_tokens": 109,
        "total_tokens": 17013
      }
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture's sustained $3.4 billion investment in strategic acquisitions, $1.1 billion in research and development, and $1.1 billion in learning and professional development—resulting in over 8,300 patents—creates a differentiated portfolio of industry‑specific solutions, advanced platforms (e.g., MyWizard, MyNav, SynOps) and deep ecosystem partnerships. This enables the firm to deliver 360° value—combining financial business outcomes, inclusion and diversity progress, reskilling, sustainability goals, and innovative client experiences—far beyond the narrower service and cost‑focused offerings of many competitors, positioning Accenture as a trusted, innovation‑led partner capable of driving large‑scale, end‑to‑end enterprise transformation at speed and scale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36715,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9412,
        "completion_tokens": 192,
        "total_tokens": 9604
      }
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "AT&T classified **WarnerMedia, Vrio, Xandr and Playdemic** as discontinued operations in 2023. This classification required the company to present the financial results of these businesses separately, removing their revenues, expenses and related cash flows from continuing‑operations metrics and reporting them as a distinct line item (“Net loss from discontinued operations”) in the income statement and cash‑flow statement. Consequently, the 2023 consolidated results reflect only the ongoing communications and Latin America businesses, while the discontinued entities’ performance is shown in the “Results of Discontinued Operations” tables.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45958,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11715,
        "completion_tokens": 161,
        "total_tokens": 11876
      }
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "The 2022 10‑K filing reports that the unrealized loss on auction‑rate securities held by MDT was **$3 million**. This loss is disclosed in the “Debt Securities” footnote (page 70) under the Level 3 fair‑value table, which lists auction‑rate securities with an unrealized loss of $3 million. The loss is not broken out by maturity period in the provided excerpt; it is simply aggregated as part of the total unrealized loss on available‑for‑sale debt securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53294,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13547,
        "completion_tokens": 115,
        "total_tokens": 13662
      }
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "During the May 2024 Class B‑1 common stock exchange offer, Visa issued approximately **120 million shares of Class B‑2 common stock**. This amount represented roughly **33 %** of the total shares issued in that exchange (the exchange resulted in about 360 million shares total: 241 million Class B‑1 shares tendered, exchanged for ~120 million Class B‑2 shares and ~48 million Class C shares).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62593,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15879,
        "completion_tokens": 98,
        "total_tokens": 15977
      }
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023 was 3.2 GW (11.7 GW in 2021 → 8.5 GW in 2023), and this decline is reflected in the reduction of Wind Turbines sold from 3,590 units in 2021 to 2,225 units in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60134,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15253,
        "completion_tokens": 61,
        "total_tokens": 15314
      }
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, AT&T paid a total of **$23,406** for C-Band licenses (including $550 upfront deposit, $22,856 in cash payments in Q1 2021, and $955 in incentive payments in December 2021), with additional **$2,112 paid in 2023 for Phase II spectrum clearing costs**. These costs, including $1,100 in compensable relocation expenses over several years (with $650 paid in 2021, $98 in 2022, and $109 in 2023), were classified as **\"Licenses - Net\"** on the balance sheet and **included in \"Acquisitions, net of cash acquired\"** on the consolidated statement of cash flows. The document confirms these expenses were treated as part of the spectrum acquisition costs, not as operating expenses, and were reflected in investing activities of the cash flow statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46474,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11837,
        "completion_tokens": 197,
        "total_tokens": 12034
      }
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "Medtronic disclosed that its June 2021 decision to discontinue the HVAD System reduced HVAD sales to $141 million in fiscal 2021 and eliminated further revenue from that device in fiscal 2022, contributing to the overall 6 % increase in Cardiovascular net sales ($11.4 billion) that was instead driven by growth in Cardiac Rhythm Management (e.g., Micra, TYRX envelopes, CRT‑D), Cardiac Ablation Solutions (Arctic Front), and Structural Heart/Aortic products (TAVR, ECLS).  The document also highlighted Structural Heart & Aortic (8 % growth), Coronary & Peripheral Vascular (5 % growth), and the broader Cardiovascular pipeline—including Micra AV expansion, Azure XT/S SureScan pacing systems, Evolut PRO TAVR, VenaSeal and Abre vascular devices—as the key growth drivers for the segment in fiscal 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42428,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10829,
        "completion_tokens": 201,
        "total_tokens": 11030
      }
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This transaction increased Walmart’s ownership stake in Flipkart from roughly 75 % (as of January 31 2023) to approximately 85 % (as of January 31 2024).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52835,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13455,
        "completion_tokens": 88,
        "total_tokens": 13543
      }
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft's revenue recognition for volume licensing programs, including unearned revenue and timing of invoicing, requires complex judgments in determining standalone selling prices (SSP) for bundled products and services (e.g., on-premises licenses with Software Assurance). This complexity directly impacts the presentation of financial statements by necessitating estimates for variable consideration and contract liabilities, while also increasing audit focus on the accuracy of revenue timing and SSP assessments, as highlighted by the auditor's critical audit matter regarding distinct performance obligations and SSP estimation methods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41760,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10699,
        "completion_tokens": 161,
        "total_tokens": 10860
      }
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $126 million in 2022, $110 million in 2021, and $107 million in 2020. No profit‑sharing contributions were made in any of these years; the plan’s terms allow discretionary profit‑sharing contributions but none were approved or paid for fiscal years 2022, 2021, or 2020.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49652,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12638,
        "completion_tokens": 102,
        "total_tokens": 12740
      }
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "The total change in ConocoPhillips’ consolidated natural‑gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024 is an increase of 117 billion cubic feet (from 289 BCF at year‑end 2023 to 406 BCF at year‑end 2024).  \n\nIn contrast, Africa’s natural‑gas reserves declined by 57 billion cubic feet over the same period (from 465 BCF at the end of 2023 to 408 BCF at the end of 2024).  \n\nThus, the Asia Pacific/Middle East region saw a net upward revision of about 117 BCF, while Africa experienced a net downward revision of roughly 57 BCF during 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 143,
          "pages": [
            141,
            142,
            143,
            144,
            145
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 86769,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21931,
        "completion_tokens": 146,
        "total_tokens": 22077
      }
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received $0.7 billion of equity funding from PhonePe during fiscal 2024, and it paid $3.5 billion to acquire shares from non‑controlling interest holders of PhonePe in the same fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57579,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14629,
        "completion_tokens": 49,
        "total_tokens": 14678
      }
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "The Company recorded a combined pre‑tax charge of $918 million in 2024 related to the resolution of the SEC Administrative Order and the associated legal matters, and the compliance monitor will oversee RTX’s obligations for three years from the date the monitor is engaged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14843,
        "completion_tokens": 68,
        "total_tokens": 14912
      }
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "Microsoft Cloud revenue in fiscal year 2023 was $137.4 billion, encompassing Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365 and other commercial cloud offerings. This growth was driven primarily by Dynamics 365 and the broader Dynamics cloud‑based business solutions, which contributed to the overall Cloud revenue figure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38659,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9881,
        "completion_tokens": 94,
        "total_tokens": 9975
      }
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort's $3.5 billion debt is recorded in Comcast’s consolidated balance sheet as part of the company’s overall debt structure. Although the debt is issued by the resort’s own financing arrangement with Chinese lenders, it is fully consolidated by Comcast because the resort is a variable interest entity that Comcast controls. Consequently, the $3.5 billion appears in Comcast’s consolidated debt totals, while the underlying financing remains a direct liability of Universal Beijing Resort.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53077,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13496,
        "completion_tokens": 127,
        "total_tokens": 13623
      }
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "The Company's investment in commercial paper and bonds declined from $660 million (as part of Level 2 short‑term investments) at May 31 2021 to $660 million of gross carrying amount (with $37 million classified as cash and equivalents) at May 31 2022, reflecting a modest reduction in the commercial‑paper/bond component. This shift reduced the proportion of short‑term investments allocated to these securities and increased the relative weight of other Level 2 assets such as money‑market funds and time deposits within the overall short‑term investment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45326,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11550,
        "completion_tokens": 141,
        "total_tokens": 11691
      }
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The introduction of Class B‑2 common stock does not affect the diluted earnings‑per‑share calculation for fiscal 2023 because no Class B‑2 shares were outstanding prior to the Class B‑1 exchange offer; consequently, there are no incremental shares to include in the diluted share count for that year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67650,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17140,
        "completion_tokens": 75,
        "total_tokens": 17215
      }
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "The Raytheon segment’s pension and post‑retirement benefit expense is presented using U.S. government Cost Accounting Standards (CAS), which results in a different cost‑recognition pattern than the Financial Accounting Standards (FAS) basis used for Collins and Pratt & Whitney. Specifically, the CAS‑based pension expense for Raytheon is recorded outside of segment results as a “FAS/CAS operating adjustment” that reflects the timing difference in when the liability is recognized and recovered through product pricing, whereas Collins and Pratt & Whitney record their pension costs solely under FAS. This adjustment is highlighted in Note 20 where the FAS/CAS operating adjustment of $833 million for 2024 is shown separately from the segment operating profit of the Raytheon business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66600,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16878,
        "completion_tokens": 197,
        "total_tokens": 17075
      }
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Based on the provided excerpts, there are **two separate Supplemental Indentures** specifically related to the **1.850% Notes due 2020** (identified as the \"Ninth Supplemental Indenture\" in Exhibit 4.12 and the \"Fifteenth Supplemental Indenture\" in Exhibit 4.18). The trustees involved across these agreements are **The Bank of New York Mellon Trust Company, N.A.** (for all indentures prior to 2015) and **U.S. Bank National Association** (for the 2015 indenture and subsequent ones).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41302,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10544,
        "completion_tokens": 121,
        "total_tokens": 10666
      }
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal 2022 was $40 million, which is the amount recorded in Other (income) expense, net for derivatives not designated as hedging instruments. This gain is modest compared with the fair‑value amount of the foreign‑exchange forwards and options assets, which totaled $880 million as of May 31 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58371,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14826,
        "completion_tokens": 94,
        "total_tokens": 14921
      }
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "During 2021, AIG’s U.S. Personal Insurance segment recognized $412 million of favorable prior‑year development (net of external reinsurance but before ADC), while U.S. Property & Special Risk experienced $118 million of favorable prior‑year development. In contrast, the UK/Europe Casualty and Financial Lines segment recorded $210 million of unfavorable prior‑year development, driven by large losses in Financial PI and Commercial D&O. Thus, prior‑year developments had a net positive impact on U.S. Personal Insurance and U.S. Property, but a net negative impact on the UK/Europe Casualty and Financial Lines during 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 276,
          "pages": [
            274,
            275,
            276,
            277,
            278
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 286015,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 71732,
        "completion_tokens": 156,
        "total_tokens": 71888
      }
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart's 2018 acquisition of a majority stake in Flipkart exposes the company to financial and operational risks stemming from ongoing regulatory proceedings in India. The Directorate of Enforcement has initiated proceedings related to alleged foreign direct investment rule violations by Flipkart prior to Walmart's acquisition, which could result in monetary penalties, restrictions on business operations, or reputational damage—potentially affecting Walmart's investment returns and global expansion strategy. This regulatory exposure aligns with Walmart's broader international investment approach, as highlighted in its 2023 10-K filing, which emphasizes strategic investments in e-commerce and technology (e.g., Flipkart and PhonePe) to expand its global footprint, while acknowledging that such initiatives carry inherent risks, including \"adverse decisions in litigation or other proceedings\" that could materially impact the company's financial position or operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46967,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11996,
        "completion_tokens": 244,
        "total_tokens": 12241
      }
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "The total dollar value of Class A ordinary shares issued during the 2023 fiscal year was approximately $15 billion, and this issuance contributed to an increase in Accenture plc’s total shareholders’ equity to $28.3 billion as of August 31 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46486,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11843,
        "completion_tokens": 61,
        "total_tokens": 11905
      }
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG applies loss development methods and expected loss ratio techniques to its excess casualty reserves, especially for policies with attachment points above $10 million. For these high‑attachment layers, the company first estimates losses using traditional development and expected loss‑ratio approaches for amounts capped at $10 million, then extrapolates those estimates to the higher‑limit layers, reflecting the attachment point and limit structure. Expected loss ratios—derived from projected ultimate loss ratios adjusted for rate changes, loss trends (including inflation) and recent COVID‑19 impacts—are used primarily for the three most recent accident years where reported loss credibility is low. These expected loss ratios feed into the reserve estimates for both U.S. Property and aerospace exposures, ensuring that the lagged development patterns typical of excess casualty lines are accounted for in the overall reserving methodology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 296931,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 74481,
        "completion_tokens": 237,
        "total_tokens": 74718
      }
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "Based on the provided financial statements, the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, was $4,509,392. As of August 31, 2024, the remaining share purchase authorization was $2,694,281, which was subsequently increased to $6,694,281 following a $4,000,000 approval in September 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42616,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10896,
        "completion_tokens": 98,
        "total_tokens": 10994
      }
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "The shift from “legitimate interests” to “consent” for behavioral advertising in Europe—implemented to comply with GDPR, ePrivacy, DMA and other EU regulations—has reduced the ability to target ads, leading to less personalized and less effective ads. This has lowered user engagement and pressured advertising revenue, prompting Meta to introduce a “subscription for no ads” option and offer less‑personalized free‑ad tiers while it works with regulators on a compliant consent model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 39373,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10084,
        "completion_tokens": 121,
        "total_tokens": 10205
      }
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption of Accenture plc Class X ordinary shares is directly tied to the number of Accenture Canada Holdings Inc. exchangeable shares outstanding: Accenture may redeem Class X shares only to the extent that the aggregate number of Class X shares does not exceed the aggregate number of exchangeable shares held, and it will redeem Class X shares when exchangeable shares are redeemed or exchanged. This mechanism ensures that the total number of Class X shares outstanding remains aligned with the number of exchangeable shares, preserving a one‑to‑one relationship between the two classes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40595,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10393,
        "completion_tokens": 149,
        "total_tokens": 10542
      }
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million at the end of 2020 to $136.1 million at the end of 2021, reflecting a $20.1 million reduction that results from amortizing the previously capitalized milestones over the collaboration’s contractual term. This decline illustrates the company’s practice of recording milestone payments as intangible assets and then amortizing them to cost of sales (or collaboration revenue) over the life of the related product, causing the deferred balance to shrink as the amortization expense accumulates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44084,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11236,
        "completion_tokens": 142,
        "total_tokens": 11378
      }
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "The reserving approach for UK/Europe Property and Special Risks relies more heavily on loss development methods due to the long‑tail nature of these lines, whereas U.S. Property uses a combination of frequency/severity and IBNR factor methods for short‑tail classes. Consequently, UK/Europe reserves are generally more stable but still subject to adjustments for factors such as COVID‑19 and judicial trends, while U.S. reserves are more sensitive to frequency changes and require frequent updates to expected loss ratios. This difference leads to a more pronounced reliance on development factors in the UK/Europe process and a greater emphasis on IBNR factor adjustments in the U.S. reserving process.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 280,
          "pages": [
            278,
            279,
            280,
            281,
            282
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 249506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 62614,
        "completion_tokens": 175,
        "total_tokens": 62790
      }
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Based on the document, Procter & Gamble holds a global market share of more than 60% in blades and razors (within the Grooming segment) and over 25% of the male electric shavers market. The document does not provide a separate market share figure specifically for \"global market share in male electric shavers\" as a distinct metric; however, it explicitly states that P&G holds \"over 25% of the male electric shavers market,\" which is part of the broader blades and razors segment. Thus, the combined global market share for blades and razors is over 60%, and the share for male electric shavers is over 25%, with the latter being a subset of the former. The document does not indicate a separate or combined percentage for these two metrics beyond these figures. \n\n(Word count: 149)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13401,
        "completion_tokens": 195,
        "total_tokens": 13597
      }
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023, and it offsets a portion of these costs through cost‑sharing arrangements with suppliers that provide reimbursements for supplier‑incurred development expenses, which are recorded as a reduction of R&D expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36477,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9337,
        "completion_tokens": 74,
        "total_tokens": 9411
      }
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent $4,509,392 on Class A Ordinary Share purchases during fiscal 2024, which increased its treasury shares by 13,913,393 shares (including 11,753,807 shares acquired through its open-market program and 2,159,586 shares purchased via employee equity plans). This activity contributed to the company's treasury share balance growing to $10,564,572 as reflected in the consolidated shareholders' equity statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39699,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10144,
        "completion_tokens": 105,
        "total_tokens": 10249
      }
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "The year‑over‑year dollar increase in the value of META’s Servers and Network Assets is $21.5 billion (from $68.397 billion at Dec 31 2023 to $89.897 billion at Dec 31 2024). This increase reflects the addition of new server and network capacity that was placed in service during 2024, and the assets are depreciated over an estimated useful life of four to five years (extended to 5.5 years effective Jan 2025), with the remaining carrying amount depreciated prospectively over the revised useful life.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46161,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11775,
        "completion_tokens": 125,
        "total_tokens": 11901
      }
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "In 2022, Eli Lilly had one FDA Breakthrough Therapy designation that remained in the submitted status – tirzepatide for obesity – while the other Breakthrough‑designated product, donanemab for early Alzheimer’s disease, was discontinued from further development. The submitted indication (tirzepatide obesity) is focused on the obesity therapeutic area, whereas the discontinued indication (donanemab early Alzheimer’s disease) pertained to the Alzheimer’s disease therapeutic area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58168,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14778,
        "completion_tokens": 120,
        "total_tokens": 14899
      }
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG applies loss development methods more heavily to its long‑tail U.S. Other Casualty lines, where it combines frequency/severity and loss‑development techniques and supplements them with external specialist inputs, while for U.S. Property it relies primarily on frequency/severity and IBNR factor methods for short‑tail exposures. In 2021 the company recorded $412 million of favorable prior‑year development in U.S. Personal Insurance, largely from subrogation recoveries on the 2017‑2018 catastrophe years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 266,
          "pages": [
            264,
            265,
            266,
            267,
            268
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 281504,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 70617,
        "completion_tokens": 127,
        "total_tokens": 70744
      }
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "The Baby, Feminine & Family Care segment contributed approximately 24% of Procter & Gamble's fiscal year 2024 net sales, and the Charmin brand (within this segment) accounts for over 25% of the North American toilet paper market, representing roughly one-quarter of the segment's sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13420,
        "completion_tokens": 71,
        "total_tokens": 13491
      }
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "General Dynamics' $510 million R&D investment in 2023 is channeled through its Combat Systems segment to fund next‑generation upgrades for platforms such as the M1E3 Abrams tank—introducing advanced communications, power generation, fuel‑efficiency, optics and armor via the SEPv3 package—and to expand capabilities of the Stryker vehicle and robotic systems like the MUTT and TRX. This spending supports modernization programs that enhance lethality, survivability and mobility, delivering long‑term value through operational excellence and faster technology insertion. Financially, the investment underpins revenue growth in the segment (which accounted for 29 % of total 2023 revenue) and drives future contract awards and export opportunities, while strategically reinforcing GD’s market‑leading position in land combat solutions and sustaining its competitive edge in next‑generation warfare.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30576,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7889,
        "completion_tokens": 224,
        "total_tokens": 8113
      }
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "Based on the provided document pages, the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs, was $605 million for the open-market program plus $72,255 in transactions unrelated to the program (as noted in the table footnote). However, the document does not provide a single aggregate dollar value for all purchases combined. The $605 million figure specifically refers to the open-market program purchases during the fourth quarter of fiscal 2024, while the unrelated transactions were minimal (72,255 shares) and not quantified in dollar value. The total authorization for share purchases and redemptions was $2,694 million as of August 31, 2024, but this represents remaining authorization, not total spending. Therefore, the exact total dollar value of all Class A Ordinary Shares purchased during fiscal 2024 cannot be determined from the provided information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46348,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11821,
        "completion_tokens": 257,
        "total_tokens": 12078
      }
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T's 2021 cash payments to Crown Castle under the sublease arrangement ($253) are substantially lower than the initial $4,827 cash proceeds it received from Crown Castle in the 2013 tower transaction. The 2013 deal involved a one-time cash payment for the sale of tower assets and purchase rights, while the 2021 payments are ongoing sublease rentals under the existing tower lease agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43641,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11127,
        "completion_tokens": 98,
        "total_tokens": 11226
      }
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "Based on the market risk disclosures in the GM 10-K (pages 64-68), GM's valuation methodology for Stellantis warrants is described as using a Black-Scholes formula with key inputs including Stellantis stock price and estimated dividend yield. The sensitivity analysis explicitly states that \"a 10% adverse change in quoted security prices in Stellantis would have had an insignificant effect at December 31, 2021 and 2020.\" This indicates that GM's equity investment in Stellantis warrants would experience only an insignificant financial impact from a 10% adverse change in Stellantis stock price.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57586,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14632,
        "completion_tokens": 149,
        "total_tokens": 14782
      }
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "Based on the \"Baby, Feminine & Family Care\" segment description, P&G's adult incontinence sub-category (sold under the Always Discreet brand) accounts for approximately 15% of the segment's market share in the markets where it competes. This represents about 15% of the total global market share for the Baby, Feminine & Family Care segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13404,
        "completion_tokens": 85,
        "total_tokens": 13489
      }
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "Based on the provided document pages, the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was **$303.05**. This figure is derived from the total cash outlay of $605 million for 2,000,308 shares purchased under the publicly announced open-market program, plus an additional $18.6 million for 72,255 shares acquired in transactions unrelated to share plans (as noted in the \"Purchases of Accenture plc Class A Ordinary Shares\" table under Item 5). The total shares acquired (2,072,563) and total cash outlay ($623.6 million) confirm the average price of $303.05 per share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35598,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9154,
        "completion_tokens": 155,
        "total_tokens": 9310
      }
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net milestones capitalized for Jardiance increased from $156.2 million in 2020 to $136.1 million in 2021, a decrease of $20.1 million. In 2021, collaboration revenue reported for Jardiance was $1,490.8 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49005,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12472,
        "completion_tokens": 53,
        "total_tokens": 12526
      }
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "In 2021 GM recorded a **$316 million gain** from the valuation of its Stellantis warrants (the warrants were valued at $1.4 billion at year‑end 2021 versus $1.1 billion at year‑end 2020, generating a $316 million increase in interest income and other non‑operating income).  \n\nThe ongoing business relationship that affects GM’s post‑sale operations is the **indemnification and supply arrangement with Stellantis**—GM continues to purchase vehicles, parts and engineering services from Stellantis and, under the sale agreement, GM guarantees the seller’s indemnification obligations for certain post‑sale liabilities (e.g., emission‑related lawsuits), which could result in payments to Stellantis.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48701,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12392,
        "completion_tokens": 174,
        "total_tokens": 12566
      }
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "The deconsolidation of AIG Financial Products Corp. (AIGFP) resulted in a **pre‑tax loss of $114 million** that was recorded in “Net gain (loss) on divestitures and other” in AIG’s consolidated statements of income.  This loss reflects the financial impact of AIGFP’s Chapter 11 reorganization, as the subsidiary and its consolidated subsidiaries were removed from AIG’s balance sheet and replaced by a re‑classified third‑party asset (the $37.6 billion loan receivable) that is fully reserved for credit losses.  Consequently, AIG’s consolidated financial statements now present AIGFP as an unconsolidated variable‑interest entity, and the $114 million pre‑tax loss is the primary accounting effect of the deconsolidation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 204,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 204,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38314,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9811,
        "completion_tokens": 180,
        "total_tokens": 9992
      }
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The total net value of Acquired Franchise Rights as of December 28 2024 is $598 million, which represents a decrease from the prior‑year net amount of $626 million. Consequently, the net value of this asset category declined by $28 million (approximately 4.5 %) compared with the reported gross value in the previous year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37604,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9616,
        "completion_tokens": 80,
        "total_tokens": 9697
      }
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "Based on the AT&T 10-K filing (pages 12-16, 52-56), the total financial commitment for C-Band licenses includes the $23,406 auction payment (comprising $550 deposit paid in 2020 and $22,856 paid in Q1 2021) plus estimated future costs of $2,112 for Phase II clearing and $1,000 for compensable relocation costs, totaling approximately $26,518 in committed expenditures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44711,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11408,
        "completion_tokens": 92,
        "total_tokens": 11500
      }
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting a $20.1 million reduction. This decline contributed to the overall financial performance of Lilly’s diabetes portfolio, as evidenced by the $1,490.8 million in Jardiance revenue in 2021 (up from $1,153.8 million in 2020) and the associated amortization of the remaining capitalized milestones.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38976,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9965,
        "completion_tokens": 103,
        "total_tokens": 10068
      }
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "Based on the provided document pages, the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants, is **$0**. The document does not disclose any pension income or gains from Stellantis warrants in the provided excerpts. The only reference to Stellantis is in the context of the sale of the Opel/Vauxhall Business (Note 17), where GM has indemnification obligations and guarantees for certain liabilities, but no financial benefit (e.g., pension income or warrant gains) is reported. The document also mentions \"gains related to Stellantis N.V. (Stellantis) warrants\" in the context of GM Financial's interest income and other non-operating income ($0.2 billion), but this is unrelated to pension income or direct financial benefit from Stellantis. No specific dollar amount for such benefit is provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55894,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14195,
        "completion_tokens": 228,
        "total_tokens": 14423
      }
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "The changes in Corebridge’s stock price directly affected AIG’s retained equity‑method investment in Corebridge, which is recorded in “Other invested assets” at fair value. Increases in the stock price raised the carrying amount of AIG’s ownership interest and generated gains in net investment income, while decreases reduced that carrying amount and produced losses; the resulting fair‑value adjustments are reflected in AIG’s earnings and are disclosed as part of the equity‑method investment’s impact on AIG’s financial statements after the deconsolidation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 100484,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 25351,
        "completion_tokens": 140,
        "total_tokens": 25491
      }
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "Based on the provided document pages, the total net value of Other Identifiable Intangibles for PEP in 2024 is $144 million, and it decreased by $30 million from 2023 to 2024 (from $174 million in 2023 to $144 million in 2024). This decrease is derived from the amortization data in Note 4, where the \"Other identifiable intangibles\" net value is explicitly listed as $144 for 2024 and $174 for 2023. The difference ($174 - $144 = $30) represents the reduction in value over the year. The amortization expense for 2024 is $74 million, but the net decrease in the account balance is $30 million, as confirmed by the comparative table.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39376,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10061,
        "completion_tokens": 158,
        "total_tokens": 10219
      }
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "Based on the provided financial data in the document, the total revenue generated from nuclear-powered submarines in 2023 was **$8,631 million**, while revenue from surface ships was **$2,698 million**. This highlights the strategic emphasis on submarine programs like the Columbia-class and Virginia-class, as nuclear-powered submarines (accounting for 69% of Marine Systems revenue) represent a significantly larger revenue stream compared to surface ships (22% of Marine Systems revenue), driven by their critical role in national defense and long-term naval priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33220,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8539,
        "completion_tokens": 143,
        "total_tokens": 8682
      }
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The fair value of GM’s investment in Stellantis warrants increased by $0.3 billion from $1.2 billion at December 31, 2020 to $1.5 billion at December 31, 2021. Over the same period, the change in the fair value of marketable debt securities was not material (the sensitivity analysis indicates a potential decrease from a 50‑basis‑point interest‑rate increase would be insignificant).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48942,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12467,
        "completion_tokens": 96,
        "total_tokens": 12563
      }
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The net decrease in the value of Acquired Franchise Rights for PepsiCo from 2023 to 2024 is $22 million (from $840 million in 2023 to $598 million in 2024). This reduction is reflected in the amortization expense, which increased slightly to $74 million in 2024 (compared with $75 million in 2023), consistent with the lower carrying amount of the acquired franchise rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39376,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10061,
        "completion_tokens": 93,
        "total_tokens": 10154
      }
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The increase in service costs related to F‑35 sustainment contracts at Aeronautics contributed approximately $570 million of the $775 million (8 %) rise in total service costs for 2023. This $570 million increase is comparable to the $788 million (7 %) growth in service sales reported for the same Aeronautics business unit and reason.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44927,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11470,
        "completion_tokens": 84,
        "total_tokens": 11554
      }
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25 2024, Accenture’s board approved an additional $4 billion of share‑repurchase authority, bringing the total outstanding authorization to $6.694 billion. This expanded authority underscores the company’s strategy of returning capital to shareholders while maintaining flexibility to support growth initiatives and manage its cash position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42765,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10910,
        "completion_tokens": 89,
        "total_tokens": 10999
      }
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "A failure to meet membership growth expectations would directly pressure Netflix’s financial flexibility and profitability because its content costs are largely fixed. If growth slows, the company cannot easily reduce those fixed content expenses or raise per‑membership revenue (e.g., via price hikes) without risking further member loss, leading to compressed margins, tighter liquidity, and potentially lower profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55850,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14187,
        "completion_tokens": 106,
        "total_tokens": 14293
      }
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The 5.15% 2041 Notes had a carrying value of $729 million, which represented roughly 2.2 % of AMGN’s total debt carrying value of $33,309 million in 2022. Approximately $245 million of principal of these notes was exchanged in the 2020 debt‑exchange transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42300,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10808,
        "completion_tokens": 65,
        "total_tokens": 10873
      }
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "McDonald's writes off all goodwill associated with a Company-operated restaurant acquisition if the restaurant is sold within 24 months, but for sales beyond 24 months, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This treatment is explicitly detailed in the \"GOODWILL\" section of the financial statements (page 45).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 86291,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21799,
        "completion_tokens": 98,
        "total_tokens": 21898
      }
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "AIG's equity method income from Corebridge after the deconsolidation date in 2024 was $601 million, representing the sum of dividends received and the increase in the investment’s fair value (reflecting Corebridge’s stock price) during the post‑deconsolidation period. This income is recorded in Net investment income within Other Operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 85193,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21517,
        "completion_tokens": 85,
        "total_tokens": 21603
      }
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Based on the provided document pages, McDonald's does not disclose a specific percentage of its global workforce that is employed by franchisees. However, the document states that approximately 95% of its 41,822 restaurants at year-end 2023 were franchised, and that \"the over two million individuals who work in McDonald's franchised restaurants around the world are critical to the Company's success.\" The company's recruitment initiative for diverse franchisees aims to increase the number of franchisees from underrepresented groups in the U.S. and International Operated Markets by reducing upfront equity requirements and providing ongoing learning and development, which would influence the demographic composition of the franchisee-owned workforce.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59024,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15018,
        "completion_tokens": 189,
        "total_tokens": 15207
      }
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program, together with the lower Black Hawk production volume, reduced RMS operating profit by roughly $100 million in 2023. This decline was offset in part by a $65 million favorable adjustment on an international surveillance program and higher volume on the Aegis program. Overall, RMS’s net profit‑booking rate adjustments were $100 million lower than in 2022, while the backlog grew primarily due to higher orders on Sikorsky programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46794,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11940,
        "completion_tokens": 130,
        "total_tokens": 12071
      }
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "Broadcom's acquisition of VMware was completed for approximately $30.8 billion in cash and stock, a transaction that was undertaken to enhance its infrastructure‑software capabilities and expand its portfolio of enterprise‑grade solutions. This deal aligns directly with Broadcom’s strategic focus on building a comprehensive suite of infrastructure and security software that modernizes, optimizes, and secures complex hybrid‑cloud environments for its customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53265,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13535,
        "completion_tokens": 116,
        "total_tokens": 13651
      }
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The $6.99 ad‑supported tier is part of Netflix’s strategy to broaden market penetration while carefully managing ARPU; the company notes that this tier is designed to attract price‑sensitive subscribers without cannibalizing higher‑priced plans, thereby supporting overall subscriber growth. This approach helped drive the 18% year‑over‑year increase in global paid memberships reported in 2024, as the tier expanded the addressable market and contributed to the net addition of 9.5 million paid members in the United States and Canada and 7.3 million in the rest of the world.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55042,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14003,
        "completion_tokens": 144,
        "total_tokens": 14147
      }
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "McDonald's employs approximately 1.9 million people globally across its Company-operated and franchised restaurants. This extensive workforce directly supports the company's purpose of \"feeding and fostering communities\" and its mission to \"make delicious feel-good moments easy for everyone\" by enabling the delivery of its standardized menu and service model worldwide, while also advancing its core values of Serve, Inclusion, Integrity, Community, and Family through its global operations and employee development initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62660,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15897,
        "completion_tokens": 132,
        "total_tokens": 16029
      }
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "The total fair value of the VMware acquisition was $53.4 billion, and the transaction was completed to enhance Broadcom’s infrastructure software capabilities, adding VMware’s multi‑cloud services and expanding Broadcom’s enterprise‑wide license model to drive revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53265,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13532,
        "completion_tokens": 69,
        "total_tokens": 13601
      }
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "Based on the 2024 10‑K, Netflix’s pricing strategy—highlighted by its tiered, region‑specific subscription fees (including a low‑priced ad‑supported plan) and frequent price adjustments—must balance revenue growth against the risk of member churn. The filing warns that any price increase or change perceived as reducing value could trigger cancellations, especially as macro‑economic pressures tighten household budgets, making it harder for Netflix to retain its existing subscriber base while still pursuing the pricing flexibility needed to boost revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65083,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16501,
        "completion_tokens": 139,
        "total_tokens": 16641
      }
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald's exposure to franchisee performance directly impacts its goodwill accounting when acquiring and selling restaurants. The company uses a discounted cash flow methodology (Level 3 inputs) to assess goodwill impairment, and if a Company-operated restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. Ongoing risks to franchisee profitability—such as operational failures, brand damage, or inability to meet financial obligations—could trigger goodwill impairment by reducing expected future cash flows from those locations. This is particularly relevant given the risks outlined in the franchise business model and the company's reliance on franchisee success for its overall financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 72488,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18362,
        "completion_tokens": 188,
        "total_tokens": 18550
      }
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin’s hypersonics programs are positioned as a key growth driver within its Space segment, which is focused on advanced strike and defensive systems, missile warning capabilities, and next‑generation space platforms such as the Trident II D5 fleet, GPS III, and the Orion crew vehicle.  The company expects several hypersonic programs with the U.S. Army and Navy to transition from testing to early production phases through 2026, feeding into its broader strategy of expanding classified programs, modernizing existing offerings, and securing new awards that reinforce its 21st‑Century Security vision and drive revenue growth through the mid‑2020s.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52900,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13435,
        "completion_tokens": 165,
        "total_tokens": 13601
      }
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflects its projected financial contribution through the use of the multi-period excess earnings method under the income approach. This technique estimates the economic benefit by calculating the present value of projected cash flows generated by the developed technology, after deducting charges representing the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, ensuring the valuation aligns with expected revenue generation over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49165,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12524,
        "completion_tokens": 160,
        "total_tokens": 12684
      }
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The launch of Sky Glass added to the expense base of Comcast’s Corporate and Other segment in 2021, as the company recorded higher costs tied to the new hardware rollout and related marketing initiatives. Looking ahead, Comcast expects these costs to rise further in 2022 as it continues to invest in Sky Glass and the newly introduced XClass TV platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 37998,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9720,
        "completion_tokens": 88,
        "total_tokens": 9809
      }
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "The Company's acquisition accounting policy requires that goodwill associated with a Company-operated restaurant acquired from a franchisee be written off in full if the restaurant is sold within 24 months of acquisition. If sold after 24 months, the goodwill write‑off amount is based on the relative fair value of the business sold compared to its reporting unit. This policy can result in significant goodwill write‑offs when restaurants are sold shortly after acquisition, as seen in the 2023 activity where net restaurant purchases and sales impacted goodwill balances, though no material impairment was identified in the current period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69196,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17542,
        "completion_tokens": 160,
        "total_tokens": 17702
      }
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "The concentration of Boeing’s customer‑financing portfolio in the 717 and 747‑8 aircraft, combined with the $1.8 billion of defaults tied to COVID‑19‑related airline revenue and cash‑flow declines, creates a dual vulnerability: if a major lessee defaults or the specialized jet values fall, the company may be unable to refinance or redeploy those planes, amplifying the impact of the pandemic‑driven losses on its overall financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40217,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10300,
        "completion_tokens": 110,
        "total_tokens": 10411
      }
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The launch of Sky Glass in Q4 2021 contributed to a sharp rise in the Corporate and Other segment’s revenue—up 86 % year‑over‑year to $461 million—driven by sales of the new smart‑TV hardware.  However, this revenue boost was offset by higher operating costs tied to the product rollout, resulting in a $1.3 billion Adjusted EBITDA loss for the segment in 2021, reflecting the upfront hardware expense and related marketing outlays.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 37873,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9702,
        "completion_tokens": 108,
        "total_tokens": 9810
      }
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "As of December 31, 2023, the fair value of CVS’s commercial mortgage‑backed securities was $975 million, and this category represented an unrealized loss of $100 million within the total debt‑securities portfolio, which had a fair value of $21,713 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57005,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14479,
        "completion_tokens": 64,
        "total_tokens": 14543
      }
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "The growth in third-party seller unit sales contributed to Amazon's overall sales increase in 2023 by driving higher unit sales across North America and International segments, which were cited as key factors behind the 12% consolidated sales growth. This growth was specifically attributed to increased unit sales by third-party sellers, alongside advertising and subscription services.  \n\nA key international risk related to third-party sellers that could impact Amazon's expansion strategy is the potential for regulatory changes in China and India, where government restrictions on foreign investment, ownership, and operations of e-commerce platforms could disrupt Amazon's ability to sustain or scale its marketplace activities in these high-growth regions. Specifically, China's regulations on foreign investment and India's restrictions on foreign control of multi-brand retail could force structural changes to Amazon's business model, potentially affecting revenue from third-party sellers in these markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50448,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12846,
        "completion_tokens": 254,
        "total_tokens": 13100
      }
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "Based on the \"Equity Compensation Plan Information\" table in the document (page 10), the number of shares remaining available for future issuance under the **Non-Qualified Deferred Compensation Plan for Independent Contractors** (a plan not approved by security holders) is **140,553 shares**. This is explicitly listed in the \"Plans not approved by security holders\" section of the table. \n\nThe question asks for the difference in shares remaining available between the **Deferred Compensation Plan** and the **Non-Qualified Deferred Compensation Plan for Independent Contractors**. The Deferred Compensation Plan (also not approved by security holders) has **1,853,363 shares** remaining. \n\nThe difference is:  \n**1,853,363 – 140,553 = 1,712,810 shares**.  \n\nHowever, the question specifically asks for the *difference in the number of shares remaining available* between the two plans, and the provided data directly states the remaining shares for each. The Non-Qualified Deferred Compensation Plan for Independent Contractors has **140,553 shares** remaining, while the Deferred Compensation Plan has **1,853,363 shares** remaining. The difference is **1,712,810 shares**, but the question requires the *number of shares remaining available for the Non-Qualified Deferred Compensation Plan for Independent Contractors* as the answer to the comparison. \n\n**Answer**: The Non-Qualified Deferred Compensation Plan for Independent Contractors has **140,553 shares** remaining available for future issuance.  \n\n*(Note: The question phrasing conflates \"difference\" with the value for the Non-Qualified plan, but the document explicitly provides the 140,553 figure for that plan. The answer is derived directly from the table.)*",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54914,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13957,
        "completion_tokens": 431,
        "total_tokens": 14388
      }
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "Based on the 2022 10‑K filing (pages 31‑35, 95‑99), PMI’s reduced‑risk product line includes **heated‑tobacco units (HTUs), heat‑not‑burn devices, e‑vapor products and oral nicotine products**.  Within the “Reduced‑Risk Products” category, **heated‑tobacco units account for a significant portion of the $9.1 billion net revenue from reduced‑risk products in 2021**, reflecting sales of brands such as HEETS, Marlboro HeatSticks, TEREA and other licensed HTU consumables across its geographic segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41556,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10614,
        "completion_tokens": 125,
        "total_tokens": 10739
      }
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "The provided document does not contain any information about a customer named \"DirectCustomerA\" or its revenue contribution to NVIDIA's total revenue for fiscal year 2025. The only customer-related data shows that \"DirectCustomerA\" accounted for 12% of total revenue in fiscal year 2025 (based on the table listing \"DirectCustomerA\" as 12% for Jan26,2025), but it does not specify what percentage of NVIDIA's revenue came from DirectCustomerA specifically. Furthermore, the document does not provide any data about DirectCustomerA's revenue for the previous fiscal year (2024), as the table only shows \"DirectCustomerA\" as 12% for 2025 and \"*\" (less than 10%) for 2024. Therefore, it is impossible to determine the percentage of NVIDIA's revenue from DirectCustomerA in fiscal year 2025 or how it compares to the previous year based on the provided document.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35060,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8976,
        "completion_tokens": 214,
        "total_tokens": 9191
      }
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "\nBased on the 2023 10-K filing (pages 11–15), the document lists two distinct versions of the Restricted Share Rights Award Agreement in the \"EXHIBITS\" section. Specifically, one version is referenced for \"grants on or after January 24, 2023\" (incorporated by reference to Exhibit 10(a) to the 2022 Annual Report on Form 10-K), and a separate version is referenced for \"grants on or after January 23, 2024\" (filed herewith). Thus, there is 1 distinct version for each specified grant date threshold.",
      "llm_thought": "Based on the provided pages from Wells Fargo's 2023 10-K filing, the question asks for the number of distinct versions of the Restricted Share Rights Award Agreement that were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively.\n\nFrom the \"EXHIBITS\" section (page 15), the relevant information is found in the table listing exhibits related to award agreements. Specifically, under \"Forms of Restricted Share Rights Award Agreement,\" the document specifies:\n\n- \"For grants on or after January 23, 2024\" (incorporated by reference to Exhibit 10(a) to the Company's Annual Report on Form 10-K for the year ended December 31, 2022).\n- \"For grants on or after January 24, 2023\" (incorporated by reference to Exhibit 10(a) to the Company's Annual Report on Form 10-K for the year ended December 31, 2022).\n\nThese are two distinct versions of the Restricted Share Rights Award Agreement, each corresponding to a specific grant date threshold. The document explicitly lists both versions as separate entries in the exhibit table, confirming that two distinct versions were filed or incorporated by reference for the specified grant dates.\n\nThus, the answer is 2 distinct versions for the grant occurring on or after January 24, 2023, and 1 distinct version for the grant occurring on or after January 23, 2024. However, the question asks for the number of distinct versions for each threshold, and the document shows one version for each threshold. Therefore, the number of distinct versions for grants on or after January 24, 2023, is 1, and for grants on or after January 23, 2024, is 1. But the question phrasing implies a single answer for the pair, and the document lists two separate versions (one for each date threshold), so the total distinct versions referenced are two, but the question asks for the count per threshold.\n\nRe-reading the question: \"How many distinct versions... were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively?\"\n\nThe \"respectively\" indicates that the first number corresponds to January 24, 2023, and the second to January 23, 2024. From the exhibit table:\n- For grants on or after January 24, 2023: one version is listed (\"For grants on or after January 24, 2023\").\n- For grants on or after January 23, 2024: one version is listed (\"For grants on or after January 23, 2024\").\n\nThus, there is 1 distinct version for each threshold. However, the question might be interpreted as asking for the total number of distinct versions mentioned in the context of both dates, but the phrasing specifies \"respectively,\" so it's asking for two numbers. But the answer format requires a concise response (2-3 sentences), and the question likely expects the count for the first date (January 24, 2023) as the primary focus, but the question says \"for grants occurring on or after January 24, 2023, and January 23, 2024, respectively,\" meaning it wants the number for each.\n\nBut the document shows one version for each, so the answer should be 1 for the first and 1 for the second. However, the question is phrased to ask for \"how many distinct versions\" in the context of the two dates, and the answer is that there is one version for each. But the user's question is: \"How many distinct versions... were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively?\"\n\nThe key is that the document lists two separate versions: one for \"on or after January 24, 2023\" and one for \"on or after January 23, 2024.\" Therefore, there are two distinct versions in total, but the question is asking for the number corresponding to each date. However, the way it's phrased, \"for grants occurring on or after January 24, 2023, and January 23, 2024, respectively,\" means that the first number is for January 24, 2023, and the second for January 23, 2024. From the document:\n- For grants on or after January 24, 2023: 1 version (as stated in the exhibit).\n- For grants on or after January 23, 2024: 1 version (as stated in the exhibit).\n\nBut the question might be misinterpreted. Looking at the exhibit table, it lists:\n- \"For grants on or after January 23, 2024\" (which is one version)\n- \"For grants on or after January 24, 2023\" (which is another version)\n\nSo, there are two distinct versions mentioned, each associated with a specific date threshold. The question asks for the number of distinct versions for each threshold, so for the threshold \"on or after January 24, 2023,\" there is 1 version, and for \"on or after January 23, 2024,\" there is 1 version. However, the question says \"respectively,\" so the answer should be 1 and 1, but the answer format expects a concise response.\n\nThe user's question is: \"How many distinct versions... were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively?\"\n\nIn the context of the document, the phrase \"for grants occurring on or after January 24, 2023\" refers to one version, and \"for grants on or after January 23, 2024\" refers to another version. Therefore, there is one distinct version for the first date and one distinct version for the second date. But the question is asking for the number, so the answer should be 1 for the first and 1 for the second. However, the way the question is phrased, it might be expecting a single number, but it says \"respectively,\" so it's two numbers.\n\nBut the answer format requires a concise response (2-3 sentences), and the question is likely designed to have a specific answer. From the document, the key is that the exhibit lists two different versions: one for \"on or after January 24, 2023\" and one for \"on or after January 23, 2024.\" So, for the grant date threshold \"on or after January 24, 2023,\" there is one distinct version, and for \"on or after January 23, 2024,\" there is one distinct version. Therefore, the number for the first part (January 24, 2023) is 1, and for the second part (January 23, 2024) is 1.\n\nHowever, the question might be interpreted as asking for the total number of distinct versions mentioned in the context of both dates, but the phrasing \"respectively\" suggests it's asking for two separate numbers. But in the answer, we need to provide a concise response. The most accurate answer based on the document is that there is one distinct version for grants on or after January 24, 2023, and one distinct version for grants on or after January 23, 2024.\n\nBut let's double-check the document. In the exhibit table, it says:\n- \"For grants on or after January 23, 2024\" (this is one version)\n- \"For grants on or after January 24, 2023\" (this is another version)\n\nSo, the version for \"on or after January 24, 2023\" is listed, and the version for \"on or after January 23, 2024\" is listed. Therefore, for the threshold \"on or after January 24, 2023,\" there is one distinct version, and for \"on or after January 23, 2024,\" there is one distinct version.\n\nThe question asks: \"How many distinct versions... were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively?\"\n\nSo, the answer should be: 1 for January 24, 2023, and 1 for January 23, 2024.\n\nBut the user might expect a single number, but the question says \"respectively,\" so it's two numbers. However, the answer format requires a concise response, so we can say \"There is 1 distinct version for grants on or after January 24, 2023, and 1 distinct version for grants on or after January 23, 2024.\"\n\nBut to be precise, the document shows that the version for \"on or after January 24, 2023\" is one, and the version for \"on or after January 23, 2024\" is another, so two distinct versions in total, but the question is asking for the count per threshold.\n\nGiven the context, the intended answer is that there are two distinct versions mentioned, but the question is phrased to ask for the number for each date. However, in the document, the two versions are for different date thresholds, so the number for the first date (January 24, 2023) is 1, and for the second date (January 23, 2024) is 1.\n\nBut let's look at the exact wording in the exhibit: \n- \"For grants on or after January 23, 2024\" — this is one version.\n- \"For grants on or after January 24, 2023\" — this is another version.\n\nSo, the version for \"on or after January 24, 2023\" is one distinct version, and the version for \"on or after January 23, 2024\" is one distinct version. Therefore, the number for the first part (January 24, 2023) is 1, and for the second part (January 23, 2024) is 1.\n\nThe question says \"for grants occurring on or after January 24, 2023, and January 23, 2024, respectively,\" so the first number (1) corresponds to January 24, 2023, and the second number (1) corresponds to January 23, 2024.\n\nThus, the answer is 1 and 1, but since the answer format is concise, we can state it as: \"There is 1 distinct version for grants on or after January 24, 2023, and 1 distinct version for grants on or after January 23, 2024.\"\n\nHowever, the user's question might be expecting a single number, but the phrasing \"respectively\" indicates two numbers. But in the context of the document, it's clear that there are two separate versions listed for the two different date thresholds.\n\nAfter re-examining the question: \"How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively?\"\n\nThe key is that \"grants occurring on or after January 24, 2023\" refers to one version, and \"grants occurring on or after January 23, 2024\" refers to another version. So, for the first phrase (\"grants occurring on or after January 24, 2023\"), there is 1 distinct version, and for the second phrase (\"grants occurring on or after January 23, 2024\"), there is 1 distinct version.\n\nTherefore, the answer is 1 for the first and 1 for the second.\n\nBut to confirm with the document, in the exhibit table, it lists:\n- \"For grants on or after January 24, 2023\" — this is one entry, so one version.\n- \"For grants on or after January 23, 2024\" — this is another entry, so one version.\n\nSo, the number for the first date (January 24, 2023) is 1, and for the second date (January 23, 2024) is 1.\n\nThus, the concise answer is: \"There is 1 distinct version for grants on or after January 24, 2023, and 1 distinct version for grants on or after January 23, 2024.\"\n\nHowever, the question might be interpreted as asking for the total number of distinct versions that cover both date ranges, but that doesn't make sense because the versions are defined for specific thresholds. The document lists two separate versions, each for a different threshold, so there are two distinct versions in total, but the question is asking for the count per threshold.\n\nGiven the instructions to provide a focused, concise response (2-3 sentences), and based on the document, the answer is that there is one distinct version for each threshold.\n\nBut let's see what the document actually says. In the exhibit table, it lists:\n- \"For grants on or after January 23, 2024\" — this is one version.\n- \"For grants on or after January 24, 2023\" — this is another version.\n\nSo, the version for \"on or after January 24, 2023\" is one distinct version, and the version for \"on or after January 23, 2024\" is one distinct version.\n\nTherefore, for the question, the number for \"grants occurring on or after January 24, 2023\" is 1, and for \"grants occurring on or after January 23, 2024\" is 1.\n\nSo, the answer should be 1 and 1.\n\nBut the user's question is phrased to ask for \"how many distinct versions\" for the two dates respectively, so the response should indicate that there is 1 for the first and 1 for the second.\n\nIn the context of the answer, we can say: \"Based on the 2023 10-K filing, there is 1 distinct version of the Restricted Share Rights Award Agreement for grants on or after January 24, 2023, and 1 distinct version for grants on or after January 23, 2024.\"\n\nThis is concise and directly answers the question.\n\nNow, to ensure accuracy, let's verify the document. In the exhibit table on page 15, under \"Forms of Restricted Share Rights Award Agreement,\" it lists:\n- \"For grants on or after January 23, 2024\" — Filed herewith.\n- \"For grants on or after January 24, 2023\" — Incorporated by reference to Exhibit 10(a) to the Company's Annual Report on Form 10-K for the year ended December 31, 2022.\n\nSo, yes, two separate versions are listed, each corresponding to a different date threshold. Therefore, for the threshold \"on or after January 24, 2023,\" there is one distinct version, and for \"on or after January 23, 2024,\" there is one distinct version.\n\nThus, the answer is 1 for each.\n\nFinal answer: There is 1 distinct version for grants on or after January 24, 2023, and 1 distinct version for grants on or after January 23, 2024.\n",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65750,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16668,
        "completion_tokens": 3373,
        "total_tokens": 20042
      }
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The continued uncertainty surrounding FAA approval to resume 787 deliveries created significant estimation risk for Boeing’s 787 program accounting revenue and margin forecasts.  Management’s estimates of when the FAA would lift the grounding—and which aircraft would trigger contractual termination rights—were subject to wide ranges of reasonable outcomes, leading to potential reach‑forward losses and lower margins if the approval timeline shifted.  Auditors addressed this by testing the reasonableness of the delivery‑resumption assumptions, evaluating related controls, and corroborating key data, but the inherent uncertainty meant that cost‑of‑sales and margin projections remained highly sensitive to the unresolved FAA timing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 136,
          "pages": [
            134,
            135,
            136,
            137,
            138
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 31542,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8124,
        "completion_tokens": 184,
        "total_tokens": 8309
      }
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "In 2023, third‑party sellers drove growth in both North America and International net sales, contributing to the 12 % rise in North America sales and the 11 % rise in International sales. The net effect of foreign‑exchange movements was a $71 million reduction in consolidated net sales, with foreign‑exchange rates boosting International sales by $88 million but offsetting overall growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50448,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12839,
        "completion_tokens": 97,
        "total_tokens": 12936
      }
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Deficiencies in Wells Fargo’s anti‑money‑laundering program could trigger regulatory actions that limit or prohibit future bank acquisitions, as the Federal Reserve would consider such deficiencies when evaluating any proposed acquisition. The Federal Reserve (FRB) would be the regulator that assesses these deficiencies during the approval process.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67448,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17101,
        "completion_tokens": 87,
        "total_tokens": 17188
      }
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020 was 2.4%, and heated tobacco units fall under the \"Reduced-Risk Products\" category in PMI's financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39282,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10055,
        "completion_tokens": 60,
        "total_tokens": 10115
      }
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "Based on the provided document, Boeing's $1.8 billion customer financing portfolio includes receivables rated CCC, for which a default rate of 24.2 % is applied. If every CCC‑rated receivable within this portfolio were to default, the potential loss would be 24.2 % of the exposure tied to those CCC ratings. The document indicates that the total exposure for CCC‑rated receivables is $445 million (the “CCC” column in the rating‑category table), so the maximum loss would be roughly $108 million (24.2 % × $445 million). However, the question asks for the increase in potential losses if **all** CCC‑rated receivables in the $1.8 billion portfolio defaulted. Since the entire $1.8 billion portfolio is subject to the 24.2 % default rate for CCC‑rated items, the loss would be 24.2 % × $1.8 billion ≈ **$436 million**. Thus, the potential increase in losses would be about **$436 million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35916,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9225,
        "completion_tokens": 222,
        "total_tokens": 9448
      }
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "Based on the provided document pages, NVIDIA did not disclose a specific customer named \"DirectCustomerC\" in its fiscal year 2025 revenue breakdown. The only customer concentration data presented shows:\n\n- DirectCustomerA: 12% of total revenue (fiscal year 2025)\n- DirectCustomerB: 11% of total revenue (fiscal year 2025)\n- DirectCustomerC: * (less than 10% of total revenue)\n\nThe document explicitly states \"* Less than 10% of total revenue\" for DirectCustomerC in fiscal year 2025, confirming it did not account for 10% or more of total revenue. Therefore, the percentage of revenue from DirectCustomerC cannot be determined from the provided information, and no comparison to the prior year's data for this specific customer is available. The document only provides revenue percentages for DirectCustomerA and DirectCustomerB, with DirectCustomerC falling below the 10% disclosure threshold.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38283,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9793,
        "completion_tokens": 223,
        "total_tokens": 10016
      }
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "Based on the provided document pages, the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, is $975 million. This is explicitly stated in the \"Amortized Cost and Fair Value of Debt Securities at December 31, 2023\" table under \"Commercial mortgage-backed securities\" (Fair Value: $975). \n\nRegarding the comparison to unrealized losses, the document indicates that CMBS securities in an unrealized loss position had a total unrealized loss of $100 million as of December 31, 2023, as shown in the \"Debt securities in an unrealized capital loss position\" table (Unrealized Losses: $100 for \"Commercial mortgage-backed securities\"). This $100 million unrealized loss represents the aggregate of losses across all maturities (both less than 12 months and greater than 12 months), confirming that the unrealized losses associated with CMBS are $100 million, which is consistent with the $975 million fair value figure. The document further notes that these unrealized losses were primarily caused by interest rate increases rather than credit quality deterioration, and the Company did not intend to sell these securities prior to recovery. \n\nThus, the fair value of CMBS ($975 million) and its associated unrealized losses ($100 million) are directly supported by the provided data. \n\n(2 sentences)",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58726,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14922,
        "completion_tokens": 341,
        "total_tokens": 15263
      }
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "Based on the disclosed components, changes in estimated fair value of Unit-linked securities are recorded within **net investment income**, whereas changes in estimated fair value of net derivative gains (losses) are recorded within **net derivative gains (losses)**. This distinction is reinforced by Note 1, which states that amortization of premium/accretion of discount is included in net investment income, impairments are recorded in net investment gains (losses), and “lapses associated with net embedded derivatives are included in net derivative gains (losses).” Consequently, fair‑value fluctuations of Unit‑linked securities flow through net investment income, while similar fluctuations related to embedded derivatives and net derivative positions flow through net derivative gains (losses).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 252,
          "pages": [
            250,
            251,
            252,
            253,
            254
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 102940,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 25966,
        "completion_tokens": 200,
        "total_tokens": 26167
      }
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "In the fourth quarter of 2021 Boeing recorded a $3.5 billion loss on the 787 program, driven by rework‑related delivery delays and the associated customer considerations. Because the timing of the FAA’s approval to resume deliveries—and therefore when delayed‑delivery penalties or termination rights may trigger—remains uncertain, the revenue estimates for undelivered 787 aircraft are highly judgmental; any further delay or additional rework could lower margins or generate additional reach‑forward losses, making future revenue projections especially volatile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 136,
          "pages": [
            134,
            135,
            136,
            137,
            138
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34058,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8760,
        "completion_tokens": 141,
        "total_tokens": 8901
      }
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "Based on the provided document, NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. This contrasts with the prior fiscal year (January 28, 2024), where DirectCustomerA contributed less than 10% of total revenue (indicated by an asterisk \"*\" meaning \"Less than 10% of total revenue\"). Thus, the percentage increased from below 10% in the prior year to 12% in the current year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38283,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9800,
        "completion_tokens": 105,
        "total_tokens": 9905
      }
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "Based on the document, the total financial impact from Amgen's 2023 equity investment and collaboration with BeiGene is calculated as follows:  \n- The fair value of the investment in BeiGene was **$4.2 billion** (as of December 31, 2022), and the carrying value was **$2.2 billion**.  \n- Net cost recoveries from BeiGene for oncology product candidates were **$109 million** (recorded as an offset to R&D expense).  \n- Product sales from Amgen to BeiGene were **$125 million** (recorded in Product sales).  \n- Profit and loss sharing expenses related to the collaboration were **$40 million** (recorded in SG&A expense).  \n\nThe combined financial impact for 2023 is **$4.2 billion (fair value) + $109 million (net cost recoveries) + $125 million (product sales) - $40 million (profit/loss sharing expenses) = $4.4 billion**. However, the question specifically asks for the *total financial impact combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses*. The fair value of the investment ($4.2 billion) is the primary component, and the other items ($109M + $125M - $40M = $194M) are offsets that reduce the net impact. Thus, the total financial impact is **$4.2 billion (fair value) + $194 million (net of offsets) = $4.394 billion**, which rounds to **$4.4 billion** as the aggregate impact.  \n\n**Answer:** The total financial impact on Amgen from its 2023 equity investment and collaboration with BeiGene, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million), is **$4.4 billion**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54642,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13905,
        "completion_tokens": 416,
        "total_tokens": 14322
      }
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "The Company applies estimated lifetime loss rates over the contractual term of each loan, adjusted for expected prepayments and extensions, and then reverts to historical loss experience on a straight‑line basis after the forecast period. For commercial and agricultural mortgage loans the forecast period is generally two years, while for residential mortgage loans it is also two years; after these forecast periods the estimated loss rates transition to historical experience over one‑ to two‑year straight‑line periods before the allowance is finalized.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 216,
          "pages": [
            214,
            215,
            216,
            217,
            218
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63793,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16181,
        "completion_tokens": 139,
        "total_tokens": 16321
      }
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco funds its employee health‑care benefits through a self‑insurance program that relies on actuarial assumptions to estimate claim costs. Because actual claims can be highly unpredictable—fluctuating with medical inflation, regulatory changes, and unforeseen developments—the actuarial estimates may underestimate or overestimate the required reserves. If actual costs exceed the reserves, the company could face higher expenses that strain cash flow, especially when combined with labor‑related risks such as rising health‑care benefit costs and potential liability from workers’ compensation or other exposures. This makes the self‑insurance approach a material risk factor for Costco’s overall financial condition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37394,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9585,
        "completion_tokens": 180,
        "total_tokens": 9765
      }
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "3M recorded a total pre‑tax charge of **$4.2 billion** in 2023 related to the CAE Settlement (including the $5.3 billion present‑value contribution and the $1.1 billion existing accrual). As of December 31, 2023, the reconsolidation of the Aearo Entities added back **$0.7 billion of equity‑method investments** and **$0.6 billion of net intercompany liabilities** to the consolidated balance sheet, restoring those amounts that had been removed when the entities were previously deconsolidated.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54264,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13800,
        "completion_tokens": 123,
        "total_tokens": 13923
      }
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "Google's integration of Gemini 2.0 into Vertex AI expands developers' capabilities on Google Cloud by giving them direct access to the latest multimodal Gemini model within the Vertex AI platform. This enables developers to train, fine‑tune, augment, test, and deploy applications using Gemini and other generative AI models, as well as leverage pre‑packaged AI agents for tasks such as code assistance, documentation, testing, and cybersecurity threat detection.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44681,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11383,
        "completion_tokens": 115,
        "total_tokens": 11498
      }
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities raises the reported investment income by adding the $205 million (2024) and $188 million (2023) of investment income (loss) from those securities, and it increases sensitivity to fair‑value changes because FVO securities are classified as Level 3 and their valuations rely on significant unobservable inputs; consequently, any shifts in those inputs affect the reported yield and earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81587,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20645,
        "completion_tokens": 119,
        "total_tokens": 20764
      }
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The total pre-tax financial impact of the Aearo deconsolidation in 2022 and its reconsolidation in 2023 was $1.2 billion, reflecting a $1.0 billion charge recorded in 2022 and a $0.2 billion charge in 2023. Both events were directly tied to the Combat Arms Earplugs litigation, as the bankruptcy proceedings of the Aearo Entities—triggered by that litigation—caused the initial deconsolidation and subsequent reconsolidation, and the related settlement and accrual adjustments impacted 3M’s financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55704,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14162,
        "completion_tokens": 128,
        "total_tokens": 14290
      }
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "Adobe's integration of Firefly into Creative Cloud and Document Cloud supports its strategy of growing recurring revenue and expanding its customer base by embedding AI-driven capabilities that enhance product value and attract new users. Specifically, Firefly’s generative AI features—such as automated photo editing, content-aware tools, and text-to-image generation—are now accessible across Creative Cloud applications like Photoshop and Express, driving subscriber growth and engagement through affordable, AI-enhanced workflows. Additionally, Firefly’s inclusion in Document Cloud enables intelligent document services (e.g., AI-powered PDF summarization and automation), further solidifying Adobe’s subscription-based revenue model and broadening its appeal to both creative professionals and non-traditional users. This AI-driven innovation directly contributes to the 14% year-over-year growth in Digital Media ARR ($15.17B in fiscal 2023), underpinning Adobe’s shift toward predictable, recurring revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51228,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13048,
        "completion_tokens": 255,
        "total_tokens": 13304
      }
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "As of December 31, 2022, the fair value of Amgen’s U.S. Treasury bills and money‑market mutual funds was $1,676 million and $2,659 million, respectively, for a combined total of $4,335 million. This amount represents the full fair value of all available‑for‑sale investments reported on the balance sheet for that year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52285,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13305,
        "completion_tokens": 79,
        "total_tokens": 13384
      }
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The valuation techniques for Unit‑linked securities rely on significant unobservable inputs—particularly long‑term equity volatility and non‑performance risk spreads—used in option‑pricing and present‑value models. Because these inputs are embedded in the fair‑value calculations, increases in long‑term equity volatility or wider non‑performance risk spreads produce a measurable increase in the estimated fair value of the Unit‑linked liabilities, while decreases have the opposite effect. Consequently, fair‑value measurements are directly sensitive to changes in these inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 296,
          "pages": [
            294,
            295,
            296,
            297,
            298
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 74237,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18793,
        "completion_tokens": 145,
        "total_tokens": 18938
      }
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe's introduction of Generative Credits within Creative Cloud—providing subscribers with a monthly allocation of credits to use Firefly's AI-powered content creation features—directly advances its strategy to deepen engagement and drive subscription revenue by expanding AI capabilities across both creative professionals and broader stakeholder groups. By embedding generative AI into flagship applications like Photoshop, Illustrator, and Express, Adobe enhances the value of its core subscriptions, encourages adoption among non-traditional users (e.g., marketers, educators, and enterprise teams), and creates new revenue opportunities through paid credit purchases once free limits are exhausted, reinforcing its vision of democratizing creativity while fueling recurring revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51641,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13151,
        "completion_tokens": 198,
        "total_tokens": 13350
      }
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "The integration of Gemini 2.0 into Google’s billion‑user products and the Vertex AI platform expands Google Cloud’s AI‑optimized infrastructure and developer services, enabling enterprises to train, tune, and deploy AI workloads at scale and driving higher consumption‑based revenue from cloud compute, networking, storage, and AI‑accelerator offerings. This broad reach also fuels demand for Google Cloud’s developer platform (Vertex AI) and related services such as cybersecurity and data‑analytics, directly boosting the company’s AI‑focused revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45414,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11580,
        "completion_tokens": 140,
        "total_tokens": 11720
      }
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "Changes in prepayment and default rates affect the amortization of premium and accretion of discount on structured products, which in turn influences the timing and amount of income recognized on FVO securities. Additionally, unobservable inputs such as default rates, loss severity, and prepayment speeds are used in fair value measurements of these securities and impact their valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 209,
          "pages": [
            207,
            208,
            209,
            210,
            211
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 84075,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 21244,
        "completion_tokens": 97,
        "total_tokens": 21341
      }
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco’s Kirkland Signature private‑label brand is a key driver of both member loyalty and higher profitability. Because Kirkland products are priced lower than comparable national brands yet carry higher margins, they boost overall gross margin performance while reinforcing the value proposition that keeps members renewing. However, the company acknowledges risks tied to production and supply‑chain reliability—disruptions can affect product availability, potentially eroding the brand’s reputation and, consequently, membership retention and margin benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47160,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12016,
        "completion_tokens": 140,
        "total_tokens": 12157
      }
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair value of \"Other short-term interest-bearing securities\" increased from $0 million at December 31 2022 to $138 million at December 31 2023. This rise contributed to the total available‑for‑sale investments growing from $4,335 million in 2022 to $10,404 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52285,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13310,
        "completion_tokens": 69,
        "total_tokens": 13379
      }
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The Proposed Plan of compromise and arrangement filed by RBH on January 24 2025 signaled that the allocation of the CAD 32.5 billion settlement among RBH, ITL and JTI was uncertain, which indicated a potential impairment of PMI’s equity investment in RBH. Accordingly, PMI performed a quantitative valuation as of December 31 2024, concluded that the fair value of the investment ($714 million) was below its carrying amount, and recorded a non‑cash impairment charge of $2,316 million in the consolidated statement of earnings for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 147,
          "pages": [
            145,
            146,
            147,
            148,
            149
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44521,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11387,
        "completion_tokens": 134,
        "total_tokens": 11522
      }
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "Based on the filing, the TAC rate is explicitly stated as 22% in the \"Critical Accounting Estimates\" section (Note 1). With advertising revenues from Google Network properties growing by $10 billion in 2023 versus 2022, and assuming the TAC rate remains constant at 22%, the absolute dollar increase in TAC paid to Google Network partners would be calculated as $10 billion × 22% = $2.2 billion. This is derived from the consistent TAC rate referenced in the document and the direct revenue growth figure provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39641,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10196,
        "completion_tokens": 128,
        "total_tokens": 10324
      }
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "Based on the provided financial statements, the carrying value of UnitedHealth Group's long-term debt and other financing obligations increased from $75,604 million at December 31, 2023 to $75,604 million at December 31, 2024 (no change), while the fair value of this debt increased from $70,565 million to $70,565 million (also no change). However, the document indicates that the fair value of long-term debt is estimated using the same methodologies as debt securities, and the carrying value of long-term debt and other financing obligations is reported as $75,604 million at the end of 2024 compared to $61,449 million at the end of 2023 in the summary table (which appears to be a typo in the document, as the 2024 carrying value is listed as $75,604 million but the fair value is $70,565 million). The change in carrying value is therefore $14,155 million (from $61,449 to $75,604), while the change in fair value is $10,714 million (from $59,851 to $70,565), indicating the carrying value increased more than the fair value over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58292,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14803,
        "completion_tokens": 262,
        "total_tokens": 15065
      }
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com drove a **108.4% increase in merchant gross bookings** and contributed to a **94.6% rise in merchant revenues** in 2022, outpacing the growth in agency revenues. This expansion also led to higher merchant transaction costs, as noted in the sales and other expenses section, where merchant-related costs increased by $573 million due to the growth in merchant transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38034,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9745,
        "completion_tokens": 112,
        "total_tokens": 9857
      }
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "The introduction of AMD’s Zynq UltraScale+ RFSoCs strengthens its FPGA and Adaptive SoC portfolio by adding the industry’s first RF‑centric System‑on‑Chip that integrates high‑performance RF data converters directly with programmable logic. This move aligns with AMD’s broader strategy to address markets—such as wireless, radar, and cable access—that demand advanced RF data‑conversion capabilities, expanding its reach into high‑value embedded and communications applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48511,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12367,
        "completion_tokens": 119,
        "total_tokens": 12487
      }
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "\nBased on the provided document pages, the total carrying value of UnitedHealth Group's debt securities - held-to-maturity as of December 31, 2024, is $512 million, and the total fair value is $508 million. The carrying value ($512 million) is $4 million higher than the fair value ($508 million). The document does not provide a combined carrying value for both 2023 and 2024, but the 2024 carrying value ($512 million) and fair value ($508 million) are explicitly stated in the \"Debt securities - held-to-maturity\" row of the fair value hierarchy table. The 2023 fair value is $596 million, but the 2023 carrying value is not provided in the text. Thus, the comparison is based on the 2024 figures. \n\n(Word count: 100)",
      "llm_thought": "Based on the provided document pages, the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined is $512 million (as reported in the \"Debt securities - held-to-maturity\" row of the fair value hierarchy table for December 31, 2024, which reflects the carrying value for 2024, and the corresponding $596 million fair value for 2023 is not directly additive to the carrying value). However, the question asks for the combined carrying value for both years, but the document only provides the carrying value for 2024 ($512 million) and the fair value for 2023 ($596 million) is not the carrying value. The carrying value for 2023 is not explicitly stated in the provided text, but the fair value for 2023 is $596 million, and the carrying value is typically close to fair value for held-to-maturity securities. The document states the total fair value of held-to-maturity debt securities as $508 million as of December 31, 2024, and $596 million as of December 31, 2023. The carrying value for 2024 is $512 million (as shown in the table: \"Total debt securities - held-to-maturity\" row with \"Total debt securities - held-to-maturity\" Amortized Cost = $512). The fair value for 2024 is $508 million. Therefore, the combined carrying value for both years is not directly additive, but the question likely intends to reference the 2024 carrying value as the relevant figure for the current period. The total fair value for 2024 is $508 million, and for 2023, the fair value is $596 million, but the carrying value for 2023 is not provided. However, the question asks for the carrying value combined, but the document only gives the 2024 carrying value as $512 million. The fair value for 2024 is $508 million, and the fair value for 2023 is $596 million, but the carrying value for 2023 is not stated. The document states \"Total debt securities - held-to-maturity\" Amortized Cost for 2024 is $512, and for 2023, the fair value is $596, but the carrying value for 2023 is not explicitly given. The question likely expects the 2024 carrying value as the answer, but it asks for combined. Given the context, the total carrying value for the held-to-maturity securities as of December 31, 2024, is $512 million, and the fair value is $508 million. The question asks for the combined carrying value for both years, but the document does not provide a combined figure. However, the document shows the carrying value for 2024 is $512 million, and the fair value for 2024 is $508 million. The fair value for 2023 is $596 million, but the carrying value for 2023 is not provided. The question might be misinterpreted, but based on the data, the carrying value for 2024 is $512 million, and the fair value for 2024 is $508 million. The document does not provide a combined carrying value for both years, so the answer should be based on the 2024 figures as the most recent. The total carrying value for held-to-maturity debt securities as of December 31, 2024, is $512 million, and the total fair value is $508 million. The question asks for the combined carrying value for both years, but since the document only provides the 2024 carrying value, and the 2023 carrying value is not stated, the answer should reflect the 2024 carrying value as the relevant figure. However, the question says \"for both 2023 and 2024 combined,\" which might imply summing the carrying values, but the document does not provide a 2023 carrying value. The document states the fair value for 2023 is $596 million, and the carrying value for 2024 is $512 million, but the carrying value for 2023 is not given. The only carrying value mentioned is for 2024 ($512 million). Therefore, the answer should be that the total carrying value as of December 31, 2024, is $512 million, and the total fair value is $508 million. The comparison is that the carrying value ($512 million) is slightly higher than the fair value ($508 million). The question asks for the combined carrying value for both years, but since the document does not provide a 2023 carrying value, the answer should be based on the 2024 data as the most recent. The document shows the carrying value for held-to-maturity as $512 million as of December 31, 2024, and the fair value as $508 million. The fair value for 2023 is $596 million, but the carrying value for 2023 is not provided. The question likely expects the 2024 figures, so the total carrying value for the held-to-maturity securities is $512 million, and the total fair value is $508 million. The comparison is that the carrying value is $512 million, which is $4 million higher than the fair value of $508 million. However, the question says \"combined,\" but the document does not provide a combined figure for both years. Given the context, the answer should be that the total carrying value as of December 31, 2024, is $512 million, and the total fair value is $508 million, with the carrying value being slightly higher. The document does not provide a combined carrying value for both years, so the answer is based on the 2024 data. Therefore, the total carrying value is $512 million, and the total fair value is $508 million, with the carrying value being $4 million higher than the fair value.\n\nTo be precise, the document states: \"Total debt securities - held-to-maturity\" Amortized Cost = $512 (as of December 31, 2024), and \"Total debt securities - held-to-maturity\" Fair Value = $508 (as of December 31, 2024). The fair value for 2023 is $596, but the carrying value for 2023 is not stated. The question asks for the combined carrying value for both years, but since the document does not provide a 2023 carrying value, the answer should be based on the 2024 carrying value as the relevant figure for the current period. However, the question says \"for both 2023 and 2024 combined,\" which might be a misinterpretation, but the document only provides the 2024 carrying value. Therefore, the total carrying value as of December 31, 2024, is $512 million, and the total fair value is $508 million. The comparison is that the carrying value ($512 million) is slightly higher than the fair value ($508 million).\n\nThus, the answer is: The total carrying value of UnitedHealth Group's debt securities - held-to-maturity as of December 31, 2024, is $512 million, and the total fair value is $508 million, with the carrying value being $4 million higher than the fair value.\n\nBut the question asks for \"both 2023 and 2024 combined,\" which is not directly provided. However, the document shows the carrying value for 2024 is $512 million, and the fair value for 2023 is $596 million, but the carrying value for 2023 is not given. The only carrying value mentioned is for 2024. Therefore, the answer should be based on the 2024 data, as it is the most recent and the only carrying value provided. The total carrying value for the held-to-maturity securities is $512 million (as of December 31, 2024), and the total fair value is $508 million (as of December 31, 2024). The comparison is that the carrying value is $512 million, which is $4 million higher than the fair value of $508 million.\n\nSo, the concise answer is: The total carrying value is $512 million, and the total fair value is $508 million, with the carrying value being $4 million higher than the fair value.\n\nBut the question says \"for both 2023 and 2024 combined,\" which might be a mistake, but based on the document, the carrying value for 2024 is $512 million, and the fair value for 2024 is $508 million. The fair value for 2023 is $596 million, but the carrying value for 2023 is not provided. Therefore, the answer should be that the total carrying value as of December 31, 2024, is $512 million, and the total fair value is $508 million, with the carrying value being slightly higher.\n\nThus, the answer is: The total carrying value of the held-to-maturity debt securities is $512 million, and the total fair value is $508 million, with the carrying value being $4 million higher than the fair value.\n\nNow, to confirm with the document: In the table \"Debt securities - held-to-maturity\" under \"Total debt securities - held-to-maturity\", it shows \"Amortized Cost\" as $512 and \"Fair Value\" as $508 for December 31, 2024. The fair value for 2023 is $596, but the carrying value for 2023 is not stated. The question asks for the combined carrying value for both years, but since the document does not provide a 2023 carrying value, the answer should be based on the 2024 data. The question might have a typo, but the answer should be the 2024 carrying value and fair value.\n\nTherefore, the answer is: The total carrying value is $512 million, and the total fair value is $508 million, with the carrying value being $4 million higher than the fair value.\n\nSo, the concise response: The total carrying value of UnitedHealth Group's debt securities - held-to-maturity is $512 million, and the total fair value is $508 million, with the carrying value being $4 million higher than the fair value.\n",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58292,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14797,
        "completion_tokens": 2430,
        "total_tokens": 17228
      }
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com drove a 108.4% year-over-year increase in merchant gross bookings in 2022, which directly contributed to the 94.6% growth in merchant revenues. This expansion was a key factor behind the overall 58.3% increase in total gross bookings, as merchant gross bookings grew significantly faster than agency gross bookings (108.4% vs. 32.8%).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38189,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9777,
        "completion_tokens": 102,
        "total_tokens": 9879
      }
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "PayPal reported a crypto asset safeguarding liability of $2,886 million and a corresponding safeguarding asset of $2,886 million as of December 31 2024 (see Note 7 and the fair‑value tables on pages 92‑94). This liability and asset reflect the company’s custodial responsibility for users’ crypto holdings and its practice of recording a matching asset to offset the obligation, underscoring PayPal’s active involvement in crypto‑related financial activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52243,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13294,
        "completion_tokens": 114,
        "total_tokens": 13409
      }
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The $157 million impairment charge recorded in 2024 reflects FedEx’s decision to permanently retire 22 Boeing 757‑200 aircraft and related engines as part of its Network 2.0 fleet‑modernization effort, aligning air‑capacity with current and anticipated shipment volumes. Cumulatively, the impairment charges from 2023 ($70 million) and 2024 ($157 million) represent a total of $227 million of non‑cash asset write‑downs tied to the DRIVE transformation and Network 2.0 initiatives through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 35194,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9031,
        "completion_tokens": 123,
        "total_tokens": 9154
      }
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024 is $4,327 million. The gross unrealized losses on these obligations increased from $234 million at December 31, 2023 to $274 million at December 31, 2024, representing an increase of $40 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57630,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14636,
        "completion_tokens": 73,
        "total_tokens": 14710
      }
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "The 54% merchant basis transaction mix in 2023 contributed to lower operating margins despite incremental revenue, as it drove higher merchant-related expenses in \"Personnel\" and \"Sales and other expenses\" (e.g., payment processing, chargebacks, fraud). These costs offset revenue gains from the merchant model, which generated incremental revenue recorded as \"Merchant revenues.\" The key cost components were personnel costs for managing merchant transactions and increased sales/marketing expenses tied to payment processing and fraud mitigation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 41266,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10547,
        "completion_tokens": 137,
        "total_tokens": 10684
      }
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "The reclassification of eligible consumer installment receivables to “Loans and interest receivable, held for sale” and the shift to measuring these assets at the lower of cost or fair value (with changes recorded in restructuring and other income) reduced the allowance for credit losses that had previously been recorded for that portfolio (the allowance was reversed in 2023) and now reflects only the fair‑value adjustments and charge‑offs recognized in restructuring expense, thereby lowering the reported allowance and influencing income‑statement presentation of credit‑loss provisions. This change also moves the assets out of the “Loans and interest receivable, net” category and into a distinct held‑for‑sale classification, affecting the balance‑sheet presentation of assets and the timing of income recognition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55425,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14108,
        "completion_tokens": 205,
        "total_tokens": 14314
      }
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "As of December 31 2024, the €1.5 billion revolving credit facility (≈ $1.6 billion) adds to the existing short‑term credit capacity, giving a combined borrowing capacity of roughly **$3.7 billion** (the $2.1 billion of uncommitted short‑term lines plus the €1.5 billion facility). This is up from about **$2.7 billion** of short‑term credit capacity at the end of 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9559,
        "completion_tokens": 92,
        "total_tokens": 9651
      }
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "Based on the provided financial data in the document, NVIDIA's Compute & Networking segment contributed $47,405 million in revenue for fiscal year 2024. This figure is explicitly stated in the \"Revenue by Reportable Segments\" table under the \"Compute & Networking\" row for the year ended January 28, 2024. The document also confirms that one direct customer accounted for 13% of total revenue and one indirect customer accounted for 19% of total revenue within this segment, but the segment's total revenue is clearly reported as $47,405 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48920,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12476,
        "completion_tokens": 136,
        "total_tokens": 12613
      }
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG's Internal Capital Framework quantifies aggregate economic risk at a given confidence level while incorporating diversification benefits across risk factors and business lines, and its stress testing framework assesses exposure to significant financial and insurance risks to determine the capital resources needed at the AIG Parent level to support subsidiaries and maintain consolidated target capitalization. This framework directly informs capital planning by evaluating how stress testing results and risk diversification impact the capital required to sustain target capital levels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67454,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17108,
        "completion_tokens": 148,
        "total_tokens": 17256
      }
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Target’s owned and exclusive brands generate roughly one‑third of its merchandise sales and carry higher margins, but they also require longer lead times, tighter forecasting, and deeper involvement in the supply chain. Consequently, any supply‑chain disruption—whether from sourcing delays, transportation bottlenecks, or vendor failures—can quickly create inventory shortages or excesses for these brands. If Target cannot meet consumer demand for its owned brands, sales and margins decline; if it over‑stocks, it must markdown inventory, eroding profitability. Effective inventory management is therefore critical: accurate demand forecasting, robust vendor relationships, and agile replenishment help maintain in‑stock levels, minimize markdowns, and protect the profitability of the owned‑brand portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39123,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10040,
        "completion_tokens": 202,
        "total_tokens": 10243
      }
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "The 2024 carrying values are $1,000 million for the 3.50% Notes Due 2040 and $2,000 million for the 3.50% Notes Due 2050, giving a difference of $1,000 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40396,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10303,
        "completion_tokens": 40,
        "total_tokens": 10343
      }
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2024, the 2020 Stock Incentive Plan had approximately 48 million shares remaining available for future issuance, and the ESPP had about 16 million shares available. The 2020 Stock Incentive Plan may issue a range of award types, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based incentives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53808,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13696,
        "completion_tokens": 98,
        "total_tokens": 13794
      }
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG’s use of the Bornhuetter Ferguson expected‑loss‑ratio method—augmented by loss‑development and frequency/severity models—helps mitigate the volatility inherent in long‑tail U.S. Workers’ Compensation reserves by anchoring reserve estimates to premium‑based expected loss ratios while still incorporating observed paid and incurred loss patterns; this hybrid approach allows the company to adjust reserves more gradually and avoid over‑reacting to anomalous early‑development loss emergence, thereby providing a more stable and credible estimate of ultimate losses for these extremely long‑tail lines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 176596,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 44393,
        "completion_tokens": 151,
        "total_tokens": 44544
      }
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "Based on the exhibit listings in the 2024 Form 10-K (pages 71-76), the Credit Card Program Agreement with TDBank USA, N.A. has been amended four times: the original agreement was dated October 22, 2012 (10.21), with subsequent amendments filed on February 24, 2015 (10.21.1), November 19, 2019 (10.21.2), and November 1, 2022 (10.21.3). This indicates a progressive evolution of the financial partnership through formalized amendments to adapt to changing business needs and regulatory environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54716,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13915,
        "completion_tokens": 124,
        "total_tokens": 14039
      }
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "Based on the document, FedEx spent $582 million on business optimization activities related to Network 2.0 in 2024 and $273 million in 2023, for a combined total of $855 million. The primary purpose of these expenditures was to improve the company’s long‑term profitability by driving efficiency across its transportation segments, consolidating sortation facilities and equipment, reducing pickup‑and‑delivery routes, and transforming its digital capabilities through the Network 2.0 multi‑year initiative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44436,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11327,
        "completion_tokens": 126,
        "total_tokens": 11454
      }
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The ad‑supported subscription plan introduces additional revenue streams and pricing flexibility, but it also creates forecasting uncertainty because Netflix must predict consumer adoption of the new tier, the impact on existing subscription rates, and the resulting changes in revenue mix and margins—all of which are highlighted in the 2023 10‑K as key risks to financial projections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44278,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11296,
        "completion_tokens": 96,
        "total_tokens": 11393
      }
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "The 2023 intangible asset impairment charge of $964 million for Prevnar 13’s developed‑technology rights reflects the updated commercial forecasts that show a transition to higher‑serotype vaccines, which shortens the effective patent‑exclusivity period for Prevnar 13 outside the United States. According to the patent‑expiration table in the filing, the basic U.S. product patent for Prevnar 13 expires in 2026, while key European and Japanese patents are projected to expire later (e.g., Europe (3) and Japan 2029). This impending loss of exclusivity—especially as competing vaccines with broader serotype coverage enter the market—was a primary driver behind the impairment recorded in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 73409,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18588,
        "completion_tokens": 173,
        "total_tokens": 18761
      }
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald’s relies on franchisees to run the majority of its restaurants, so it does not consolidate the franchisee‑related entities in its financial statements; instead, it records only the revenue and fees earned from those franchisees. If franchisees fail to execute key customer‑experience initiatives, the resulting decline in sales or brand perception could materially reduce the royalties, rent and other fees the Company depends on, weakening its cash flow and profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65055,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16507,
        "completion_tokens": 120,
        "total_tokens": 16628
      }
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG adopted the LDTI standard on January 1 2023 with a transition date of January 1 2021, resulting in a $1.264 billion decrease to beginning total equity as of January 1 2021. The adoption required adjustments to previously reported financial statements for the years ended December 31 2022 and 2021, including a $2 million decrease and $983 million increase to net income for those years and a $1.219 billion increase to total equity as of December 31 2022. These adjustments stemmed from changes related to market‑risk benefits and the discount rate used to measure the liability for future policy benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 89344,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22564,
        "completion_tokens": 152,
        "total_tokens": 22716
      }
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "The increase in Gulfstream aircraft orders contributed to a rise in cash provided by operating activities to $4.3 billion in 2021, which represented 131 % of net earnings ($3.3 billion). Consequently, cash flow from operating activities accounted for roughly 131 % of net earnings for the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30124,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7761,
        "completion_tokens": 73,
        "total_tokens": 7835
      }
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG's integrated bottom-up risk identification process, which extends to the product-line level, provides the foundational data for quantifying aggregate economic risk within its internal capital framework. This process enables the company to assess material risks across business lines and develop analytics for measuring risks, which are then used to quantify aggregate economic risk at a specified confidence interval after accounting for diversification benefits between risk factors and business lines. The internal capital framework leverages this detailed risk identification to support the assessment of resources needed at the AIG Parent level to maintain consolidated capitalization targets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67454,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17105,
        "completion_tokens": 175,
        "total_tokens": 17280
      }
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The RTX 4080 launch is part of NVIDIA’s broader product‑transition strategy that accelerates new GPU architectures while simultaneously expanding demand for data‑center and AI‑related offerings. Because these transitions involve tighter lead times, larger supplier commitments, and the need to coordinate multiple new architectures, they increase supply‑chain complexity and forecasting uncertainty. If demand forecasts are inaccurate—either over‑ or under‑estimating—NVIDIA may face excess inventory, inventory write‑downs, or supply constraints that can depress gross margins and overall financial performance. Thus, the RTX 4080’s introduction magnifies both supply‑chain risks and demand‑forecasting challenges, potentially weighing on NVIDIA’s near‑term revenue and profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58353,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14812,
        "completion_tokens": 196,
        "total_tokens": 15009
      }
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "The Starbucks Rewards loyalty program requires the company to defer revenue for the estimated selling price of Stars earned toward free product, establishing a liability in deferred revenue that is recognized when the reward is redeemed; this timing of revenue recognition can affect when revenue is recorded relative to when points are earned. In fiscal 2022, Starbucks’ total advertising expense was $416.7 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47770,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12160,
        "completion_tokens": 104,
        "total_tokens": 12264
      }
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The notional amount of intercompany loans and forecasted interest payments rose from $2,860 million in 2023 to $4,406 million in 2024, a $1,546 million increase.  In 2024, $75 million of interest‑payment hedges were recognized in earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53292,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13550,
        "completion_tokens": 59,
        "total_tokens": 13610
      }
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million (rising from $9,979 million in 2020 to $10,526 million in 2021). This growth outpaces the revenue increase for nuclear‑powered submarines, which rose by $179 million (from $6,938 million in 2020 to $7,117 million in 2021).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 27378,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7066,
        "completion_tokens": 78,
        "total_tokens": 7144
      }
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "The dollar amount change in Mac sales from 2023 to 2024 was an increase of $627 million (from $29.357 billion to $29.984 billion, a 2 % rise). In the same period, iPad sales declined by $1.606 billion (from $28.300 billion to $26.694 billion, a 6 % decrease). Thus, Mac sales grew modestly while iPad sales fell significantly over the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40019,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10217,
        "completion_tokens": 85,
        "total_tokens": 10302
      }
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The unfavorable volume/mix in chocolate reduced total net revenue growth in 2024, offsetting $452 million of the overall $452 million increase in net revenue that the company reported. While chocolate’s volume/mix drag lowered revenue, the company’s total net revenue still rose by $452 million, driven by higher pricing and gains elsewhere.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49005,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12491,
        "completion_tokens": 85,
        "total_tokens": 12576
      }
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Initial capacity constraints for custom components create supply bottlenecks that can delay product launches and strain Apple’s ability to meet demand, especially when relying on single-source suppliers in Asia. These constraints amplify supply chain risks by limiting flexibility to shift production, increase costs, and potentially reduce product availability amid geopolitical tensions or regional disruptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47330,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12067,
        "completion_tokens": 103,
        "total_tokens": 12170
      }
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported TV/SVOD distribution licensing revenue of $4,452 million in 2022, but after accounting for the $1,023 million content‑license early termination fee the net amount recognized was $3,429 million. This compares with $5,266 million of TV/SVOD distribution licensing revenue in the prior year (2021).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44361,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11324,
        "completion_tokens": 77,
        "total_tokens": 11402
      }
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Based on the 2022 10-K disclosures, Starbucks' integration of its Mobile App with the Starbucks Rewards loyalty program directly drives customer engagement and increased store visit frequency by embedding rewards and mobile ordering into the core customer experience. The document highlights that registered Starbucks Rewards members earn Stars through the Mobile App (including Mobile Order and Pay functionality), which incentivizes repeat visits and higher spending, particularly in international markets like China where \"Starbucks Now\" stores leverage the app for seamless digital ordering and pickup. This strategy aligns with evolving customer preferences for contactless, convenient experiences, directly contributing to higher store traffic and loyalty program participation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 43594,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11116,
        "completion_tokens": 196,
        "total_tokens": 11312
      }
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "The audit of PayPal’s internal control over financial reporting for 2021 excluded Paidy, Inc. because it was acquired during the year, and Paidy’s assets and revenues together represented less than 1 % of the consolidated amounts, so they were not included in that audit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39730,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10164,
        "completion_tokens": 67,
        "total_tokens": 10232
      }
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "The 0.6% rise in Latin America operating income was driven by higher net pricing that offset the negative impact of volume/mix declines in chocolate and refreshment beverages, but these gains were largely eroded by unfavorable currency translation, higher raw‑material costs and other expense increases, leaving only a modest net increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51388,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13080,
        "completion_tokens": 84,
        "total_tokens": 13165
      }
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, and the G650ER is explicitly credited with leading this achievement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30162,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7755,
        "completion_tokens": 36,
        "total_tokens": 7792
      }
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded total contingent consideration of $1,217 million in fiscal 2024 and $1,092 million in fiscal 2023. The $704 million of contingent consideration related to the Abiomed acquisition was recorded in fiscal 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38788,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9925,
        "completion_tokens": 58,
        "total_tokens": 9984
      }
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "The 2020 adoption of CECL (ASU 2016‑13) changed how PayPal measures credit losses on the merchant receivables it purchases for the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products.  Under the prior guidance, allowances were based on historical roll‑rate forecasts; under CECL the allowance is derived from lifetime‑loss estimates, forward‑looking macro‑economic scenarios and segmented portfolio analysis, and credit‑loss provisions are recorded directly against earnings (or other comprehensive income for non‑credit‑related impairment).  Consequently, the nature, timing and magnitude of credit‑loss expense for these participation interests shifted to a current‑expected‑credit‑loss model that is updated each reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45293,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11570,
        "completion_tokens": 188,
        "total_tokens": 11758
      }
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The cheese & grocery category’s volume/mix decline was a key driver of the Latin America segment’s unfavorable volume/mix impact on net revenues, contributing to the overall revenue dip despite higher net pricing. This unfavorable mix pressure, combined with currency headwinds, resulted in a modest $3 million increase in segment operating income for 2024, as higher net pricing and lower certain costs offset the volume/mix drag.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51388,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13083,
        "completion_tokens": 107,
        "total_tokens": 13191
      }
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The combined redemption value of the Telco Class A‑4 preferred interests ($2,250 million) and the Mobility noncontrolling interests ($2,000 million) totals **$4,250 million**.  Because these obligations must be settled in cash (or cash‑plus‑stock for the Tower and Telco preferred interests), AT&T has committed to make cash payments over the next several years—primarily through scheduled distributions on the preferred interests and the eventual redemption of the Mobility noncontrolling interests beginning in 2028—thereby constraining its cash‑flow flexibility through 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51142,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13010,
        "completion_tokens": 144,
        "total_tokens": 13155
      }
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "The Orthopaedics segment generated $9.2 billion in revenue for 2024. Within that segment, sales from Hips were $1.6 billion and from Knees were $1.5 billion, together accounting for roughly 34 % of the Orthopaedics total.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43449,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11080,
        "completion_tokens": 55,
        "total_tokens": 11135
      }
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan’s proportional adjustment mechanism increased the number of RSU shares available by approximately 128,000 shares following the 2024 special dividend, as documented in Note 7 (Stock‑Based Compensation) of the filing. This adjustment is formally recorded in the company’s 2023 Form 10‑K, specifically in Note 7, which details the RSU share increase and the related plan amendment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34697,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8900,
        "completion_tokens": 100,
        "total_tokens": 9001
      }
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "The Intel 4 transition to high-volume manufacturing in Ireland in 2024 is expected to increase the share of Intel 4-based products in Intel’s 2025 portfolio, building on the performance gains of Intel 4 (≈20% performance-per-watt improvement over Intel 7) and supporting the upcoming Panther Lake processors on Intel 18A. Intel 3, already in high-volume manufacturing for data center products like Xeon 6, will continue to be optimized for external foundry customers, while Intel 18A—featuring gate-all-around transistors and backside power—will begin high-volume production in 2025 to deliver further performance-per-watt and density scaling improvements over Intel 3.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50806,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12942,
        "completion_tokens": 167,
        "total_tokens": 13109
      }
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "The book value of AT&T’s investment in DIRECTV fell from $877 million at December 31 2023 to $0 at December 31 2024, a $877 million decrease. This deconsolidation occurred after AT&T had already deconsolidated Gigapower in May 2023, when it began accounting for Gigapower as an equity‑method investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49426,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12582,
        "completion_tokens": 75,
        "total_tokens": 12658
      }
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "Shockwave contributed $564 million in sales to Johnson & Johnson’s MedTech segment in 2024, reflecting its inclusion in the Cardiovascular franchise’s $7.7 billion total MedTech revenue. In the Company’s human‑capital reporting, Shockwave is counted within the global employee headcount and is highlighted as part of the MedTech workforce that the Company seeks to attract, develop and retain through its talent‑focused strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10284,
        "completion_tokens": 107,
        "total_tokens": 10392
      }
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The Optimized Application Experiences category grew 11% year‑over‑year, driven primarily by growth in ThousandEyes and Intersight, and the decline in AppDynamics offerings contributed to that growth; the category increased by $75 million in dollar terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46036,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11745,
        "completion_tokens": 63,
        "total_tokens": 11808
      }
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T paid $5,414 million in total to repurchase the remaining Mobility preferred interests in April 2023, which included $5,340 million of redemption value plus approximately $74 million of accrued and unpaid distributions. The redemption settled the outstanding Mobility preferred interests, reclassifying the associated liabilities from equity to cash‑based obligations and eliminating the noncontrolling interest related to those interests on the consolidated balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53900,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13714,
        "completion_tokens": 119,
        "total_tokens": 13833
      }
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit, acquired in December 2022, generated $1.5 billion in sales in 2024, reflecting a 14.5 % increase over the prior year (14.9 % on an operational basis).  Within the MedTech segment, this contributed to a total Cardiovascular franchise growth of 21.4 % in 2024, outpacing the overall segment’s 4.8 % revenue increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45317,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11563,
        "completion_tokens": 85,
        "total_tokens": 11648
      }
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan has **19 amendments** listed in the exhibits (from Exhibit 4.1 through Exhibit 4.20). The most recent amendment referenced in the 2022 10-K filing is **Exhibit 4.20**, which corresponds to the **Nineteenth Supplemental Indenture dated September 20, 2021**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 6,
        "total_chars": 28902,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7443,
        "completion_tokens": 75,
        "total_tokens": 7518
      }
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "As of January 1 2024, Capital One had phased in **75 %** of the $2.4 billion CECL transition amount, which equals **$1.8 billion**.  \nUnder the Stress Capital Buffer framework that became effective on October 1 2024, the company must maintain a CET1 capital ratio of **10.0 %** (i.e., it must hold at least 10 % CET1 capital relative to risk‑weighted assets).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51154,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13038,
        "completion_tokens": 89,
        "total_tokens": 13128
      }
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney’s executive compensation uses both time‑based and performance‑based RSU awards to align pay with long‑term shareholder value. Time‑based RSUs (e.g., Exhibit 10.43) vest over a fixed schedule, providing a steady equity incentive, while performance‑based RSUs (e.g., Exhibits 10.44‑10.48) tie vesting to specific financial metrics such as total shareholder return, ROIC and Section 162(m) thresholds, ensuring that payouts are contingent on achieving measurable value‑creation goals. This dual‑approach balances guaranteed equity grants with contingent, performance‑driven rewards that directly link executive compensation to sustained shareholder returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81408,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20579,
        "completion_tokens": 165,
        "total_tokens": 20744
      }
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "The Orthopaedics segment grew 2.4% overall in 2024, driven primarily by strong performance in its core sub-franchises. Hips sales rose 5.0% and Knees sales increased 6.1% year-over-year, contributing significantly to the segment's growth. These gains were partially offset by broader Orthopaedics restructuring impacts and currency headwinds, but the growth in Hips and Knees directly fueled the segment's 2.4% total sales increase compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43010,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10959,
        "completion_tokens": 112,
        "total_tokens": 11072
      }
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Based on the document, Capital One added back $2.4 billion to its regulatory capital under the CECL Transition Rule, and it has phased in 75 % of that amount by January 1 2024 (the remaining 25 % will be phased in on January 1 2025). The CECL Transition Rule allows a five‑year phase‑in of the CECL impact on capital, with the “day‑2” impact scaled by 25 % each year; thus, the $2.4 billion delayed impact is being added back to regulatory capital at 25 % per year, reaching full phase‑in in 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41771,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10679,
        "completion_tokens": 124,
        "total_tokens": 10803
      }
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The issuance of $500 million of Guaranteed Senior Notes by Costco’s Japanese subsidiary in November 2023 increased the company’s long‑term debt balance, and the subsequent repayment of $77 million of those notes in July 2024 reduced it. Because the notes are valued at fair value (Level 3 for the Japanese debt), these movements altered the reported fair‑value of total long‑term debt—from $5.738 billion at the end of 2023 to $5.919 billion at the end of 2024—while also being reflected in financing‑activities cash flows as a source of funds followed by a partial cash outflow for the repayment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32925,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8468,
        "completion_tokens": 149,
        "total_tokens": 8617
      }
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "The total estimated environmental remediation liability that Caterpillar accrues for all sites is not material and is recorded in “Accrued expenses” on the balance sheet; the company reassesses these accrued amounts quarterly and believes there is only a remote chance that a material amount will be required at any individual site or in the aggregate.  \n\nCaterpillar estimates remediation costs on a site‑by‑site basis using currently available data, applicable laws and regulations, and prior remediation experience, without considering potential recoveries from insurers; for individual sites it may accrue the minimum amount when no single estimate is more likely, while for multi‑party sites it evaluates its proportionate share of probable costs and aggregates the estimated shares across all such sites.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41460,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10595,
        "completion_tokens": 202,
        "total_tokens": 10798
      }
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "The percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022 was a decline of 29% (from $15 million to $11 million), representing a $4 million decrease. This underperformance aligns with the company's strategic shift in fiscal 2022 to restructure its product reporting into categories like \"Secure, Agile Networks\" and \"Internet for the Future,\" which better reflect its strategic priorities and allow for more targeted investment and focus on high-growth areas, while deprioritizing lower-performing segments such as \"Other Products.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 106,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38847,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9955,
        "completion_tokens": 145,
        "total_tokens": 10100
      }
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The executive employment agreement with Ron Vachris, effective January 1 2024, follows the same renewal pattern as Craig Jelinek’s agreement: Jelinek’s contract was originally set for a three‑year term and has been extended annually—through 2023—by separate 10‑Q filings (2019, 2020, 2021, 2022 extensions). Vachris’s agreement mirrors this cadence, being filed as an executive employment agreement in a 10‑Q filing dated December 20 2023 with an effective date of January 1 2024, indicating a comparable annual renewal approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53291,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13558,
        "completion_tokens": 132,
        "total_tokens": 13690
      }
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net value of Customer Relationships decreased by $181 million from $893 million at December 31 2020 to $712 million at December 31 2021. Over the same period, the net value of Intellectual Property declined by $86 million, from $366 million to $280 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37062,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9492,
        "completion_tokens": 65,
        "total_tokens": 9557
      }
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "The total revenue contribution from the \"Secure, Agile Networks\" product category in fiscal 2022 was $23,829 million. Revenue recognition differs by arrangement type: hardware and perpetual software licenses are recognized upfront upon transfer of control, while SaaS arrangements have a single performance obligation with revenue recognized ratably over the contract term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 106,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43643,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11138,
        "completion_tokens": 93,
        "total_tokens": 11231
      }
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "Amazon's revenue from third-party seller fees in 2021 was $125.3 billion, representing 13% of its total consolidated net sales of $469.8 billion. This revenue stream aligns with Amazon's stated business model of enabling sellers to grow their businesses through its platform, as evidenced by its focus on programs that allow sellers to sell products in its stores and fulfill orders through the company, which generated the majority of these fees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41715,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10657,
        "completion_tokens": 111,
        "total_tokens": 10769
      }
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "Based on the provided document, Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio as of December 31, 2024 is 13.5% (as shown in Table 12). The Minimum Capital Adequacy requirement for CET1 under the Basel III framework is 4.5% (the regulatory minimum ratio stated in the \"Basel III and U.S. Capital Rules\" section). Therefore, the difference between Capital One's CET1 ratio and the minimum requirement is 13.5% - 4.5% = 9.0 percentage points.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48310,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12294,
        "completion_tokens": 116,
        "total_tokens": 12410
      }
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Regulatory risks threatening Altria's $1.7 billion JUUL investment include potential FDA actions that could restrict or remove e‑vapor products from the market, as well as ongoing FTC and class‑action challenges that could force divestiture or rescission of the transaction. If such adverse regulatory or legal outcomes occur, Altria could lose the ability to commercialize JUUL’s products, impair the investment’s fair value, and jeopardize the revenue and strategic growth objectives tied to the JUUL stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63877,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16186,
        "completion_tokens": 127,
        "total_tokens": 16313
      }
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million 2060 senior notes are part of NVIDIA’s $11 billion of long‑term indebtedness, and the filing warns that maintaining such debt can “adversely affect our financial position and cash flows from operations” by forcing a substantial share of operating cash to service and repay the notes, limiting flexibility to finance working capital, acquisitions or other corporate needs, and potentially triggering default if covenants are breached. Consequently, the 2060 notes heighten the risk that NVIDIA may be unable to refinance or roll‑over the debt on favorable terms, which could strain liquidity and constrain strategic initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 33441,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8608,
        "completion_tokens": 161,
        "total_tokens": 8769
      }
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The expanded FDA approval of Vemlidy to include pediatric patients as young as six years old (with compensated liver disease) and weighing at least 25 kg significantly broadens Gilead’s addressable market in chronic hepatitis B, adding a sizable pediatric population to its existing adult HBV portfolio (Viread, Epclusa‑related assets) and reinforcing the commercial strength of its liver‑disease franchise. This pediatric label extension enhances revenue potential and market share in a disease area where few long‑acting, well‑tolerated therapies exist, complementing Gilead’s broader antiviral and liver‑disease product suite.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56717,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14402,
        "completion_tokens": 157,
        "total_tokens": 14559
      }
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "Based on the provided document pages, Lowe's reports that installed sales accounted for approximately 5% of total sales in fiscal 2023. This figure represents the share of total sales derived from product categories that are covered by Lowe's extended protection plans (specifically Appliances, Kitchens & Bath, Millwork, Rough Plumbing, Electrical, Seasonal & Outdoor Living, Tools, and Hardware). Among these categories, **Appliances** is explicitly mentioned in both the \"Installed Sales\" section (as one of the primary categories accounting for the majority of installed sales) and the \"Lowe's Protection Plans and Repair Services\" section (where extended protection plans are specifically offered for Appliances, among other categories).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46913,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11959,
        "completion_tokens": 185,
        "total_tokens": 12145
      }
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "The cumulative impact of the CECL Transition Election from 2020 through 2024, factoring in the 25% scaling factor applied to the \"day 2\" ongoing impact and the phase‑in schedule (25% in 2022, 50% in 2023, 75% in 2024, and 100% in 2025), results in a total $2.4 billion after‑tax amount added back to regulatory capital, which would have increased the CET1 ratio from 12.4% to 13.1% if excluded.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 204,
          "pages": [
            202,
            203,
            204,
            205,
            206
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 32953,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8472,
        "completion_tokens": 98,
        "total_tokens": 8571
      }
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "The net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales was a $21 million reduction to cost of sales (recorded as a reduction to cost of sales in the third quarter of 2021).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57850,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14674,
        "completion_tokens": 60,
        "total_tokens": 14734
      }
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "Based on the provided document pages, the total liabilities for non-qualified deferred compensation plans and other postemployment benefits were $67 million at December 31, 2021 and $63 million at December 31, 2020. This represents an increase of $4 million from 2020 to 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60888,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15454,
        "completion_tokens": 69,
        "total_tokens": 15523
      }
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1,170 million (the sum of the $1,640 million developed technology, $440 million customer relationships, $190 million order backlog, and $70 million trade names, which are amortized over their 5‑year, 3‑year, shipment‑based, and 5‑year useful lives, respectively). This amortization schedule is separate from the $630 million indefinite‑lived intangible asset recorded for Mellanox's in‑process research and development project, which is not amortized and is only tested for impairment until the project reaches technological feasibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10369,
        "completion_tokens": 167,
        "total_tokens": 10536
      }
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "The combined U.S. and EU patent expiration for Biktarvy is 2033. The expanded FDA approval for Biktarvy to treat HIV patients with M184V/I resistance does not alter the patent expiration timeline, as the exclusivity remains tied to the underlying patent protection (which expires in 2033), though regulatory exclusivity in the U.S. is noted to expire in 2032.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 60758,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15414,
        "completion_tokens": 89,
        "total_tokens": 15504
      }
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve’s supervisory stress‑testing models impose a binding capital‑buffer requirement that limits how much capital Capital One can distribute to shareholders; under the Dodd‑Frank Act’s enhanced prudential standards, firms must hold sufficient capital to survive stress scenarios, and any shortfall identified by the Fed’s models can trigger restrictions on dividends and share repurchases. Consequently, the Dodd‑Frank‑mandated stress‑testing framework directly constrains Capital One’s ability to return capital to stockholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55203,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14040,
        "completion_tokens": 136,
        "total_tokens": 14176
      }
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The total payments made by PM USA under the State Settlement Agreements for 2019, 2020, and 2021 combined were $4.3 billion (2019), $4.4 billion (2020) and $4.2 billion (2021), which sum to $12.9 billion. For 2020 alone, the maximum potential NPM Adjustment was $572 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 65200,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16532,
        "completion_tokens": 68,
        "total_tokens": 16601
      }
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The fair value of the 2.85% Notes Due 2030 reported in the first table is $3,224 million, while the net carrying amount of the same notes disclosed in the second table for fiscal year ending January 30, 2022 is $3,113 million. This results in a difference of $111 million between the fair value and the net carrying amount.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10356,
        "completion_tokens": 80,
        "total_tokens": 10436
      }
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "The Tailoring Rules classify Capital One as a Category III institution, allowing it to exclude certain elements of AOCI from its regulatory capital calculations. Consequently, the Stress Capital Buffer Rule applies to Capital One’s consolidated capital ratios, but the resulting capital requirements (e.g., 7.0% CET1, 8.5% Tier 1, 10.5% total capital for 2021‑2022) are calculated after this exclusion, meaning the buffer is applied to a capital base that is effectively higher than it would be under the full Basel III framework. This tailored approach therefore relaxes the effective capital adequacy threshold for Capital One relative to institutions not subject to the Category III carve‑out.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 28128,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7275,
        "completion_tokens": 174,
        "total_tokens": 7449
      }
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "The total change in the fair value of Altria's JUUL investment from 2020 to 2021 was a $1.7 billion decrease, which was reflected as a negative adjustment in the \"income (losses) from equity investments\" line of Altria's consolidated statements of earnings (losses). This change was recorded using Level 3 fair value measurements and impacted the carrying value of the JUUL investment on the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62627,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15873,
        "completion_tokens": 101,
        "total_tokens": 15975
      }
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Based on the \"RAIL EQUIPMENT\" table in the document, Union Pacific reports **7,154 total locomotives** as of December 31, 2023, with **1,037 leased** and **6,117 owned**. This means leased locomotives account for **14.5%** of the total fleet (1,037 ÷ 7,154 ≈ 0.145 or 14.5%).  \n\nRegarding switching locomotives, the document states there are **132 switching locomotives** (all owned, as shown in the \"Switching\" row under \"Locomotives\" with \"Owned: 132\" and \"Leased: -\"). However, the question asks how this compares to the *total number of switching locomotives in their fleet*, which is **132**. The leased percentage (14.5% of total locomotives) is unrelated to the switching locomotive count, as all switching locomotives are owned.  \n\n**Answer**: Union Pacific leases 14.5% of its total 7,154 locomotives (1,037 leased), and the fleet contains 132 switching locomotives (all owned).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34908,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8941,
        "completion_tokens": 221,
        "total_tokens": 9163
      }
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The fair value change of the 2.20% Notes Due 2021 from January 31 2021 to January 30 2022 is disclosed in the “Fair Value Disclosures” table on page 78, where the note’s fair value is reported as $2,970 million (up from $2,760 million the prior year). This same figure appears in the debt‑specific maturity and interest‑rate table on page 79, which lists the note’s maturity value, interest rate, and fair‑value amount for the reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10354,
        "completion_tokens": 111,
        "total_tokens": 10465
      }
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio reduced the leverage exposure used in the calculation, thereby lowering the supplementary leverage ratio. This adjustment was made in accordance with an interim final rule issued by the Federal Reserve that temporarily excluded such securities and deposits from the supplementary leverage ratio calculation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44250,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11300,
        "completion_tokens": 115,
        "total_tokens": 11415
      }
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million, as disclosed in the fair value measurements table showing \"Significant Other Observable Inputs (Level 2)\" for assets including federal government securities ($1,508 million), bonds and debentures ($1,696 million), and corporate stock ($5 million). These assets were valued using observable inputs other than quoted prices in active markets, such as bid evaluations from independent pricing sources for securities like federal government securities and corporate bonds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46990,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11955,
        "completion_tokens": 146,
        "total_tokens": 12102
      }
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "NVIDIA Omniverse is highlighted in the 10‑K filing as a real‑time 3D design collaboration and virtual‑world simulation platform that enables enterprise‑grade workflows such as virtual car showrooms, architectural walkthroughs and training simulations, all powered by NVIDIA GPUs.  Its integration with the DRIVE ecosystem—specifically via DRIVE Software components like Drive Concierge and NVIDIA Omniverse Avatar—allows the company to combine AI‑driven cockpit experiences with immersive, collaborative simulation, reinforcing its end‑to‑end AI computing strategy that spans training, inference, and continuous over‑the‑air updates across the DRIVE Hyperion hardware and DRIVE Sim/Constellation testing environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 4,
        "total_chars": 23634,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 6131,
        "completion_tokens": 179,
        "total_tokens": 6310
      }
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "The percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023 was approximately 12.5% (from $2,346 million to $2,082 million, representing 4.5% of total revenues in 2022 versus 4.1% in 2023). However, the provided documents do not contain information on Converse's operating income or its percentage change over the same period, so a comparison of operating‑income growth cannot be determined from the given data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47848,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12189,
        "completion_tokens": 112,
        "total_tokens": 12302
      }
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The changes to TDR accounting guidance eliminated the “reasonably expected” and “concession” assessment criteria, resulting in trial modifications and Chapter 7 loans being treated as TDRs rather than FDMs. Consequently, for the year ended December 31 2023, residential real‑estate loan modifications (including trial modifications) totaled $136 million, while credit‑card modifications (including trial modifications) totaled $27 million, reflecting the new classification of these modifications as TDRs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48757,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12416,
        "completion_tokens": 126,
        "total_tokens": 12542
      }
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "As of December 31 2023, Union Pacific had **1,059,344 retention shares and retention units outstanding under its 2021 Stock Incentive Plan**, and **16,000 restricted shares outstanding under the Directors Plan**. This means the retention awards under the 2021 Plan exceed the restricted shares under the Directors Plan by roughly 1.04 million shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51476,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13109,
        "completion_tokens": 87,
        "total_tokens": 13197
      }
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "\nAMD's total investment in the ATMP JV as of December 28, 2024, comprising the $149 million carrying value of its equity method investment and the $100 million secured loan it provided to the JV, totals $249 million. This is based on the equity investment recorded as \"Investments: equity method\" on the Consolidated Balance Sheets and the $100 million term loan agreement entered into on October 9, 2024, which was recorded within \"Receivables from related parties.\"",
      "llm_thought": "Based on the provided document pages, AMD's investment in the ATMP JV as of December 28, 2024, includes both the carrying value of its equity investment and the secured loan it provided. The carrying value of the Company's investment in the ATMP JV was approximately $149 million as of December 28, 2024, recorded as \"Investments: equity method\" on the Consolidated Balance Sheets. Additionally, on October 9, 2024, the Company entered into a one-year term loan agreement with one of the ATMP JVs for $100 million, which was recorded within \"Receivables from related parties\" on the Consolidated Balance Sheets. Therefore, the total investment amount, combining the equity method investment and the secured loan, is $149 million (carrying value of equity investment) plus $100 million (secured loan), totaling $249 million. However, the question specifically asks for the total amount of AMD's investment in the ATMP JV, which includes both components. The document confirms the $100 million loan was provided to the JV for general corporate purposes and is secured by the JV's receivable balance due from AMD. The carrying value of the equity investment is $149 million, and the loan amount is $100 million, making the total investment $249 million. But note: the question asks for the total amount of AMD's investment, which is the sum of the equity investment carrying value and the secured loan provided. The document states the loan was recorded within \"Receivables from related parties,\" but the investment itself (equity method) is $149 million, and the loan is a separate financial instrument. However, the question likely refers to the total capital committed or the sum of the investment components. The document does not explicitly state a single \"total investment\" figure, but the equity investment carrying value is $149 million, and the loan is $100 million. The answer should be the sum of these two, which is $249 million. But let's verify: the document says \"the carrying value of the Company's investment in the ATMP JV was approximately $149 million\" and the loan of $100 million was provided. The question asks for \"the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided.\" Therefore, the total is $149 million (equity investment carrying value) + $100 million (secured loan) = $249 million. However, the document does not explicitly state the loan amount as part of the investment; the loan is a separate financial instrument. But the question specifically says \"including both,\" so we add them. The answer is $249 million. But wait, the document says \"the Company entered into a one-year term loan agreement with one of the ATMP JVs for $100 million,\" and this loan is recorded as a receivable, but the investment in the JV (equity method) is $149 million. The total investment would be the sum. However, in the context of the question, it's asking for the total amount of AMD's investment, which includes both the equity stake and the loan. So the total is $149 million + $100 million = $249 million. But let's check if the loan is considered part of the investment. The document says \"the Company accounts for its equity interests in the ATMP JV under the equity method,\" and the loan is a separate agreement. The question says \"including both the carrying value of its equity investment and the secured loan it provided.\" So the carrying value of the equity investment is $149 million, and the secured loan provided is $100 million, so the total is $249 million. Therefore, the answer is $249 million. However, the document does not explicitly state \"total investment\" as $249 million, but it provides the two components. So the answer should be $249 million. But let's confirm the numbers: carrying value of equity investment as of December 28, 2024: $149 million. Secured loan provided: $100 million. Total: $249 million. Yes. So the answer is $249 million. But wait, the document says \"the carrying value of the Company's investment in the ATMP JV was approximately $149 million\" and the loan is separate. The question is asking for the total amount including both, so it's $149 million (equity investment) + $100 million (loan) = $249 million. Therefore, the answer is $249 million. However, the document does not have a single number for \"total investment,\" but the question specifies to include both, so we add them. So the answer is $249 million. But let's make sure: the document says \"the Company contributed $17 million to the ATMP JV, representing additional equity that is in proportion to the Company's existing 15% equity interest.\" This $17 million contribution is part of the equity investment, but the carrying value is $149 million as of December 28, 2024. The $100 million loan is separate. So the equity investment carrying value is $149 million, and the loan is $100 million, so total is $249 million. Yes. So the answer is $249 million. But the question says \"as of December 28, 2024,\" and the loan was entered into on October 9, 2024, so it's included. Therefore, the total amount is $249 million. However, the document does not explicitly state the total, but the question asks to include both, so we calculate it. So the answer is $249 million. But let's check if the loan is considered part of the investment. The question says \"the total amount of AMD's investment in the ATMP JV,\" and the investment includes the equity method stake and the loan provided. So yes, $149 million + $100 million = $249 million. Therefore, the answer is $249 million. But wait, the document says \"the carrying value of the Company's investment in the ATMP JV was approximately $149 million\" — this is the equity method investment. The loan is a separate financial instrument, but the question says \"including both the carrying value of its equity investment and the secured loan it provided.\" So the total is $149 million (equity investment carrying value) + $100 million (secured loan) = $249 million. So the answer is $249 million. However, the document does not have a table that sums these, but it provides the two numbers. So the answer should be $249 million. But let's see if there's any other information. The document also says \"the Company's purchases from the ATMP JV during 2024 amounted to $1.7 billion,\" but that's not relevant to the investment amount. The key is the equity investment carrying value and the loan amount. So the total investment amount as defined by the question is $149 million + $100 million = $249 million. Therefore, the answer is $249 million. But the question says \"as of December 28, 2024,\" and the loan was entered into on October 9, 2024, so it's included. So the answer is $249 million. However, the document does not explicitly say \"total investment is $249 million,\" but it provides the two components. So we have to calculate it. So the answer is $249 million. But let's confirm the numbers: carrying value of equity investment: $149 million (as of December 28, 2024). Secured loan provided: $100 million (entered into October 9, 2024). So total: $249 million. Yes. So the answer is $249 million. But the question might be expecting the sum. However, in the document, the loan is recorded as a receivable, not as part of the investment, but the question specifically says to include both. So we add them. Therefore, the answer is $249 million. But wait, the document says \"the carrying value of the Company's investment in the ATMP JV was approximately $149 million\" — this is the equity method investment. The secured loan is a separate transaction. The question says \"including both the carrying value of its equity investment and the secured loan it provided.\" So the total amount of investment (as defined by the question) is $149 million + $100 million = $249 million. So the answer is $249 million. Therefore, the answer is $249 million. But let's make sure about the loan: \"the Company entered into a one-year term loan agreement with one of the ATMP JVs for $100 million.\" This loan is provided by AMD to the JV, so it's a loan from AMD to the JV, meaning AMD is lending money to the JV, so it's an asset for AMD (receivable). But the question is about \"AMD's investment in the ATMP JV,\" which typically refers to the equity stake, but the question explicitly says to include both the equity investment carrying value and the secured loan provided. So the total is the sum. So $149 million (equity investment carrying value) + $100 million (loan) = $249 million. So the answer is $249 million. However, the document does not have a single number for this total, but it provides the two numbers. So we have to add them. Therefore, the answer is $249 million. But let's check if the $100 million loan is included in the $149 million. No, the $149 million is the equity investment, and the loan is separate. The $17 million contribution was to the equity, but the carrying value is $149 million, which includes that contribution. The loan is a separate $100 million. So yes, total is $249 million. So the answer is $249 million. But the question might be tricky. Let's see the exact wording: \"the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV.\" So \"investment\" here is being used broadly to include both the equity stake and the loan. So the total is $149 million + $100 million = $249 million. Therefore, the answer is $249 million. But in the document, the loan is recorded as \"Receivables from related parties,\" which is an asset, but the question is asking for the \"investment,\" which might be confusing. However, the question explicitly says to include both, so we add them. So the answer is $249 million. But let's see if the document has any other clues. The document says \"the carrying value of the Company's investment in the ATMP JV was approximately $149 million\" — this is the equity method investment. The secured loan is not part of that $149 million; it's a separate financial instrument. So the total investment amount as defined by the question is $149 million (equity investment) + $100 million (loan) = $249 million. So the answer is $249 million. Therefore, the answer is $249 million. But the question might expect the number as stated in the document, but it's not directly stated. However, based on the information, we have to calculate it. So the answer is $249 million. But let's confirm the numbers: $149 million (equity investment carrying value) + $100 million (secured loan) = $249 million. Yes. So the answer is $249 million. However, the document says \"the Company contributed $17 million to the ATMP JV\" — this is part of the equity investment, but the carrying value is $149 million, which includes that and other contributions. The loan is $100 million separate. So yes. Therefore, the answer is $249 million. But the question says \"as of December 28, 2024,\" and the loan was entered into on October 9, 2024, so it's included. So the answer is $249 million. So I will go with $249 million. But the answer format should be 2-3 sentences. So the answer is: AMD's total investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment ($149 million) and the $100 million secured loan it provided, totals $249 million. This is based on the equity method investment carrying value of $149 million and the separate $100 million term loan agreement entered into on October 9, 2024. So the answer is $249 million. But the question asks for the total amount, so we state it. So the answer is $249 million. But let's make sure: the document says \"the carrying value of the Company's investment in the ATMP JV was approximately $149 million\" — this is the equity investment. The secured loan is $100 million. So total is $249 million. Yes. So the answer is $249 million. Therefore, the final answer is $249 million.\n",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44683,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11391,
        "completion_tokens": 3118,
        "total_tokens": 14509
      }
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "The total financial impact of the Envista Holdings disposition was a $451 million pretax gain, offset by a $109 million foreign‑currency translation adjustment loss that was re‑classified from accumulated OCI to discontinued‑operations earnings, and $69 million of IPO/Separation‑related costs.  In addition, Danaher incurred $28 million of transaction‑related costs for the Aldevron acquisition (2021) and $59 million for the Cytiva acquisition (2020), which are separate from the Envista disposal.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43864,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11195,
        "completion_tokens": 124,
        "total_tokens": 11319
      }
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, directly reduced the segment’s reported revenue by 15% (from $2,427M to $2,082M). This decline contributed to a significant 30% drop in Converse’s EBIT (from $676M to $474M), as the revenue contraction was compounded by a 130 basis point gross margin contraction due to unfavorable foreign currency exchange rates, further pressuring profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50486,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12868,
        "completion_tokens": 111,
        "total_tokens": 12979
      }
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 eliminated the “reasonably expected” and “concession” assessment criteria, causing trial‑modification and Chapter 7 loans to be classified as TDRs. Consequently, the allowance for credit losses increased by $587 million in 2023, reflecting the additional reserves needed for the newly‑identified TDR portfolio (primarily residential‑real‑estate modifications and Chapter 7 loans). This increase contributed to a higher total allowance for credit losses, improving the Firm’s loss‑coverage ratios across its loan books.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50011,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12752,
        "completion_tokens": 146,
        "total_tokens": 12898
      }
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "Based on the \"Fair Value Measurements\" section (page 58), the pension plan's assets measured at fair value on a recurring basis include $1,508 million of Federal government securities classified as Level 2 investments, which are valued using a bid evaluation process with independent pricing sources. The total fair value of plan assets measured at Level 2 is $3,209 million (comprising $1,508 million for Federal government securities and $1,696 million for bonds and debentures).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46990,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11970,
        "completion_tokens": 120,
        "total_tokens": 12090
      }
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "The research and medical products segment (reported as \"Research and medical products\" under the \"Analytical and physical instrumentation\" and \"Research and medical products\" line items in the consolidated sales table) grew from $13.512 billion in 2019 to $17.979 billion in 2020 and $24.802 billion in 2021—a compound annual growth rate of roughly 38 % over the two‑year period. In contrast, DHR’s total revenue increased from $17.911 billion in 2019 to $22.284 billion in 2020 and $29.453 billion in 2021, representing a cumulative growth of about 64 % over the same span. Thus, while the research and medical products segment expanded at a much faster pace than the company overall, it still accounted for a modest share of total sales, indicating that the segment’s outsized growth contributed significantly to DHR’s overall revenue expansion but did not dominate the company’s total financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47000,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11987,
        "completion_tokens": 227,
        "total_tokens": 12214
      }
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The adoption of the revised TDR accounting guidance effective January 1 2023 required JPMorgan to reclassify trial‑period modifications for credit‑card loans as TDRs, which increased the allowance for credit‑card loan losses by $27 million and added $1.2 billion to the allowance for First Republic loans. Consequently, the allowance for credit losses rose to $24.8 billion, reflecting the $1.2 billion addition for First Republic and the $27 million impact of the new TDR classification on credit‑card modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52384,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13337,
        "completion_tokens": 129,
        "total_tokens": 13466
      }
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "3M changed its accounting for pension and postretirement costs effective in the first quarter of 2021, switching from the calculated value approach to a fair‑value approach for determining the market‑related value of fixed‑income plan assets. This change altered the expected return on assets and the amortization of unamortized actuarial gains and losses, resulting in lower net periodic pension expense and a corresponding adjustment to retained earnings, accumulated other comprehensive income, and the presentation of pension‑related balances across all prior reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 42869,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10953,
        "completion_tokens": 145,
        "total_tokens": 11099
      }
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 eliminated the “reasonably expected” and “concession” assessment criteria, causing trial‑modification and Chapter 7 loans to be classified as TDRs while FDMs are not. This change reduced the allowance for credit losses by $587 million in 2023. Consequently, the allowance for loan losses fell from $2,040 million at the beginning of 2023 to $1,856 million at year‑end, a net reduction of $184 million attributable to the TDR guidance change.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52384,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13317,
        "completion_tokens": 126,
        "total_tokens": 13444
      }
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "The Africa/Eurasia region contributed $254 million to operating profit in 2023, while capital expenditures in that region totaled $10 million. This operating profit represents a modest increase from $228 million in 2022, and the capital spending remains relatively low compared to the broader regional investment patterns observed across other segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36873,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9453,
        "completion_tokens": 88,
        "total_tokens": 9542
      }
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The 2021 business segment reporting changes required 3M to reassign goodwill to new reporting units using the relative fair value method, but the reassignment was immaterial and no goodwork impairment was identified; the company subsequently performed its annual goodwill impairment test in Q4 2021 and concluded that no impairment existed, indicating that the reporting‑unit structure did not introduce additional impairment risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51161,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13010,
        "completion_tokens": 107,
        "total_tokens": 13118
      }
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD acquired Silo AI to accelerate the deployment and development of AI models and software solutions on AMD hardware, integrating Silo AI's expertise into its Data Center segment. This acquisition supports AMD's strategic goals of expanding its AI software ecosystem and enhancing AI model deployment capabilities on its hardware platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36560,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9351,
        "completion_tokens": 85,
        "total_tokens": 9436
      }
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "Based on the provided document pages, specifically Exhibit 10.45 and its subsequent amendments listed in the table, the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology was amended multiple times between September 2, 2014, and September 1, 2015. The amendments occurred on the following dates: October 31, 2014 (First Amendment), December 15, 2014 (Second Amendment), February 12, 2015 (Third Amendment), March 30, 2015 (Fourth Amendment), June 30, 2015 (Fifth Amendment), and September 1, 2015 (Sixth Amendment). This indicates a total of six amendments were made during that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41388,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10565,
        "completion_tokens": 157,
        "total_tokens": 10723
      }
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The 2023 10-K shows that PM's acquisition of Swedish Match (completed November 11, 2022) required segment reporting adjustments, with Swedish Match's results consolidated beginning in 2022 and fully reflected in 2023 financials. The separate shipment volume commentary for Swedish Match indicates that its oral product volume (e.g., ZYN nicotine pouches) grew 17.1% year-over-year in 2023, suggesting integration was progressing but still separate from core geographical segments, as evidenced by its distinct reporting in the Swedish Match segment rather than being folded into regional Americas/Europe volumes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34529,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8860,
        "completion_tokens": 153,
        "total_tokens": 9013
      }
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "Based on the document, the total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million, as stated in the section describing \"During the second and third quarters of 2021, 3M entered into interest rate swaps with an aggregate notional amount of $800 million.\" These swaps were specifically designed to hedge the fixed-rate notes due in 2049 ($1.0 billion principal) and 2050 ($650 million principal), converting $500 million and $300 million of these amounts, respectively, into floating-rate debt. This matches the combined principal amount of the fixed-rate notes due in 2049 and 2050 that the swaps were intended to hedge ($1.0B + $650M = $1.65B), though the swaps covered only portions of these amounts ($500M + $300M = $800M notional). The document confirms this in the fair value hedging description and the table of cumulative basis adjustments for fair value hedges, which shows the swaps were executed to hedge these specific debt issuances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 71960,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18221,
        "completion_tokens": 244,
        "total_tokens": 18465
      }
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "The total consideration transferred by AbbVie for both the Allergan and Soliton, Inc. acquisitions was $64.084 billion, of which $39.675 billion represented cash payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 31763,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8161,
        "completion_tokens": 42,
        "total_tokens": 8204
      }
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America's CET1 capital ratio of 11.9% under the Standardized approach at December 31, 2024 exceeds the regulatory minimum of 10.7% and comfortably meets the requirements needed to support its $25 billion stock repurchase program, as the capital position is strong enough to absorb the planned distributions without triggering restrictions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68737,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17400,
        "completion_tokens": 86,
        "total_tokens": 17486
      }
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "The Company’s 2021 10‑K filing lists a $650 million Medium‑term note with a 2.26 % fixed rate that matures in 2023 and shows a carrying value of $649 million (and the same $649 million reported for 2020). This $649 million represents the total carrying value of the Medium‑term note maturing in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47244,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12023,
        "completion_tokens": 75,
        "total_tokens": 12098
      }
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "The 2.900% Notes due 2030 carry an interest rate of 2.900%, while the highest‑yielding debt instrument listed in IBM’s 2024 10‑K filing is the 7.125% Debentures due 2096, which carries an interest rate of 7.125%. Thus, the 7.125% Debentures due 2096 have the higher interest rate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48354,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12302,
        "completion_tokens": 70,
        "total_tokens": 12372
      }
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "The total financial value of AbbVie's acquisition of Allergan was $64.1 billion, and the company acquired approximately $762 million of right‑of‑use assets as part of the lease obligations assumed in the transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40111,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10254,
        "completion_tokens": 54,
        "total_tokens": 10308
      }
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "According to the 2024 10-K filing, 391 shares of common stock remained issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan (as noted in the Equity Compensation Plan Information table under \"Plans not approved by security holders\" where footnote (4) specifies this amount). No future awards or deferrals are possible under this plan because the plan explicitly states \"No future stock awards or deferrals may be made under this plan\" in its description of material features.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61881,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15702,
        "completion_tokens": 129,
        "total_tokens": 15832
      }
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The amortization of intangible assets associated with the Allergan acquisition reduced AbbVie's gross margin in 2021, as noted in the \"Gross Margin\" discussion which states that the increase in gross margin percentage was \"primarily due to lower amortization of inventory fair value step-up adjustment associated with the Allergan acquisition and favorable changes in product mix, partially offset by higher amortization of intangible assets associated with the Allergan acquisition.\" The total amortization expense for definite-lived intangible assets in 2021 was $7.7 billion, as reported in the \"Definite-Lived Intangible Assets\" section which states \"Amortization expense was $7.7 billion in 2021.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12444,
        "completion_tokens": 175,
        "total_tokens": 12619
      }
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that would otherwise be limited under the Internal Revenue Code, serving as a supplemental benefit to the primary Benefit Plans. According to the 2023 10-K filing, The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43858,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11185,
        "completion_tokens": 108,
        "total_tokens": 11294
      }
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The Variable Rate Notes balance was $22 million at both December 31 2023 and December 31 2024, so there is no percentage change in their value over that period. Consequently, this $0 million change does not affect the overall change in total borrowings, which increased from $20.4 billion in 2023 to $31.1 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55418,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14077,
        "completion_tokens": 80,
        "total_tokens": 14157
      }
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "Based on the provided financial data, the carrying amount of HD's 4.95% Senior Notes due September 2026 is $744 million and due September 2052 is $980 million as of January 28, 2024. These figures are explicitly stated in the Long-Term Debt table under the \"Carrying Amount (1)\" column for the respective notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48256,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12278,
        "completion_tokens": 77,
        "total_tokens": 12356
      }
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "Based on the provided financial data, PM experienced a **79% decrease** in its net derivative asset position from 2022 to 2023 (from $186 million to $101 million). This reduction aligns with the decline in the total gross amount of derivative contracts, which increased slightly from $40,401 million in 2022 to $43,265 million in 2023, but the net amount (after offsetting and collateral) decreased significantly due to the reclassification of $78 million in derivative gains from accumulated other comprehensive losses to earnings, as noted in the \"Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses\" section.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44600,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11370,
        "completion_tokens": 160,
        "total_tokens": 11530
      }
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31 2024, the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non‑Employee Directors together have **29,345,020 shares available for future issuance**. This includes the remaining shares under the 2016 Stock Incentive Plan (27,143,929 shares) and the 2016 Directors Plan (1,425,693 shares). The number of shares that will actually be issued upon exercise of options and vesting of RSUs under these plans is lower—approximately **12,926,938 shares** are currently outstanding for options, warrants and rights, while the plans collectively allow for up to **29,345,020** shares to be issued in the future.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53837,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13712,
        "completion_tokens": 155,
        "total_tokens": 13868
      }
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "The Dynamics 365 revenue grew by 39% in fiscal year 2022, which helped drive the overall Dynamics products and cloud services revenue up 25% for the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 37738,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9654,
        "completion_tokens": 38,
        "total_tokens": 9692
      }
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million (a 40% rise) in 2021 versus 2020, driven primarily by higher deployments of Megapack as well as growth in Powerwall, Solar Roof and solar cash/loan projects. Megapack serves as the flagship commercial‑scale battery storage offering that anchors Tesla's broader energy‑storage portfolio, which also includes the residential Powerwall, the Powerpack (now being phased out), and integrated solar solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49668,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12650,
        "completion_tokens": 118,
        "total_tokens": 12769
      }
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Based on the provided document pages, the total pre-tax loss recognized by Walmart related to the divestiture of Asda in fiscal 2021 and 2022 was $5.5 billion in fiscal 2021 (recognized upon classifying Asda as held for sale in Q4 FY2021) and $0.2 billion in fiscal 2022 (recorded as an incremental pre-tax loss in other gains and losses upon closing the transaction in Q1 FY2022). This loss included $2.3 billion related to the derecognition of the Asda pension plan, which was part of the disposal group's net assets. The pension-related obligations were a significant component of the loss, as the $2.3 billion accumulated pension components were included in the disposal group and contributed directly to the pre-tax loss recognized during the divestiture process.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 46016,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11753,
        "completion_tokens": 192,
        "total_tokens": 11945
      }
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "Based on the provided document, the More Personal Computing segment reported $56.5 billion in revenue for fiscal year 2022, and Windows OEM contributed 42% of that segment's revenue. Therefore, the combined revenue from Surface devices and Windows OEM licensing represented 42% of the $56.5 billion segment revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39413,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10104,
        "completion_tokens": 78,
        "total_tokens": 10183
      }
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "The $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion of accumulated pension liabilities that were transferred to the disposal group upon the sale of Asda together represent the total financial impact on Walmart’s pension‑related obligations and gains/losses. These amounts are disclosed in Note 11 (pension contribution) and Note 12 (disposal of Asda).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 52741,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13444,
        "completion_tokens": 95,
        "total_tokens": 13540
      }
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The value of pre-owned aircraft inventories increased by $8 million, rising from $15 million at December 31 2023 to $23 million at December 31 2024. The company records pre‑owned aircraft at the lower of trade‑in value or estimated net realizable value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33636,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8631,
        "completion_tokens": 63,
        "total_tokens": 8694
      }
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The growth in Xbox Game Pass's curated library directly contributed to the modest 3% increase in Xbox content and services revenue by expanding the service's value and engagement, though this growth was tempered by broader industry challenges. Microsoft highlights strategic investments in cloud gaming infrastructure, the acquisition of Activision Blizzard, and the integration of gaming into its broader Microsoft Cloud and AI-driven ecosystem as key drivers that could significantly accelerate gaming segment performance in the coming years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 35499,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9112,
        "completion_tokens": 136,
        "total_tokens": 9248
      }
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "Eli Lilly recognized **$2.0 billion** of revenue in 2023 from the sale of rights for the olanzapine portfolio (Zyprexa), which is reported in the “Collaboration and other revenue” line of the consolidated statements of operations. This amount is included in the broader “Collaboration and other revenue” category for 2023, contributing to the total collaboration‑related revenue of **$5.31 billion** for that year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11110,
        "completion_tokens": 103,
        "total_tokens": 11213
      }
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "The structure of Tesla's 5.45% Solar Bonds—evidenced by numerous Supplemental Indentures filed between June and December 2015—reveals a financing strategy centered on incremental, trustee-driven capital raises to meet recurring funding needs for solar projects through a series of bond series (e.g., Series 2015/C53-15, C87-15, C92-15, etc.). These indentures, filed as 8-K disclosures, demonstrate that Tesla (via SolarCity) relied on a standardized trustee framework to issue new bond tranches with minimal amendments, enabling efficient, repeatable access to capital markets for ongoing solar project investments. This approach underscores the critical role of bond-specific trustee agreements in systematically supporting Tesla’s recurring capital requirements without restructuring the entire financing mechanism.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58594,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14898,
        "completion_tokens": 204,
        "total_tokens": 15102
      }
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "The increase in Megapack deployments contributed $795 million to the growth of Tesla’s Energy generation and storage revenue in 2021 versus 2020, and the growth was partially offset by a decline in Powerpack deployments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61644,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15635,
        "completion_tokens": 55,
        "total_tokens": 15690
      }
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "The combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024 is $12 + 8 = $20 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36637,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9364,
        "completion_tokens": 35,
        "total_tokens": 9399
      }
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "Based on the document, TI's policy explicitly states that \"None of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock.\" This policy applies to both U.S. and non-U.S. defined benefit plans, including the non-U.S. defined contribution plans referenced in the question. The document confirms that TI's non-U.S. defined contribution plans hold TI common stock valued at $34 million (as noted in the \"Non-U.S. retirement plans\" section), but this is a separate defined contribution plan, not the non-U.S. defined benefit plans. The non-U.S. defined benefit plans (which are the focus of the question regarding \"non-U.S. defined contribution plans\" – likely a misstatement in the question) have no direct investment in TI common stock, consistent with the company's overall policy. Therefore, TI's policy regarding retiree health care benefit plan investments (which are part of the defined benefit structure) aligns with the actual holdings: there are no direct investments in TI common stock within the non-U.S. defined benefit plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54160,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13762,
        "completion_tokens": 279,
        "total_tokens": 14042
      }
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "Based on the provided financial data, LLY's revenue from Baqsimi decreased significantly between 2023 and 2024. In 2023, total revenue from Baqsimi was $645.7 million in the U.S. and $31.9 million outside the U.S., totaling $677.6 million. In 2024, this dropped to $2.5 million in the U.S. and $26.7 million outside the U.S., totaling $29.2 million—a decline of over 95% year-over-year.\n\nThe collaboration and other arrangements disclosure indicates this shift is due to the sale of rights to Baqsimi. Specifically, the note states that \"Revenue related to products we sell pursuant to these arrangements is included in net product revenue at the earlier of when control of the asset transfers to the other party or when the product has no alternative use to us and we have right to payment,\" and that \"The net gain or loss related to the sale of rights of a product is included in collaboration and other revenue when control of the asset transfers to the other party.\" This suggests LLY sold the Baqsimi rights, resulting in the revenue being reclassified from product sales to a one-time gain/loss recorded in collaboration and other revenue, rather than ongoing product sales revenue. The significant drop in Baqsimi revenue reflects the completion of this transaction, with no further product sales expected under the previous arrangement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43506,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11112,
        "completion_tokens": 336,
        "total_tokens": 11448
      }
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard classifies revenue from its \"Processing and Gateway\" services within the broader \"Value-added services and solutions\" category, as explicitly stated in Note 3: \"Revenue by category: Payment network; Value-added services and solutions.\" This classification aligns with the company's overall revenue structure, where \"Value-added services and solutions\" (including processing and gateway fees) is one of two primary net revenue categories (alongside \"Payment network\"), representing $9,274 million in 2023. The company further details that revenue from these services is recognized upon performance of the services, consistent with its broader revenue recognition policy for value-added offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43122,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11013,
        "completion_tokens": 176,
        "total_tokens": 11190
      }
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "The year‑over‑year change in the pension plan’s investments in international common stocks was an increase of $5 million (from $20 million at Dec 31 2023 to $15 million at Dec 31 2024). This reduction in the international common‑stock allocation contributed to a decline in total international plan assets from $566 million in 2023 to $537 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32895,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8447,
        "completion_tokens": 89,
        "total_tokens": 8536
      }
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The total increase in General Dynamics' Restricted Stock/RSUs expense from 2022 to 2024 was $26 million (rising from $59 million in 2022 to $85 million in 2024). This rise contributed to an overall increase in equity‑based compensation expense of $15 million over the same period, growing from $130 million in 2022 to $145 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45616,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11630,
        "completion_tokens": 84,
        "total_tokens": 11715
      }
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon's $8.0 billion unsecured 364‑day term loan taken in January 2023 illustrates its focus on maintaining ample short‑term liquidity, even though it already had a $20 billion commercial‑paper program available; the short‑term loan was used to meet immediate funding needs and was fully repaid by year‑end, while the commercial‑paper facility remained unused, underscoring Amazon’s preference for flexible, low‑cost short‑term financing options over longer‑term debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50250,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12799,
        "completion_tokens": 117,
        "total_tokens": 12916
      }
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "The Membership Rewards liability increased to $14,752 million in 2024, reflecting higher redemption costs and the impact of renegotiated third‑party partner arrangements. To address these changes, American Express updated its liability estimation methodology by incorporating updated redemption‑cost assumptions and adjusting the Ultimate Redemption Rate models to account for the increased cost of points and the effect of new partner contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 134,
          "pages": [
            132,
            133,
            134,
            135,
            136
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61265,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15556,
        "completion_tokens": 111,
        "total_tokens": 15668
      }
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Colgate-Palmolive uses selling price increases to offset inflationary pressures while managing foreign exchange risk through derivative contracts that hedge foreign currency purchases, assets, liabilities, and net investments in subsidiaries. This combined approach mitigates exposure to currency-driven cost increases and earnings volatility from foreign exchange movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37393,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9590,
        "completion_tokens": 93,
        "total_tokens": 9684
      }
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The 2022 increase in business‑to‑business activity and residential demand drove a 5.3% rise in average daily Next Day Air volume and lifted its revenue per piece to $18.83 (a 12% increase), contributing to a 17.4% jump in Next Day Air revenue. These gains were partially offset by higher operating costs—particularly fuel, labor and network expenses—plus the $281 million expense reallocation after the UPS Freight divestiture, which tempered overall revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33936,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8712,
        "completion_tokens": 116,
        "total_tokens": 8829
      }
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The regulatory exclusivity risk for Opdivo in the U.S. – stemming from the potential for patent challenges, biosimilar competition, and pricing pressures that could erode market exclusivity – is offset by the multiple international approvals Opdivo received in 2021, which strengthen its global oncology positioning and support Bristol‑Myers Squibb’s strategy of expanding its pipeline and capturing growth across diverse markets. This dual‑track approach enables BMY to maintain a robust U.S. revenue base while leveraging its worldwide approvals to drive continued demand and mitigate reliance on any single regulatory regime.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 40439,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10350,
        "completion_tokens": 157,
        "total_tokens": 10507
      }
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "As of December 31, 2024, the estimated fair value of Amazon’s convertible note investments in Anthropic, PBC was approximately **$13.8 billion**. This fair‑value estimate is lower than the total cash invested in those notes to date—about **$5.3 billion** (comprising a $1.25 billion note in Q3 2023, a $2.75 billion note in Q1 2024, and a $1.3 billion note in Q4 2024, with an additional $2.7 billion planned by Q4 2025).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40082,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10252,
        "completion_tokens": 105,
        "total_tokens": 10357
      }
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate-Palmolive accounts for pension enhancements within \"Employee-Related Costs\" in its restructuring charges, where these enhancements are recorded as \"Charges against assets\" that reduce pension assets or increase pension liabilities on the balance sheet. This distinguishes them from other severance-related costs, which are expensed directly, resulting in a specific balance sheet impact reflected in pension-related liabilities rather than general accrued severance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36959,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9470,
        "completion_tokens": 118,
        "total_tokens": 9589
      }
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "The U.S. regulatory data protection period for biologic products like Opdivo extends market exclusivity beyond patent expiration, but once exclusivity ends, BMY faces rapid revenue decline in developed markets—mirroring the steep post-exclusivity drops observed for other products—posing significant financial risk as U.S. sales erosion accelerates after exclusivity lapses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 43699,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11167,
        "completion_tokens": 93,
        "total_tokens": 11260
      }
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "\\boxed{87.5\\%}",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41669,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10647,
        "completion_tokens": 3,
        "total_tokens": 10651
      }
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "The decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, as measured by Level 1 quoted prices in active markets for identical assets, was $1 million. This $1 million unrealized loss is reflected in the “Total marketable securities” row of the unrealized‑losses table, where the fair value of U.S. government and agency debt securities fell from $184 million (2020) to $200 million (2021) with a corresponding unrealized loss of $1 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 33900,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8697,
        "completion_tokens": 121,
        "total_tokens": 8818
      }
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The joint development and cost‑sharing structure with Ono means that BMS records any up‑front or contingent milestones paid to Ono as an expense in research and development, while reimbursements from Ono are booked as a reduction of cost of products sold or other operating expense.  Because these payments are amortized over the expected period of BMS’s co‑promotion and market‑exclusivity obligations, the financial risk exposure tied to potential biosimilar competition—particularly under the U.S. 12‑year data‑exclusivity regime for biologics—is limited to the portion of milestone and royalty cash flows that are deferred or capitalized and recognized only as they are earned, rather than being fully absorbed up front.  Consequently, BMS’s exposure to biosimilar‑driven revenue pressure is mitigated by the amortization schedule and the fact that royalty and milestone receipts are classified as other income/expense, not as direct product revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 7,
        "total_chars": 37405,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9583,
        "completion_tokens": 238,
        "total_tokens": 9822
      }
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offsets roughly 9.9 % of the $6.03 billion decline in Automotive Sales Revenue (596 ÷ 6,030 ≈ 0.099). This revenue is recorded as part of the deferred‑revenue balance for FSD features and is recognized over the performance period of the over‑the‑air software updates and related services. The related deferred‑revenue schedule shows the balance growing to $3.599 billion by year‑end 2024, with about $840 million expected to be recognized in the next 12 months, reflecting the portion of the transaction price allocated to the unsatisfied performance obligations tied to FSD and other OTA updates. The guarantees and residual‑value estimates for these vehicles are accounted for in the resale‑value guarantee liabilities and affect the timing of revenue recognition, but the $596 million recognized directly reduces the net impact of the sales‑revenue decline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51502,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13128,
        "completion_tokens": 231,
        "total_tokens": 13359
      }
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo adjusts for items affecting comparability in its 2022 10-K, specifically \"Items Affecting Comparability\" which include acquisition and divestiture-related charges, restructuring and impairment charges, and mark-to-market net impacts. To account for currency fluctuations when evaluating operating profit growth, the company uses \"Operating Profit Growth Adjusted for Items Affecting Comparability on a Constant Currency Basis,\" which removes the impact of foreign exchange translation to isolate the true operational performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 39090,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9999,
        "completion_tokens": 134,
        "total_tokens": 10133
      }
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "Based on the provided exhibits in the TSLA_10k_2024.pdf document, **12 amendments** to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across Exhibits 10.31 through 10.42. The earliest effective date is **September 2, 2014** (Exhibit 10.31), and the latest effective date is **July 22, 2020** (Exhibit 10.42), resulting in a time span of **6 years and 11 months** between these dates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38954,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9978,
        "completion_tokens": 112,
        "total_tokens": 10090
      }
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 14 percentage points from the acquisition and 4.5 percentage points from favorable foreign exchange, for a total of 18.5 percentage points.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 33776,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8661,
        "completion_tokens": 73,
        "total_tokens": 8735
      }
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo’s U.S. revenue grew 7% in 2021, driven by higher demand across multiple therapies and higher average net selling prices, while its EU revenue grew 9% due to higher demand and foreign exchange impacts. The drug’s regulatory data protection timeline in both the U.S. and EU interacts with its patent expiration pattern to shape market exclusivity, as seen with other products like Revlimid and Eliquis where generic entry is tied to patent and exclusivity expirations. However, the provided text does not specify Opdivo’s exact patent expiration dates or regulatory exclusivity timelines, making it impossible to detail how they precisely influence market exclusivity in relation to the 2021 U.S. revenue growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 38674,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9897,
        "completion_tokens": 179,
        "total_tokens": 10076
      }
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "Morgan Stanley's capital distribution policies and liquidity management are constrained by the Federal Reserve's systemic risk regime, which imposes heightened capital and liquidity requirements on large bank holding companies (BHCs) with over $250 billion in assets. Specifically, the Volcker Rule restricts proprietary trading activities, while capital planning and stress test requirements limit dividend payments, stock repurchases, and other capital distributions if regulators deem them unsafe or unsound given the firm's financial condition. Additionally, the BHC Act's single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for others) and mandatory liquidity stress testing further restrict its ability to deploy capital freely.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 46722,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11908,
        "completion_tokens": 193,
        "total_tokens": 12101
      }
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The 0.750% Senior Note due 2033 carries a lower interest rate than the 1.950% Senior Note due 2031, indicating that PepsiCo is likely issuing newer debt at more favorable (lower) rates, possibly reflecting improved credit conditions or a strategic shift toward managing long‑term debt costs across different maturities. This rate differential suggests the company is taking advantage of current market conditions to finance future obligations at reduced expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 134,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 135,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 21918,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 5709,
        "completion_tokens": 115,
        "total_tokens": 5824
      }
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "Based on the provided document pages, the fair value of Medtronic's partnership units increased from $992 million at April 28, 2023 to $1,151 million at April 26, 2024, representing an increase of $159 million. This increase contributed to a $187 million rise in total investments measured at net asset value (from $2,179 million to $3,366 million), reflecting the impact of the partnership unit valuation change on the overall portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56378,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14314,
        "completion_tokens": 109,
        "total_tokens": 14423
      }
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "The 2024 10‑K notes that depreciation and amortization amounts shown for each reportable segment are derived after applying activity‑based costing methods to allocate shared expenses, meaning the segment‑level D&A totals are not raw asset values but rather expense amounts that have been apportioned across segments using these allocation estimates. Consequently, changes in the allocation estimates directly affect the D&A expense recorded for each segment and thus the reported operating profit of the segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37957,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9731,
        "completion_tokens": 128,
        "total_tokens": 9859
      }
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "The reversal of the European Commission fine and its associated interest in fiscal 2022 generated a $1.1 billion benefit recorded in other income and reduced interest expense by $62 million. This reversal was reflected in the company’s financial statements as a positive impact on other income and a corresponding decrease in interest expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55534,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14107,
        "completion_tokens": 85,
        "total_tokens": 14193
      }
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair value of Fixed Income Commingled Trusts held by the Medtronic Defined Trust (MDT) increased by **$305 million** from fiscal year 2023 to fiscal year 2024. This increase represented **approximately 9 %** of the total fair‑value increase across all investment categories for the MDT.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56378,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14329,
        "completion_tokens": 72,
        "total_tokens": 14402
      }
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley’s SPOE resolution plan ensures adequate liquidity for its subsidiaries by having the Parent Company (Morgan Stanley) provide capital and liquidity to designated “supported” subsidiaries through a secured, amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as the resolution‑funding vehicle, receiving transferred assets from the Parent and being obligated to supply the required capital and liquidity to those subsidiaries under the same support agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 56981,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14480,
        "completion_tokens": 126,
        "total_tokens": 14606
      }
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs, as the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity and relies heavily on Chinese markets for revenue. However, government actions that could cause Chinese OEMs to shift away from Qualcomm's integrated circuit products pose a material risk to its revenues, given the company's significant dependency on this market. Consequently, sustaining its automotive 5G growth strategy requires preserving relationships with Chinese OEMs amid geopolitical tensions and potential regulatory disruptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63904,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16272,
        "completion_tokens": 157,
        "total_tokens": 16430
      }
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The total fair value of investments measured at net asset value for Medtronic’s pension plans increased by **$187 million** from fiscal 2023 to fiscal 2024, and the **equity securities** category contributed the most to that change.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56378,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14318,
        "completion_tokens": 58,
        "total_tokens": 14376
      }
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab values its repurchase liabilities for client‑held fractional shares at fair value, using quoted market prices or other observable market data that reflect the same inputs as the related client‑held securities. Because the liabilities are measured at fair value and the unrealized gains and losses on the fractional shares are offset by an equal but opposite adjustment to the repurchase liability, changes in market value do not flow through the income statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43678,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11149,
        "completion_tokens": 117,
        "total_tokens": 11267
      }
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "Based on the disclosed information in the Financial Consultant Career Achievement Plan section (page 115-119), the projected benefit obligation increased from **$92 million at December 31, 2020, to $119 million at December 31, 2021**, representing a **total increase of $27 million** over the one-year period. This change reflects the cumulative effect of benefit cost ($16 million in 2021), actuarial losses ($11 million in 2021), and the prior year's obligation of $83 million at the beginning of 2020.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39464,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10100,
        "completion_tokens": 126,
        "total_tokens": 10226
      }
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The Beauty segment contributes 18% of Procter & Gamble's total net sales, while the Fabric & Home Care segment accounts for 36% of net sales. Combined, these segments represent 54% of total net sales for the fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53940,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13724,
        "completion_tokens": 55,
        "total_tokens": 13779
      }
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 related to Carrier and Otis was $(410) million, reflecting a $(33) million loss from Carrier and a $(377) million loss from Otis (the $187 million Otis gain is offset by the $(793) million separation‑related charge). This loss is presented separately in Note 3 as part of the discontinued operations and is excluded from continuing‑operations results, illustrating how the 2020 separation of Carrier and Otis into independent public companies reclassified their financial results into discontinued operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53791,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13672,
        "completion_tokens": 151,
        "total_tokens": 13824
      }
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14 2024, 27 lawsuits have been filed in the Diabetes Pump Retainer Ring Litigation on behalf of a total of 107 individual plaintiffs, and law firms have indicated they may file additional suits that could bring in thousands more claimants.  Compared with the hernia‑mesh litigation—which involves roughly 8,350 current plaintiffs and potentially thousands more—the diabetes pump case is far smaller in both the number of existing claimants and the anticipated scale of future claimants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58296,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14831,
        "completion_tokens": 124,
        "total_tokens": 14955
      }
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement requires Schwab to move certain brokerage client deposits off‑balance‑sheet to third‑party depository institutions, which creates off‑balance‑sheet liabilities that must be funded through capital and liquidity resources. Because Schwab’s internal capital‑management target is a Tier 1 Leverage Ratio of 6.75%‑7.00%, the additional off‑balance‑sheet deposits increase the amount of capital needed to keep the consolidated leverage ratio within that range, influencing capital‑allocation decisions and the pace of migrating IDA balances onto the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40343,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10316,
        "completion_tokens": 144,
        "total_tokens": 10460
      }
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "The RTX 2021 Form 10‑K does not disclose a specific dollar amount for the net cash inflow from the disposition of the Forcepoint business, nor does it break out the cash effect of that sale within the investing‑activities section. Consequently, the exact net cash inflow from the Forcepoint disposition and its contribution to the overall net cash provided by investing activities in 2021 versus 2020 cannot be determined from the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 50238,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12784,
        "completion_tokens": 111,
        "total_tokens": 12895
      }
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle's reliance on third‑party colocation providers for its global data‑center footprint introduces significant financial risk for Oracle Cloud Services. The company enters long‑term lease commitments that often require substantial early‑termination fees if market conditions or strategic priorities shift, potentially eroding profitability and cash flow. Moreover, any disruption to these facilities—whether from natural disasters, political unrest, or supplier failure—could impair the delivery of cloud services and force costly early exits from leases, further amplifying the exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40891,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10462,
        "completion_tokens": 147,
        "total_tokens": 10609
      }
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "As of December 31 2021, UnitedHealth Group had **64 million shares available for future grants under the 2020 Stock Incentive Plan** and **18 million shares available for issuance under the ESPP**. This combined pool of shares provides sufficient equity authorizations to support the company’s share‑based compensation strategy, enabling it to grant new stock options, restricted shares and ESPP purchases while also allowing flexibility to offset dilution from existing awards and to align employee incentives with long‑term shareholder value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49520,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12623,
        "completion_tokens": 136,
        "total_tokens": 12759
      }
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab accounts for client‑held fractional shares as “other securities owned” recorded at fair value, with the corresponding repurchase liability recorded at an equal fair‑value amount in accrued expenses and other liabilities. These repurchase liabilities are presented on the consolidated balance sheet within accrued expenses and other liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 38845,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9945,
        "completion_tokens": 87,
        "total_tokens": 10033
      }
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by offering automatic scaling, self-driving database capabilities, and consumption-based pricing that lowers labor and infrastructure expenses, while simultaneously driving strategic growth in Oracle's cloud and license business through increased adoption of OCI services, expanded footprint, and migration of on-premise workloads to the cloud. This integration leverages OCI's security features, hybrid deployment options like Exadata Cloud@Customer, and seamless connectivity to accelerate cloud migration and create recurring revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41056,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10479,
        "completion_tokens": 158,
        "total_tokens": 10638
      }
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "The 10‑K indicates that the AARP Program assets are held separately and are classified as current assets because they fund the program’s medical‑costs payable, rate‑stabilization fund liabilities and other related obligations. If the AARP Program contract were transferred to another entity, UnitedHealth Group would need to transfer cash equal to the fair value of those assets at the transfer date, and the related RSF liabilities would be settled accordingly. Consequently, the financial impact would be a cash outflow equal to the fair‑value of the AARP Program assets and a corresponding reduction of the associated RSF liabilities on the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51894,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13201,
        "completion_tokens": 164,
        "total_tokens": 13365
      }
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The fair value of Card Member and Other Loans is not disclosed in the provided 10-K excerpts, which only include detailed disclosures on derivatives, hedging activities, lease commitments, and legal proceedings. Consequently, there is no available information to compare its fair value to carrying value or to determine its classification within the Level 3 fair value hierarchy. The document focuses on derivative instruments and related accounting policies rather than loan portfolio valuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 140,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 140,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46548,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11851,
        "completion_tokens": 124,
        "total_tokens": 11975
      }
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2021, the UnitedHealth Group 2020 Stock Incentive Plan had **64 million shares remaining available for future issuance**. These shares may be used for a variety of award types, including **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54187,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13768,
        "completion_tokens": 85,
        "total_tokens": 13854
      }
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The total estimated fair value of foreign government bonds and obligations held by the company in 2023 was $770 million, compared to $632 million in 2022 for maturities of 12 months or more.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49015,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12486,
        "completion_tokens": 47,
        "total_tokens": 12533
      }
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021, compared with $8 million in 2019.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 28975,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7457,
        "completion_tokens": 29,
        "total_tokens": 7486
      }
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "The worldwide sales of Contact Lenses/Other within the Vision segment grew 14.9% from 2020 to 2021, which outpaced the overall Vision segment growth of 19.6% over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40360,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10331,
        "completion_tokens": 44,
        "total_tokens": 10376
      }
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "Based on the stock plan disclosures in Note 10, the total weighted‑average grant price for Service and Performance‑Based RSUs outstanding as of December 31, 2021—reflecting both the beginning balance and the new grants issued during the year—was **$114.22 per share**. This figure appears in the “Outstanding as of December 31, 2021” row for Service and Performance‑Based RSUs, which reports a weighted‑average grant price of $114.22.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55644,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14135,
        "completion_tokens": 108,
        "total_tokens": 14244
      }
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "Based on the provided pages from Boeing's 2024 10-K filing, the outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decreased from $10,135 million at the end of 2023 to $6,159 million at the end of 2024, representing a reduction of $3,976 million. In 2024, this specific tranche of debt accounted for approximately 11.4% of the company's total debt of $53,864 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41408,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10576,
        "completion_tokens": 97,
        "total_tokens": 10673
      }
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "The combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021 was $2,810 million ($1,325 million for Knees + $1,485 million for Hips), which represented approximately 32.7% of the total Orthopaedics revenue of $8.6 billion for that year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37852,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9682,
        "completion_tokens": 67,
        "total_tokens": 9749
      }
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 11.6 million for 2024, 5.7 million for 2023, and 3.5 million for 2022. These shares were excluded because the effect of including them would have been antidilutive due to the company incurring a net loss in each of these periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 33412,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8577,
        "completion_tokens": 99,
        "total_tokens": 8676
      }
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately **$1.8 billion**. This change affects U.S. non‑union employees hired before 2015 by requiring their future pension benefits to be calculated under the Retirement Value formula (based on compensation over total years of service) rather than the prior Final Average Pay formula, while leaving benefits accrued under the old formula for service before January 1, 2026 unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56236,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14295,
        "completion_tokens": 127,
        "total_tokens": 14422
      }
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The filing states that the fair value of the company cannot be estimated by aggregating the figures for financial assets and liabilities carried at amortized cost because those figures represent only estimates of the fair values of individual items as of specific dates, based on market conditions and perceived risks at those times, and do not reflect the overall fair value of the entire company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            139,
            140,
            141,
            142,
            143
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            139,
            140,
            141,
            142,
            143
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41402,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10592,
        "completion_tokens": 99,
        "total_tokens": 10691
      }
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The Benefits Plan for Members of the Board of Directors is explicitly listed in the exhibit index as **Exhibit 10.13**, with its amendment history detailed in **Exhibit 10.13.1** (Amendment Number One dated December 16, 2005). The original plan was adopted through an amendment and restatement effective **April 14, 2004**, and the first amendment became effective **December 16, 2005**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 135,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 135,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 78246,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19785,
        "completion_tokens": 96,
        "total_tokens": 19882
      }
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle's hybrid deployment model—combining on-premise, cloud, and hybrid options—enabled customers to adopt cloud services gradually while retaining existing on-premise investments. This flexibility drove strong demand for cloud services, contributing to cloud and license revenues representing 84% of total fiscal 2024 revenue, as customers increasingly migrated to and expanded their use of Oracle Cloud.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46820,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11916,
        "completion_tokens": 101,
        "total_tokens": 12018
      }
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "Based on the provided document pages, **American Express does not disclose the specific dollar amount of December 31, 2021 deferred fees tied directly to Membership Rewards program participants**. The document only states that the Membership Rewards liability (which includes points earned by participants) was $11,398 million as of December 31, 2021, and that \"Deferred card and other fees (a)\" includes deferred fees for Membership Rewards participants ($2,838 million in 2021). However, it does not isolate the portion of this $2,838 million attributable solely to Membership Rewards participants or specify how much of the $11,398 million liability represents deferred fees.  \n\nRegarding the methodology for estimating future redemption liability, the document explains that the liability is estimated using **two key assumptions**:  \n1. **Ultimate Redemption Rate (URR)**: Estimated via statistical and actuarial models based on redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes.  \n2. **Weighted Average Cost (WAC) per point**: Derived from 12 months of redemptions, adjusted for changes in redemption costs and expected future patterns.  \n\nThe liability is then calculated using these assumptions, but the document does not specify the exact percentage of Membership Rewards points tied to participants or how this relates to the $11,398 million liability figure. The $11,398 million represents the *total estimated cost of future redemptions* (not deferred fees), and the document does not break down the participant-specific portion of this liability.  \n\n**Answer**: The document does not provide the specific dollar amount of deferred fees tied to Membership Rewards participants, nor does it clarify how this relates to the $11,398 million Membership Rewards liability. The methodology for estimating future redemption liability relies on URR and WAC per point assumptions, but the participant-specific portion of the liability is not disclosed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68912,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17461,
        "completion_tokens": 500,
        "total_tokens": 17962
      }
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "Based on the Exhibit Index in the 2024 10-K filing, The Coca-Cola Company documented **13 distinct award agreements** under its 2014 Equity Plan between February 18, 2015, and February 17, 2021. These include specific forms referenced in Exhibits 10.5.1 through 10.5.21 (e.g., Stock Option Agreements, Restricted Stock Unit Agreements, and Performance Share Agreements adopted on key dates like February 18, 2015; February 17, 2016; February 15, 2017; February 14, 2018; February 20, 2019; and February 17, 2021). The count reflects unique agreement types filed within that date range, as detailed in the provided source pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 62502,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15851,
        "completion_tokens": 156,
        "total_tokens": 16007
      }
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "Based on the provided financial disclosures, AMD's total financial relationship with the ATMP JV in 2021 was valued at **$1.1 billion in purchases plus $6 million in equity gains**, reflecting the strategic importance of the joint venture as a key supply chain partner for assembly, test, mark, and packaging services. This significant procurement volume and the resulting equity income underscore the ATMP JV's critical role in AMD's manufacturing operations and supply chain strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38746,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9917,
        "completion_tokens": 121,
        "total_tokens": 10038
      }
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The patents covering DARZALEX (U.S. expiration 2029) and DARZALEX FASPRO (Europe 2032) mean the earliest point at which exclusivity could begin to erode the combined 6.4 % of J&J’s 2021 revenue would be the U.S. patent expiry in 2029.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44905,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11502,
        "completion_tokens": 58,
        "total_tokens": 11561
      }
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "Based on the provided Exhibit list in the 2022 10-K filing (pages 17-22), **The Bank of New York Company, Inc. Excess Benefit Plan was amended twice**—specifically, **Exhibit 10.23** (amendment effective Jan. 1, 2009) and **Exhibit 10.37** (amendment effective Nov. 1, 2018). These are the only two amendments to the Excess Benefit Plan documented in the filing. \n\n**Answer**: The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018 is **2**.  \n\n*(Note: Exhibit 10.31 references an amendment to the Excess Benefit Plan effective June 30, 2015, but it is not an amendment to the Plan itself—it is an amendment to the Supplemental Executive Retirement Plan. Only Exhibits 10.23 and 10.37 directly amend the Excess Benefit Plan.)*",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43677,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11135,
        "completion_tokens": 199,
        "total_tokens": 11334
      }
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx's Network 2.0 optimization expenditures and European workforce reduction costs are integral components of its 2025 capital expenditure plan and DRIVE transformation program, as explicitly stated in the MD&A. The company expects 2025 capital expenditures of approximately $5.2 billion, which includes \"continued investments related to Network 2.0, as well as the continued modernization of the Federal Express Memphis World Hub and expansion and modernization of the Federal Express Indianapolis Hub.\" Furthermore, the planned European workforce reductions (impacting 1,700-2,000 employees) are framed as part of the ongoing \"measures to reduce structural costs\" within the DRIVE program, with expected pre-tax costs ranging from $250 million to $375 million through fiscal 2026, directly contributing to the company's strategic focus on improving long-term profitability through cost optimization and network efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50263,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12792,
        "completion_tokens": 231,
        "total_tokens": 13023
      }
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD's reliance on third‑party suppliers for graphics cards and AIB partners creates inventory‑management risk because it must forecast demand and maintain sufficient stock to meet customer orders; inaccurate forecasts can lead to excess or obsolete inventory that must be written down, reducing gross margins. At the same time, the company offers price‑protection and return rights to distributors and AIB partners, which can trigger additional price‑protection obligations and force it to absorb lower margins if market prices fall or if it must discount inventory to move stale stock.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47087,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11996,
        "completion_tokens": 146,
        "total_tokens": 12142
      }
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie's total cost of products sold related to Venclexta includes the $869 million share of profits paid to Genentech (recorded in cost of products sold) plus the royalties it pays on Venclexta net revenues generated outside the United States.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47700,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12144,
        "completion_tokens": 61,
        "total_tokens": 12205
      }
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY makes its Code of Ethics publicly available, which is explicitly applicable to all directors of BNY.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 34679,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8899,
        "completion_tokens": 26,
        "total_tokens": 8925
      }
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "The Radeon RX 6600 XT and the broader gaming‑focused graphics strategy helped drive AMD’s 68% revenue growth and 3‑point gross‑margin improvement in 2021 by expanding the company’s high‑performance GPU portfolio for 1080p gaming, boosting demand for Radeon graphics in both desktop and mobile segments, and supporting higher‑margin product mix through new RDNA 2‑based cards and associated software (e.g., FidelityFX Super Resolution). These launches increased sales of higher‑margin discrete GPUs and related ecosystem revenue, directly contributing to the revenue surge and margin expansion reported for the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49316,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12567,
        "completion_tokens": 153,
        "total_tokens": 12721
      }
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's net revenue from Venclexta in 2023 was $2,288 million, and Genentech received 50% of the pre-tax profit from Venclexta sales in the United States as part of their collaboration agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45798,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11675,
        "completion_tokens": 49,
        "total_tokens": 11724
      }
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "The 10‑K shows only 10 Class C shares outstanding because the 48 million Class C shares issued in the May 2024 exchange offer were **retired and treated as authorized but unissued** shares; they are not counted as “outstanding” in the equity section of the balance sheet. Consequently, the only Class C shares that remain outstanding are the 10 shares reflected in the September 30 2024 column.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 69520,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17601,
        "completion_tokens": 98,
        "total_tokens": 17700
      }
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "Based on the provided document pages, the total cost incurred by FedEx in 2024 for Network 2.0 implementation and DRIVE transformation-related business optimization activities was **$582 million** (net of tax: $444 million, or $1.77 per diluted share). For the European workforce reduction plan announced in June 2024, the expected pre-tax cost range for severance benefits and legal/professional fees is **$250 million to $375 million**, to be incurred through fiscal 2026.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57635,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14650,
        "completion_tokens": 118,
        "total_tokens": 14769
      }
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "Based on the provided document pages, specifically the \"Revenue\" section and \"NOTE 3 - Supplemental Financial Statement Information,\" the total value of AMD's unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021 is $329 million. This is explicitly stated in the Accounts Receivable, net section: \"As of December 25, 2021 and December 26, 2020, Accounts receivable, net included unbilled accounts receivable of $329 million and $123 million, respectively. Unbilled accounts receivables primarily represent work completed for development services and on custom products for which revenue has been recognized but not yet invoiced.\" Additionally, the Revenue section confirms that \"Revenue recognized over time associated with custom products and development services accounted for approximately 23% of the Company's revenue in 2021.\" Therefore, the unbilled accounts receivable of $329 million as of December 25, 2021, represents the amount expected to be billed and collected within 12 months for these specific revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41295,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10542,
        "completion_tokens": 279,
        "total_tokens": 10821
      }
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million, and it shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech under their collaboration agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49826,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12682,
        "completion_tokens": 46,
        "total_tokens": 12728
      }
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million (from $171 million at December 31 2022 to $0 at December 15 2023). In comparison, the balance of the 3.700% notes due 2023 on December 15 2023 was $400 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39586,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10125,
        "completion_tokens": 61,
        "total_tokens": 10186
      }
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "Adverse litigation outcomes that force Visa to modify its interchange reimbursement rates could erode transaction volumes and compress margins, especially if the changes reduce the profitability of VisaNet transactions. However, the company’s U.S. and Europe retrospective responsibility plans provide financial protections that may limit the impact of such settlements, and ongoing tax disputes add uncertainty to its overall financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 52677,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13412,
        "completion_tokens": 111,
        "total_tokens": 13524
      }
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "The Performance Share Unit award schedules under the United Technologies Corporation Long‑Term Incentive Plan became effective on **January 1, 2020** (as reflected in Exhibit 10.15, Schedule of Terms for performance share unit awards, Rev. January 2016, and the LTIP Performance Share Unit Deferral Plan dated January 1, 2020).  \n\nIn contrast, the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan’s Performance Share Unit schedule was adopted on **December 6, 2020** when Amendment No. 1 to that plan took effect (see Exhibit 10.22, which notes the amendment became effective as of December 6, 2020).  \n\nThese differing effective dates illustrate separate governance updates: UTC’s schedule was updated and implemented in 2020 as part of its own LTIP amendment, while Raytheon Technologies introduced its performance‑share schedule under the 2018 plan only after the December 2020 amendment, marking a distinct governance change for each company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80094,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20275,
        "completion_tokens": 240,
        "total_tokens": 20516
      }
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "The Wearables, Home and Accessories segment's growth in 2022 was primarily driven by higher sales of Apple Watch and AirPods, as explicitly stated in the \"Wearables, Home and Accessories\" subsection under \"Fiscal 2022 Highlights\" and reiterated in the \"Wearables, Home and Accessories\" section of the segment performance analysis. This growth outpaced other categories within the segment, which showed mixed results: iPad sales declined due to lower iPad Pro demand, while Services and Mac saw growth, but Wearables, Home and Accessories specifically outperformed these with a 7% year-over-year increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 32734,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8410,
        "completion_tokens": 151,
        "total_tokens": 8561
      }
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and Enbrel are expected to experience lower first‑quarter sales in 2025 because of benefit‑plan changes, insurance‑reverification requirements and higher co‑pay costs that cause patients to work through deductibles.  Historically, each product has shown a pattern of weaker Q1 sales followed by stronger performance in the remainder of the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40448,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10336,
        "completion_tokens": 89,
        "total_tokens": 10425
      }
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "Based on the provided document pages, RTX discloses **two distinct stock appreciation rights-related exhibits**: one for the **United Technologies Corporation 2005 Long-Term Incentive Plan** (Exhibit 10.16) and one for the **Raytheon Technologies Corporation 2018 Long-Term Incentive Plan** (Exhibit 10.24). Both exhibits detail stock appreciation rights awards under their respective plans. \n\n**Answer**: 2 distinct stock appreciation rights-related exhibits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80094,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20264,
        "completion_tokens": 115,
        "total_tokens": 20379
      }
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "Based on the document, ENBREL and Otezla are expected to follow historical seasonal patterns where first-quarter sales are typically the lowest of the year due to insurance reverification and higher patient cost-sharing after deductibles. This recurring impact of insurance reverification in Q1 will likely suppress the combined sales performance of these two products in 2025 relative to their full-year potential, even as they face ongoing net selling price declines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40448,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10343,
        "completion_tokens": 117,
        "total_tokens": 10460
      }
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Based on the document, the impact of increased co‑pay expenses and Medicare price‑setting timelines could reduce AMGN’s revenue from Otezla and Enbrel beginning in 2025 and 2026 respectively, reflecting a pattern of forecasting that anticipates lower sales in the first quarter and ongoing pressure from benefit‑plan changes, insurance reverification and IRA‑driven price cuts. This pattern is evident in the company’s historical revenue outlook for its key drugs, which consistently projects volume‑driven growth offset by net‑selling‑price declines and expects first‑quarter dips due to co‑pay and deductible dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40448,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10357,
        "completion_tokens": 155,
        "total_tokens": 10512
      }
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "Based on the provided document pages, the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is $2,543 million. Schwab accounts for the unrealized gains and losses associated with these liabilities by including them in accrued expenses and other liabilities on the consolidated balance sheet, with corresponding unrealized gains and losses on the related client-held fractional shares offsetting these amounts, resulting in no impact to the consolidated statements of income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47526,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12124,
        "completion_tokens": 133,
        "total_tokens": 12257
      }
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "Based on the document, Emerson's November 5 2024 announcement states that acquiring the remaining shares of AspenTech at $240 per share would value AspenTech at a fully‑diluted market capitalization of **$15.3 billion**. This implied fully‑diluted market cap is roughly **15 times** AspenTech’s 2023 net sales of **$1.04 billion**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 40235,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10283,
        "completion_tokens": 82,
        "total_tokens": 10365
      }
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "Based on the document, the IRS Notices for the years 2010-2012 and 2013-2015 propose additional federal tax liabilities of approximately $3.6 billion (for 2010-2012) and $5.1 billion (for 2013-2015), plus interest and penalties. However, any additional tax imposed for these years would be reduced by up to approximately $900 million (for 2010-2012) and $2.2 billion (for 2013-2015) of previously accrued repatriation taxes on foreign earnings. The Company is contesting these notices in U.S. Tax Court, with a decision expected no earlier than 2026, and believes the IRS positions are without merit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50266,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12797,
        "completion_tokens": 150,
        "total_tokens": 12947
      }
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The 2024 10‑K notes that the IRA’s Medicare price‑setting program now includes ENBREL, which CMS priced at a substantially lower level beginning January 1 2026, directly reducing the drug’s Medicare profitability and therefore pressuring overall earnings.  In addition, CMS announced that Otezla will be among the next 15 drugs subject to mandatory Medicare price setting starting January 1 2027, meaning that, if selected, Otezla could also face government‑set prices and related rebate penalties, introducing further downside risk to Amgen’s future cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52503,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13359,
        "completion_tokens": 140,
        "total_tokens": 13500
      }
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Schwab’s election of the fair value option for repurchase liabilities tied to client-held fractional shares—measured using quoted market prices—results in unrealized gains and losses on these liabilities being offset by corresponding gains and losses on the underlying client-held fractional shares. This offsetting treatment ensures no net impact on the consolidated statements of income, as any fluctuations in the fair value of the repurchase liabilities are directly canceled out by the opposite movements in the fair value of the related client-held fractional shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50468,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12846,
        "completion_tokens": 143,
        "total_tokens": 12989
      }
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 resulted from the combined use of a discounted cash‑flow analysis and a market‑multiple approach to estimate the unit’s fair value, which was then compared to its carrying amount. This impairment was triggered by the November 17 2021 Board‑approved plan to close about 900 stores over three years, which created indicators of impairment for the affected retail/LTC asset groups. The store‑closure strategy—specifically the announced closure of roughly 300 stores annually through 2024—directly impacted the Retail/LTC segment’s long‑lived‑asset impairment analysis, leading to a $1.4 billion store‑impairment charge (including write‑downs of operating‑lease right‑of‑use assets and property and equipment) recorded in the fourth quarter of 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 152,
          "pages": [
            150,
            151,
            152,
            153,
            154
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51740,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13200,
        "completion_tokens": 206,
        "total_tokens": 13406
      }
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31 2023 to December 31 2024 is $978 million, and $10,015 million of that increase is attributable to Level 2 assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 68820,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17434,
        "completion_tokens": 57,
        "total_tokens": 17492
      }
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson allocates AspenTech's stock-based compensation expense between pre- and post-combination periods by attributing the portion of fair value related to pre-combination service to the purchase price (included in goodwill and intangibles) and recognizing the portion attributable to post-combination service as stock-based compensation expense over the remaining service period. The allocation uses specific inputs from the acquisition: the fair value of stock-based compensation awards attributable to pre-combination service ($102 million for Heritage AspenTech) and the total purchase consideration ($11,188 million), with the post-combination portion recorded as expense in Emerson's consolidated results. Ownership figures include Emerson's 55% beneficial ownership of AspenTech (on a fully diluted basis) after the acquisition, and the allocation of intangible assets (e.g., developed technology, customer relationships) was based on their fair values and useful lives as detailed in the purchase price allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41154,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10524,
        "completion_tokens": 255,
        "total_tokens": 10780
      }
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The percentage change in the value of CVS's investments in \"States, Municipalities and Political Subdivisions\" from December 31 2021 to December 31 2022 was an increase of approximately 15 % (from $150 million to $172.5 million). This growth modestly expanded the share of the debt‑securities portfolio allocated to municipal bonds, shifting the overall composition toward a slightly higher weighting of tax‑exempt municipal securities within the broader fixed‑income holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 166,
          "pages": [
            164,
            165,
            166,
            167,
            168
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41945,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10729,
        "completion_tokens": 119,
        "total_tokens": 10849
      }
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "The potential conversion of Visa’s class B common stock into class A shares is contingent on the final resolution of the U.S. covered litigation under the U.S. retrospective responsibility plan; the amount of that conversion hinges on the accrual activity tied to that litigation, which reflects the estimated loss exposure from the pending legal matters. Because the litigation accrual is based on management’s best estimate of a probable and reasonably estimable loss, the actual loss could differ materially, creating uncertainty that could dilute existing class A shareholders and affect the market price of Visa’s class A common stock.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 44957,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11495,
        "completion_tokens": 160,
        "total_tokens": 11655
      }
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "The fair value of Cisco's available‑for‑sale debt investments declined by **$5,727 million** from July 29 2023 to July 27 2024.  Correspondingly, the net loss on these investments increased by **$11 million** year‑over‑year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48720,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12410,
        "completion_tokens": 56,
        "total_tokens": 12466
      }
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 increased contract liabilities by $387 million from rewards earnings and gift‑card issuances, but $371 million of that was offset by redemptions and breakage, leaving a net $87 million contract‑liability balance at year‑end. Revenue allocated to ExtraBucks Rewards is recognized only when the rewards are redeemed, so the growth in these liabilities reflects the portion of sales that is deferred until future redemption, directly affecting revenue recognition timing and amount.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 134,
          "pages": [
            132,
            133,
            134,
            135,
            136
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 134,
          "pages": [
            132,
            133,
            134,
            135,
            136
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37352,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9555,
        "completion_tokens": 137,
        "total_tokens": 9693
      }
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "The U.S. litigation escrow account is funded by depositing cash (e.g., the $850 million deposit in fiscal 2022) that triggers a downward adjustment to the conversion rate of class B common stock into class A common stock, thereby diluting the class B shares. This adjustment reduces the number of as‑converted class A shares and increases the effective price per share (to $205.06 for the 2022 deposit). The resulting change is reflected in the litigation provision as an $861 million accrual for U.S. covered litigation, which includes the escrow funding and related charges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54480,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13874,
        "completion_tokens": 144,
        "total_tokens": 14018
      }
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "The fair value of Cisco's available‑for‑sale debt investments declined by **$1.1 billion** from July 29 2023 ($15.592 billion) to July 27 2024 ($14.492 billion). A hypothetical 100‑basis‑point interest‑rate increase would reduce the fair value of those investments by roughly **$0.8 billion** in 2023 and by about **$0.9 billion** in 2024, which would lower total investments by those respective amounts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49761,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12680,
        "completion_tokens": 101,
        "total_tokens": 12781
      }
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "The Company recorded an additional $861 million accrual for U.S. covered litigation in fiscal 2022 and deposited $850 million into the U.S. litigation escrow account, which is the mechanism by which settlements or judgments under the U.S. Retrospective Responsibility Plan are funded. This accrual reflects the estimated loss that will be drawn down from the escrow account, linking the litigation provision directly to the escrow funding mechanism outlined in the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52577,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13378,
        "completion_tokens": 117,
        "total_tokens": 13495
      }
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition contributed to a 0.6 percentage point increase in gross margin for 2023, as noted in the Cost of Sales section which states \"the impact of the Heritage AspenTech acquisition which benefited margins by 0.6 percentage points.\" The total gross margin percentage for 2023 was 49.0 percent, as reported in the same Cost of Sales section.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42568,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10869,
        "completion_tokens": 91,
        "total_tokens": 10961
      }
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Based on the financing receivables discussion in the Notes to Consolidated Financial Statements (particularly Note (o) and the allowance for credit losses in Note (e)), Cisco’s guarantee of channel‑partner financing arrangements can increase its credit‑loss exposure. If a channel partner experiences financial instability, the partner may be unable to meet its repayment obligations, forcing Cisco to write down or reserve against those receivables. The company acknowledges that it may be required to make payments under its guarantees in the event of non‑payment by channel partners, which could materially affect its results of operations and financial condition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56987,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14479,
        "completion_tokens": 166,
        "total_tokens": 14646
      }
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Based on the document, Emerson owns a 55% stake in AspenTech, and AspenTech generated $1,093 million of total revenue in 2024. Therefore, the portion of that revenue attributable to Emerson’s controlling interest is 55% × $1,093 million ≈ $601 million. This stake is a key component of Emerson’s overall Software and Control revenue of $5,399 million, contributing roughly $601 million (about 11% of the total) to that segment’s sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45481,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11626,
        "completion_tokens": 108,
        "total_tokens": 11735
      }
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "Pfizer's divestiture of Meridian and the Upjohn spin‑off together generated roughly $12 billion in cash proceeds (the Upjohn cash distribution of $12 billion plus the $51 million sale of Meridian). Those proceeds were used to pay down commercial paper, redeem $1.5 billion of senior notes and fund the separation‑related financing, thereby strengthening Pfizer’s overall cash position and enabling a more focused capital structure for the remaining businesses. Consequently, the transactions are reflected in the company’s financing cash flows as outflows for debt repayment and as a reduction of cash used in operating activities, while the loss on the Meridian sale and the spin‑off‑related adjustments are recorded in discontinued operations and in other comprehensive income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55936,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14198,
        "completion_tokens": 194,
        "total_tokens": 14393
      }
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022 was $1.716 billion, comprising the $850 million annual deposit into the U.S. litigation escrow account and the $866 million provision for covered legal matters (reflected in the $885 million provision for covered legal matters in 2022, net of prior balances). This contribution illustrates how the plan systematically accrues and funds probable and reasonably estimable U.S. covered litigation liabilities, using escrow deposits and periodic adjustments to manage and settle these obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 48842,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12453,
        "completion_tokens": 146,
        "total_tokens": 12600
      }
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The U.S. Retiree Health Care Plan’s allocation to equity securities remained unchanged at 20% of total plan assets from 2022 to 2023, with no shift in allocation. Consequently, the total value of equity securities in the plan increased from $54 million at the end of 2022 to $54 million at the end of 2023, reflecting no change in allocation but a stable value due to market conditions and asset management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53268,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13548,
        "completion_tokens": 101,
        "total_tokens": 13650
      }
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The adoption of the CECL accounting standard resulted in a $12.6 billion increase in total capital under the Standardized approach at December 31 2023, driven primarily by a higher allowance for credit losses included in Tier 2 capital. This difference in capital between the Advanced and Standardized approaches was attributable to the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66344,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16820,
        "completion_tokens": 106,
        "total_tokens": 16927
      }
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "Based on the target allocation ranges provided in the document, the weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all defined benefit and retiree health care plans is approximately 72% for U.S. plans (65%–80% for U.S. defined benefit and 75%–85% for U.S. retiree health care), 77% for non-U.S. defined benefit plans (60%–100%), and 80% overall when weighted by total plan assets. Applying these ranges to the respective total asset values (U.S. defined benefit: $418M, U.S. retiree health care: $264M, non-U.S. defined benefit: $1,866M), the weighted average allocation to Fixed Income and Cash Equivalents is approximately 75% of the combined total assets of $2,548M, resulting in a weighted average percentage of about 75% when rounded to the nearest whole number.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52142,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13281,
        "completion_tokens": 203,
        "total_tokens": 13484
      }
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "The Basel 3 capital framework requires the Corporation and its banking affiliates to calculate risk‑based capital ratios using the Standardized and Advanced approaches, which directly affect the amount of capital that must be held against covered trading positions. Because capital adequacy is measured under these approaches, the composition of covered trading positions is adjusted to align with the risk‑weighting and leverage requirements of Basel 3, influencing the portfolio’s risk profile and the resulting Value‑at‑Risk (VaR) metrics reported for those positions. Consequently, the implementation of Basel 3 capital calculations shapes both the types of covered trading exposures retained and the VaR figures that quantify their market‑risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 146,
          "pages": [
            144,
            145,
            146,
            147,
            148
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 81581,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20623,
        "completion_tokens": 189,
        "total_tokens": 20812
      }
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The total net book value of the 19 Boeing aircraft securing the Pass‑Through Certificates is $1.8 billion. This amount is far smaller than the $5.8 billion of debt that was retired in 2021 using proceeds from the senior unsecured debt issuance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 47202,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12043,
        "completion_tokens": 61,
        "total_tokens": 12104
      }
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "In 2023, TI contributed $75 million to its U.S. defined contribution plans, and the plans held 5 million shares of TI common stock valued at $873 million, with dividends paid on those shares amounting to $27 million. Notably, the retiree health‑care benefit plan does not directly invest plan assets in TI common stock.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51229,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13031,
        "completion_tokens": 79,
        "total_tokens": 13111
      }
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "Based on the provided financial data, the increase in Services revenue ($96.169 billion in 2024 versus $85.2 billion in 2023) accounts for $10.969 billion of the $7.75 billion rise in total net sales between 2023 and 2024. This represents approximately 141 % of the total sales growth, meaning the Services revenue increase contributed more than the entire growth in net sales.  \n\n\\[\n\\frac{96.169-85.2}{391.035-383.285}\\times100 \\approx \\frac{10.969}{7.75}\\times100 \\approx 141\\%\n\\]",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40474,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10390,
        "completion_tokens": 120,
        "total_tokens": 10511
      }
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million, and the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 creates uncertainty because the IRS has issued positions that Pfizer is disputing and appealing, making it unclear how much of the uncertain tax positions will ultimately be resolved.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 90740,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 22927,
        "completion_tokens": 100,
        "total_tokens": 23027
      }
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "The five‑year CECL transition period allows BAC to phase‑in the CECL impact, so only 50 % of the transition provision is included in CET1 and Tier 1 capital as of 31 Dec 2023. Consequently, the CET1 ratio calculated under the Standardized approach was 11.8 % (using the transition‑adjusted capital), and the TLAC ratios were derived from the Standardized‑approach RWA (≈ $1,651 bn) and the transition‑adjusted capital figures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67977,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17215,
        "completion_tokens": 106,
        "total_tokens": 17321
      }
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground applies its fuel surcharge on a weekly basis using a fuel‑price index that is set two weeks before the assessment week, while FedEx Freight calculates its indexed fuel surcharge using a price that is referenced only two days ahead of the assessment week. Consequently, FedEx Ground’s surcharge adjusts more slowly (with a two‑week lag) than FedEx Freight’s, which updates almost immediately (with a two‑day lag). Both segments update their surcharge tables on similar dates (e.g., June 21 2021, Nov 1 2021, Apr 4 2022), but the timing of the underlying price reference differs, leading to a faster response to fuel‑price changes for FedEx Freight than for FedEx Ground.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52488,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13335,
        "completion_tokens": 170,
        "total_tokens": 13506
      }
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The reorganization of the Ventilator Product Line was reflected in the restructuring and associated costs line item within the Non-GAAP adjustments, where $439 million of charges related to exiting the ventilator business were recorded in fiscal 2024. This shift moved the ventilator line out of the Medical Surgical segment and into the Other operating segment, while the remaining PMRI businesses were combined into the Acute Care & Monitoring operating unit within Medical Surgical. Consequently, the retained Acute Care & Monitoring business is positioned as a distinct, strategically focused operating segment separate from the former ventilator operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45879,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11711,
        "completion_tokens": 165,
        "total_tokens": 11877
      }
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes for fiscal years 2022 and 2023 was $119 million in 2023 and $150 million in 2022, as disclosed in the Non‑GAAP Adjustments section of the GAAP‑to‑Non‑GAAP reconciliations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46322,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11811,
        "completion_tokens": 72,
        "total_tokens": 11884
      }
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Based on the provided pages from Boeing's 2023 10-Q filing, the document explicitly lists **three distinct forms of Long-Term Incentive Restricted Stock Units (RSUs)** in the \"Table of Contents\" under Item 10 (Exhibits), specifically in the \"Form of Notice of Terms of Long-Term Incentive Restricted Stock Units\" section. These are:\n\n1. **U.S. Notice of Terms of Long-Term Incentive Restricted Stock Units** (Exhibit 10.32, 10-Q March 31, 2023)  \n2. **International Notice of Terms of Long-Term Incentive Restricted Stock Units (Stock-Settled)** (Exhibit 10.35, 10-Q March 31, 2023)  \n3. **U.S. Notice of Terms of Long-Term Incentive Performance Restricted Stock Units** (Exhibit 10.33, 10-Q March 31, 2023)  \n\nThese three forms are explicitly disclosed as separate exhibits in the filing, confirming that Boeing uses **three distinct versions** of Long-Term Incentive RSUs (including both U.S. and International variants). The document does not mention any additional forms beyond these three.  \n\n**Answer**: 3 different forms of Long-Term Incentive Restricted Stock Units are disclosed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 127,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 127,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43084,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10985,
        "completion_tokens": 272,
        "total_tokens": 11257
      }
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "The document indicates that Apple's Services revenue grew 12.9% year-over-year to $96.2 billion in 2023, driven in part by offerings like Apple Music. However, it also highlights that the Company’s ability to sustain this growth depends on continued access to third‑party software developers and digital content providers, and that any disruption—such as reduced developer support, limited licensing of third‑party content, or supply‑chain constraints affecting content distribution—could materially impair the business, reputation, and financial condition. Consequently, while the revenue growth is strong, ongoing challenges in securing third‑party software and content could constrain the long‑term sustainability of this growth trajectory.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 47512,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12142,
        "completion_tokens": 185,
        "total_tokens": 12328
      }
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife’s $12.4 billion short‑term liquidity cushion provides a strong buffer to meet cash outflows even under stress, but the company must still contend with potential losses on its GMIB guarantees that are exposed to reinsurance and derivative counterparty risk. Because the guarantees are backed by collateralized reinsurance and hedged with a large portfolio of OTC derivatives, any failure of these counterparties could force MetLife to use additional cash or sell assets, potentially straining its liquidity if market conditions deteriorate. Consequently, while the $12.4 billion position supports liquidity in normal and moderately stressed scenarios, prolonged stress that triggers counterparty defaults or ineffective hedges could erode this buffer and limit the company’s ability to manage liquidity under severe stress.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50471,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12860,
        "completion_tokens": 207,
        "total_tokens": 13067
      }
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "The total fair value of Level 3 auction rate securities held by Medtronic as of April 26, 2024, is $33 million, and these securities are classified as \"Other Assets\" on the consolidated balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50292,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12793,
        "completion_tokens": 50,
        "total_tokens": 12843
      }
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The adoption of the credit‑loss guidance on January 1 2020 required MetLife to move from an incurred‑loss model to an allowance‑for‑credit‑loss (ACL) model for both mortgage loans and fixed‑maturity securities AFS.  Under the new ACL methodology, expected lifetime credit losses are estimated and a reserve is recorded up front, rather than recognizing OTTI only when a loss is incurred.  Consequently, the 2019 impairment loss amounts reported for these assets ($129 million for fixed‑maturity securities AFS and $11 million for mortgage loans) are no longer recorded as impairments after the transition; instead, any credit‑loss provision is reflected in the ACL change recognized in earnings.  This shift is evident in the 2020 and 2021 net credit‑loss provision figures of $(280) million and $(86) million, respectively, which represent the change in the ACL recognized in earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 241,
          "pages": [
            239,
            240,
            241,
            242,
            243
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53890,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13716,
        "completion_tokens": 221,
        "total_tokens": 13938
      }
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin’s offset agreements obligate it to provide consulting support, technology transfers and local‑partner investments that often require cash outlays and depend on the performance of joint‑venture partners it does not control.  If a foreign customer imposes penalties, demands additional in‑country purchases, or terminates the offset program because the contractor fails to meet those commitments, Lockheed Martin may incur unrecoverable costs, reach‑forward losses or contract terminations that directly reduce the amount it can bill the U.S. government and can jeopardize future contract awards.  Consequently, the need to satisfy offset obligations can limit the company’s ability to recover all of the expenses it incurs on U.S. government contracts in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55521,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14105,
        "completion_tokens": 193,
        "total_tokens": 14299
      }
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "Thermo Fisher’s pharma services business contributed to strong segment revenue growth and margin expansion in 2021, driven by heightened pandemic‑related demand for vaccine and therapy development services and the integration of acquisitions such as PPD.  However, the segment’s margin was pressured by strategic growth investments and inventory accounting changes, which resulted in a modest decline in segment income margin despite higher profitability on increased sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 37826,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9678,
        "completion_tokens": 118,
        "total_tokens": 9796
      }
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife’s participation in Supervisory Colleges—led by its New York State Department of Financial Services (NYDFS) regulator in the United States and by the European Insurance and Occupational Pensions Authority (EIOPA) in Europe—creates a formal forum where U.S. and EU supervisors exchange information on the company’s cross‑border risk profile. This collaborative oversight enhances the granularity of regulatory scrutiny, allowing NYDFS and EIOPA to assess how MetLife’s global operations, capital allocations, and reserve practices affect solvency under both U.S. and European standards. Consequently, the college structure reinforces a unified risk‑management framework that shapes MetLife’s capital adequacy requirements, dividend policies, and overall risk appetite across its multinational footprint.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53031,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13476,
        "completion_tokens": 202,
        "total_tokens": 13678
      }
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The reduction in the Allowance for Credit Losses (ACL) for transfer risk outside the U.S., driven by U.S. banking law safety and soundness considerations, resulted in a net ACL release that lowered provisions and contributed to a $228 million net ACL build in 2024—significantly smaller than the prior year’s build. This reduction helped lift total Net Income by 27% to $4.9 billion, representing a 27% percentage increase over the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "C_10k_2024.pdf",
          "target_page": 232,
          "pages": [
            230,
            231,
            232,
            233,
            234
          ]
        },
        "hop_2_rel": {
          "source_file": "C_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54460,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13851,
        "completion_tokens": 110,
        "total_tokens": 13961
      }
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "Lockheed Martin’s Aeronautics segment could see near‑term revenue pressure if a debt‑ceiling impasse delays FY 2025 appropriations, because the segment derives roughly 32 % of its net sales from international customers—most of which are tied to F‑35 foreign‑military‑sales contracts. A funding disruption would likely stall or postpone new F‑35 lot purchases and related sustainment work, directly reducing Aeronautics’ backlog conversion and potentially lowering its 2024‑25 sales growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54936,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14016,
        "completion_tokens": 122,
        "total_tokens": 14138
      }
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "As of December 31, 2023, the UnitedHealth Group 2020 Stock Incentive Plan (including its related ESPP) had 70 million shares remaining available for future issuance. This figure includes the 17 million shares reserved for the ESPP and the 53 million shares reserved under the 2020 Stock Incentive Plan itself. In contrast, the document notes that 191,000 shares underlying stock options assumed through acquisitions remain outstanding but are excluded from the future‑issuance count.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54906,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13973,
        "completion_tokens": 120,
        "total_tokens": 14094
      }
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The total stock‑based compensation expense for fiscal years 2022 through 2024 related to the Multi‑Year Equity Awards is $356 million (2024), $596 million (2023) and $794 million (2022). As of November 3, 2024, the remaining unrecognized compensation cost for all unvested stock‑based awards—including those from the Multi‑Year Equity Awards—is $11,259 million, which will be recognized over the remaining weighted‑average service period of about 3.0 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45720,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11662,
        "completion_tokens": 114,
        "total_tokens": 11776
      }
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of its RWA, calculated as 6% of RWA plus its method‑2 GSIB surcharge of 3.5% (i.e., 6% + 3.5% = 9.5%). This LTD requirement is separate from the external TLAC requirement, which is 22.5% of RWA.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "C_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "C_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59914,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15192,
        "completion_tokens": 63,
        "total_tokens": 15256
      }
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "The total projected funding requirement for Lockheed Martin’s qualified defined benefit pension plans over the next decade is approximately $15.8 billion, as shown by the aggregate fair‑value of plan assets reported on page 87‑88. The annual increase in required benefit payments rises from $1.80 billion in 2025 to $1.99 billion in 2029, indicating a steady upward trend in pension obligations that continues into later years (with $9.99 billion projected for payments 2030‑2034). This pattern reflects growing funding needs as benefit payments are expected to climb each year through 2029.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48810,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12433,
        "completion_tokens": 147,
        "total_tokens": 12581
      }
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "The total combined value of Honeywell's Mortgage/Asset-backed securities held in 2021 was $1,072 million and in 2020 was $982 million, for a combined total of $2,054 million. This investment category represented approximately 5.5% of total fixed income investments in 2021 and 4.7% in 2020.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 63614,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16132,
        "completion_tokens": 72,
        "total_tokens": 16205
      }
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom’s shift to multi‑year equity awards with vesting periods of 4–7 years spreads the related stock‑based compensation expense over a longer timeframe, resulting in a more gradual recognition of expense rather than a lump‑sum charge in the year of grant. This approach smooths earnings volatility and extends the period over which the company records compensation cost for those awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49500,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12589,
        "completion_tokens": 97,
        "total_tokens": 12687
      }
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "The application of U.S. banking law—particularly safety‑and‑soundness considerations that drive the allowance for credit losses (ACL) and capital‑buffer requirements—directly influences credit‑loss provisions in both Legacy Franchises and the Markets segment. In Legacy Franchises, the higher provision for credit losses ($928 million in 2024 versus $870 million in 2023) reflects a 7% increase in net credit losses, driven by the ongoing normalization of credit quality in Mexico Consumer/SBMM and the impact of U.S. regulatory guidance on transfer‑risk reserves. In the Markets segment, provisions rose modestly to $463 million in 2024 (up from $438 million in 2023), primarily due to higher net credit losses on spread‑product loans, again shaped by U.S. banking‑law‑based ACL calculations and capital‑buffer constraints. The combined effect of these segment‑specific provisions contributed to Citi’s total provision for credit losses of approximately **$1.1 billion for 2024**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "C_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "C_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53934,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13717,
        "completion_tokens": 245,
        "total_tokens": 13963
      }
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "The total value of Insurance buy‑in contracts held by Honeywell in its Non‑U.S. pension plans was $691 million in 2021 and $767 million in 2020, for a combined $1,458 million. This amount represented roughly 17.4 % of the total fair‑value assets of the Non‑U.S. plans ($8,396 million in 2021 and $8,450 million in 2020), or about 17.3 % when averaged across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57468,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14589,
        "completion_tokens": 93,
        "total_tokens": 14682
      }
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom's heavy investment in internal R&D—highlighted by its strategy of “technology leadership” and “category‑leading semiconductor and infrastructure software solutions” achieved through “extensive internal research and development” and strategic acquisitions—directly fuels the innovation pipeline that keeps its semiconductor portfolio at the forefront of AI‑related markets, enabling it to maintain technology leadership in those high‑growth segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43114,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11009,
        "completion_tokens": 114,
        "total_tokens": 11123
      }
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Based on the provided document, the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements is $9.6 billion, as stated in the “Purchase Obligations” section of Note 7. This figure represents the portion of the $12.8 billion total purchase‑agreement obligations that is anticipated to be paid within the upcoming 12‑month period. The document does not provide a separate disclosed total of advance payments made under its multi‑year capacity purchase commitments as of September 29, 2024; however, it notes that total advance payments recorded on the balance sheet were $3.0 billion at September 29, 2024 (down from $3.3 billion at September 24, 2023). Consequently, the $9.6 billion expected payment over the next year is distinct from, and larger than, the $3.0 billion of advance payments currently recorded.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54000,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13733,
        "completion_tokens": 211,
        "total_tokens": 13945
      }
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The GTN adjustment reductions for 2024 were $159 million lower than the $134 million reduction recorded in 2023. This change was driven by non‑U.S. clawback revisions stemming from updated VAT recoverable estimates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 30302,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 7787,
        "completion_tokens": 53,
        "total_tokens": 7841
      }
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send, a key component of Mastercard’s disbursements and remittances strategy, enables the company to capture new payment flows by allowing consumers, businesses, governments and merchants to send and receive money domestically and across borders quickly and efficiently through digital messaging and payment platforms, as well as partnerships with central banks, fintechs and financial institutions for government and nonprofit disbursements. This capability is enabled through specific partner ecosystems including digital messaging and payment platforms, central banks, fintechs, financial institutions, and Mastercard’s broader network of issuers, acquirers and merchants to facilitate account-to-account payments and cross-border services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 38850,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9958,
        "completion_tokens": 188,
        "total_tokens": 10146
      }
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard's 2022 introduction of Cyber and Intelligence Solutions—part of its value‑added services—was incorporated into the “Other revenues” line item, which rose to $6.2 billion in 2021 (up from $4.7 billion in 2020). Because these cyber‑and‑intelligence fees are recognized as revenue in the period the services are performed, the new business added to “Other revenues” increased the overall composition of that category and accelerated its recognition timing in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57266,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14543,
        "completion_tokens": 118,
        "total_tokens": 14661
      }
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "The total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 ($333 million) and December 31, 2023 ($410 million) was an increase of $77 million. This change was smaller than the total unrealized loss on those securities, which rose from $31 million in 2022 to $23 million in 2023—a decrease in the loss of $8 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58752,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14919,
        "completion_tokens": 88,
        "total_tokens": 15008
      }
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "Based on the provided financial statements, the total fair value of Qualcomm's corporate bonds and notes (classified as marketable securities) is $4,634 million. This represents approximately 85% of the total marketable securities fair value of $5,451 million, which includes $176 million in U.S. Treasury and government-related securities. Thus, corporate bonds and notes constitute the vast majority of marketable securities, with U.S. Treasury and government-related securities making up a smaller portion (about 3.2%) of the total marketable securities portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53460,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13599,
        "completion_tokens": 141,
        "total_tokens": 13741
      }
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "MRK extends Keytruda's market protection beyond its compound patent expiration by leveraging pediatric market exclusivity under the U.S. Pediatric Exclusivity Provision, which grants an additional six months of regulatory exclusivity when required pediatric studies are completed. This exclusivity, combined with existing patent term extensions (PTE) and data exclusivity (e.g., U.S. data exclusivity expiring in July 2033), delays generic competition. Financially, this prolongs high-margin oncology revenue from Keytruda, sustaining its critical role as a growth driver—contributing significantly to the company's $1.1 billion royalty income and supporting overall oncology revenue stability amid patent cliffs for other products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56566,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14367,
        "completion_tokens": 183,
        "total_tokens": 14550
      }
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "Mastercard’s 2022 launch of Mastercard Installments—an open‑loop buy‑now‑pay‑later solution—directly advances its strategic goal of expanding digital payment services across multiple channels by embedding flexible installment capabilities into its broader innovation agenda, enabling consumers to transact seamlessly across cards, mobile wallets and other digital platforms while leveraging the company’s multi‑rail network and expanding its suite of value‑added services. This initiative is highlighted in the “New Payment Flows” and “Key 2021 Developments” sections, underscoring how installment functionality integrates with Mastercard’s push to capture new payment flows such as disbursements, B2B payments and consumer bill payments, thereby reinforcing its focus on diversifying payment options and driving growth in digital commerce.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 37291,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9548,
        "completion_tokens": 210,
        "total_tokens": 9758
      }
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Based on the provided financial data for the Ridgeback Biotherapeutics LP collaboration, Merck recorded $554 million of Cost of sales in 2024 related to the profit-sharing arrangement for Lagevrio, which reflects Merck's share of the profits (split equally with Ridgeback) and includes the reimbursement amounts for Ridgeback's share of third‑party milestone payments and royalties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48196,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12275,
        "completion_tokens": 95,
        "total_tokens": 12370
      }
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) enables non‑UK funds to be marketed to UK retail investors only if the home‑jurisdiction’s investor protection standards are deemed equivalent to the UK’s. Under the OFR, BlackRock must demonstrate that the regulatory regime governing its European‑domiciled funds provides an equivalent level of consumer protection to that required by the UK FCA. Meeting this equivalence requirement allows BlackRock to register and sell those funds in the UK without undergoing a full local authorisation process.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 78092,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19752,
        "completion_tokens": 132,
        "total_tokens": 19884
      }
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom’s internal manufacturing of FBAR filters—leveraging its proprietary FBAR technology, advanced RF semiconductor expertise, and dedicated U.S. and Singapore III‑V wafer facilities—gives it a performance and cost advantage that it can embed in cellular handset RF front‑end modules. This vertically integrated capability protects its IP, shortens time‑to‑market, and creates a differentiated, higher‑value offering that reinforces its competitive position in the cellular handset market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 6,
        "total_chars": 33840,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8682,
        "completion_tokens": 123,
        "total_tokens": 8805
      }
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck maximizes market protection for its biologic products by combining patent term extensions (PTEs) with regulatory exclusivity mechanisms. In the U.S., biologic products receive 12 years of data exclusivity under the BPCIA, which runs concurrently with or complements patent protection, while pediatric exclusivity can add six months to the patent term. Additional exclusivity may arise from supplementary protection certificates (SPCs) in the EU (up to five years) or pediatric extensions (six months), and Japan offers similar extensions. The company leverages these layered protections—such as the 12-year U.S. data exclusivity for Keytruda (exp. 2028) and Vaxneuvance (exp. 2031)—to delay generic or biosimilar entry, as reflected in its patent expiration tables showing U.S. exclusivity extending to 2035–2041 for pipeline candidates like MK-3000.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56099,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14253,
        "completion_tokens": 214,
        "total_tokens": 14467
      }
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 UK Stewardship Code reforms – specifically the UK Financial Reporting Council’s consultation on tailored reporting requirements for proxy advisers and investment consultants – could increase BlackRock’s compliance obligations and costs in its UK operations. These enhanced reporting rules may require additional resources to meet new disclosure standards, potentially raising operational expenses and affecting client engagement as BlackRock adapts to the stricter transparency expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 78562,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 19859,
        "completion_tokens": 125,
        "total_tokens": 19984
      }
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022 was $147 million, rising from $95 million in 2021 to $242 million in 2022. This change is directly attributable to the Heritage AspenTech acquisition, which added $148 million of amortization of intangibles (including backlog and inventory adjustments) to the segment’s depreciation and amortization expense for fiscal 2022, as noted in the “Other Financial Data” section.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40522,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10367,
        "completion_tokens": 121,
        "total_tokens": 10488
      }
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million, rising from $720 million in fiscal 2021 to $744 million in fiscal 2022. This region contributed approximately 3.5 % of the total global growth in the Subscriptions and Services business segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 42537,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10859,
        "completion_tokens": 77,
        "total_tokens": 10936
      }
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase the information required for pre‑merger notifications and extend waiting periods, which can raise compliance costs and delay strategic investments or acquisitions for BlackRock. In addition, the heightened scrutiny may deter funds from pursuing HSR‑reportable transactions, as the expanded filing requirements and potential delays could make such deals less attractive or feasible.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 73912,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 18698,
        "completion_tokens": 112,
        "total_tokens": 18810
      }
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements requires distinct accounting treatments. Stock-settled awards are classified as equity awards, while cash-settled awards are treated as cash-settled awards, impacting how the company recognizes compensation expense and classifies these liabilities on its financial statements. This distinction ensures proper alignment with accounting standards for share-based payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 8,
        "total_chars": 36716,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9395,
        "completion_tokens": 117,
        "total_tokens": 9513
      }
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These units vest over three years and upon vesting, each unit entitles the recipient to receive one share of Abbott common stock.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52672,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13402,
        "completion_tokens": 56,
        "total_tokens": 13459
      }
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "Based on the 2024 geographic sales breakdown for the Life Sciences segment, 56% of its sales (28% from high-growth markets plus 28% from other developed markets outside North America and Western Europe) came from regions outside North America and Western Europe. This geographic distribution reflects the long-term strategic impact of the 2005 Leica Microsystems acquisition, which established Danaher's Life Sciences platform and provided a foundation for subsequent acquisitions (e.g., AB Sciex, Beckman Coulter, Pall) that expanded its global footprint into high-growth markets across Asia, Latin America, and emerging economies, thereby diversifying revenue away from traditional Western markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46766,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11927,
        "completion_tokens": 175,
        "total_tokens": 12102
      }
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has made 10 acquisitions in the Life Sciences segment since its establishment in 2005, including the acquisition of Pall in 2015 and the most recent acquisition of Abcam in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46766,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11921,
        "completion_tokens": 46,
        "total_tokens": 11967
      }
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "The fair value of Abbott's interest rate hedge contracts changed from an $87 million asset at December 31 2020 to a $210 million asset at December 31 2021, reflecting a $123 million gain that was recorded in interest expense as the hedged fixed‑rate debt was marked‑to‑market. This gain offset the market movement of the underlying debt, resulting in a net increase in the fair‑value hedge position over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51983,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13229,
        "completion_tokens": 103,
        "total_tokens": 13333
      }
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMY's strategic focus on expanding its autologous CAR‑T cell therapy pipeline—including new indications for Breyanzi—directly supports the observed doubling of U.S. Breyanzi sales in 2023, as the company is actively pursuing additional indications to drive further demand. This expansion aligns with the broader growth strategy outlined in the document, which emphasizes leveraging its cell‑therapy platform to increase market share and revenue across oncology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39119,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10006,
        "completion_tokens": 115,
        "total_tokens": 10122
      }
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2,699 million, which contributed to the total cash used for acquisitions in 2023 together with CorEvitas, LLC’s $910 million purchase, bringing the combined cash used for those two acquisitions to $3,609 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50917,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12953,
        "completion_tokens": 73,
        "total_tokens": 13026
      }
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "Based on the document, the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023 are approximately $0.2 billion for 2024 and $0.6 billion for 2023, as stated in the Management's Discussion and Analysis section (page 19). The acquisition of The Binding Site Group in 2023, within the Specialty Diagnostics segment, contributes to strategic growth by expanding the segment's portfolio with pioneering innovation in diagnostics and monitoring for multiple myeloma, enhancing its capabilities in blood cancer diagnostics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 48559,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12382,
        "completion_tokens": 138,
        "total_tokens": 12520
      }
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest-term debt instrument listed in Eli Lilly’s 2023 10‑K is the 1.375% Notes due 2061. Its 2061 maturity extends beyond the other instruments listed, which range from 2025 through 2051.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39344,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10057,
        "completion_tokens": 48,
        "total_tokens": 10105
      }
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is currently under regulatory review for the treatment of early Alzheimer’s disease in the U.S., the EU, and Japan, representing one distinct indication. Lebrikizumab has received regulatory approval in the EU and Japan for atopic dermatitis and is under review in the U.S., also representing one distinct indication. Thus, both Donanemab and Lebrikizumab are each associated with one distinct indication under development or review.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50198,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12784,
        "completion_tokens": 110,
        "total_tokens": 12895
      }
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The decline in Alimta revenue in the U.S. in 2023, driven by generic entry, negatively impacted overall U.S. volume growth, contributing to a 11% increase in volume that was partially offset by other factors. However, Verzenio positively contributed to U.S. volume growth, driving a 56% increase in revenue and supporting the overall volume expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51015,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12984,
        "completion_tokens": 87,
        "total_tokens": 13071
      }
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Based on the provided 10-K filing pages, Merck has incurred a total financial commitment of **$250 million** related to its collaboration with Moderna for V940 (mRNA-4157), which was recorded as an option payment charged to research and development expenses in 2022. Additionally, Merck anticipates sharing development costs equally with Moderna under the collaboration and has recorded its share of development costs as part of research and development expenses, with reimbursements from Moderna reducing these costs. This aligns with Merck's broader immuno-oncology strategy, as V940 is being evaluated in combination with Keytruda (an anti-PD-1 therapy) in multiple Phase 3 trials for adjuvant treatment of melanoma and non-small-cell lung cancer, representing a key advancement in its immuno-oncology pipeline to enhance cancer immunotherapy combinations. The collaboration underscores Merck's focus on advancing next-generation cancer therapies through strategic partnerships, particularly in personalized neoantigen therapies that complement its established immuno-oncology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 43485,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11107,
        "completion_tokens": 272,
        "total_tokens": 11379
      }
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "Based on the document, MK-7962 (sotatercept) is a biologic product that will receive 12 years of data exclusivity upon U.S. approval. The granted patents covering its use for pulmonary arterial hypertension expire in 2037 (absent patent term extension). Additionally, the document states that data exclusivity in the U.S. expires on July 16, 2033. Therefore, the additional years of U.S. patent protection beyond the standard biologic data exclusivity period are calculated as 2037 minus 2033, resulting in 4 additional years.  \n\n**Answer:** MK-7962 could receive 4 additional years of U.S. patent protection beyond the standard biologic data exclusivity period, extending exclusivity to 2037 (2033 data exclusivity end + 4 years patent term extension).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44956,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11466,
        "completion_tokens": 188,
        "total_tokens": 11654
      }
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "Based on the provided document pages, the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, as measured by NAV, is $26 million. This is derived from the $14 million increase in the U.S. Pension Plan (from $106 million to $120 million) and the $12 million increase in the International Pension Plan (from $116 million to $128 million), as detailed in the \"Equity\" section of the document.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56818,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14424,
        "completion_tokens": 120,
        "total_tokens": 14545
      }
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "The estimated fair value of U.S. government agencies securities held by GILD increased from $35 million at December 31 2022 to $127 million at December 31 2023, a $92 million rise. Over the same period, the estimated fair value of U.S. treasury securities rose from $410 million to $426 million, an increase of $16 million. Thus, the agency‑security increase ($92 M) was substantially larger than the treasury‑security increase ($16 M).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56582,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14383,
        "completion_tokens": 109,
        "total_tokens": 14492
      }
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy revenue increased 14% to $11.85 billion in 2023, driven by higher demand, switching from other Gilead HIV products, and favorable pricing dynamics. This growth contrasts with the overall 1% decline in total revenues, reflecting the impact of patent expirations on legacy products such as Veklury and Harvoni, which are projected to lose exclusivity between 2028 and 2033. Consequently, Gilead is likely to prioritize expanding its oncology and inflammation pipelines—through collaborations, acquisitions, and new product launches—to offset declining sales from its principal HIV portfolio as patents expire.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 58330,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14813,
        "completion_tokens": 154,
        "total_tokens": 14967
      }
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "Gilead’s centralized, single‑segment resource allocation model means that cash generated by legacy HIV products such as Truvada is pooled at the corporate level and can be redeployed across its oncology, inflammation and other pipelines. Because the 2023 U.S. patent expiry of Truvada will sharply reduce royalty and sales cash flow from that franchise, the company will have fewer internal funds to finance the expensive lifecycle‑management initiatives (e.g., new formulations, combination strategies, expanded indications) that traditionally protect HIV revenues. Consequently, Gilead may need to shift capital toward higher‑growth areas or rely more heavily on external financing and partnerships to sustain its HIV portfolio’s long‑term investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 61284,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15560,
        "completion_tokens": 188,
        "total_tokens": 15748
      }
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement required certain brokerage client deposits to be swept off-balance sheet to TD Depository Institutions, which impacted Schwab's capital management strategy by necessitating sufficient capital levels to support the migration of these balances back onto the balance sheet. Schwab's capital management strategy explicitly includes supporting the migration of IDA balances as capital levels permit. The specific dollar amount of amortization associated with the 2023 IDA Agreement was $85 million, as reflected in the amortization expense for capitalized contract costs related to the agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41823,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10684,
        "completion_tokens": 153,
        "total_tokens": 10837
      }
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "The changes in LTIP units and other unit issuances during 2023 increased Simon Property Group’s total equity from $3,611,652 thousand at the end of 2022 to $3,491,649 thousand at the end of 2023, reflecting the net effect of unit issuances, redemptions, and other equity adjustments disclosed in the Consolidated Statements of Equity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 64398,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16312,
        "completion_tokens": 83,
        "total_tokens": 16395
      }
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde’s long‑term on‑site gas supply contracts—typically 10‑ to 20‑year agreements that include minimum purchase requirements and price‑escalation clauses—drive its contract structure by obligating customers to purchase volumes over extended periods and allowing cost‑pass‑through mechanisms for energy and other inputs. Because revenue from these contracts is recognized over time as product is delivered and the company has the right to invoice, Linde records the associated revenue when control transfers (i.e., product delivery), and the long‑term nature of the agreements results in a sizable stream of future performance obligations that is reflected in the disclosed $58 billion of remaining performance obligations. This accounting treatment aligns with ASC 606, where revenue is recognized when the performance obligation is satisfied and the right to invoice is exercised.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 45184,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11533,
        "completion_tokens": 220,
        "total_tokens": 11753
      }
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair value of corporate notes and obligations declined from $3,354 million at January 31 2023 to $2,978 million at January 31 2024, a decrease of $376 million. This $376 million reduction represents roughly 6.5 % of the total marketable securities’ fair value, which fell from $5,492 million to $5,722 million—a net increase of $230 million—so the corporate notes decline is a modest portion of the overall change in total marketable securities’ fair value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13507,
        "completion_tokens": 115,
        "total_tokens": 13623
      }
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "The Health Care Benefits segment’s premiums are set in a fixed‑price period that lasts roughly twelve months, so any mis‑estimate of future health‑care cost trends cannot be recouped through higher premiums. Because profits depend on the accuracy of those forecasts, even modest gaps between projected and actual costs can sharply reduce operating results, especially when cost volatility is high—as occurred during the COVID‑19 pandemic and when provider behavior shifts. Consequently, inaccurate forecasts of medical‑cost trends directly undermine the segment’s premium pricing and can materially depress its operating performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 51370,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13085,
        "completion_tokens": 158,
        "total_tokens": 13243
      }
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "Chevron's 2020 acquisition of Noble Energy added roughly 6,000 cubic feet of natural‑gas production per barrel of crude‑oil equivalent, boosting its overall production mix and cash flow. This expanded, lower‑cost upstream base helped the company maintain strong operating performance during periods of low commodity prices, which in turn supported its ability to meet debt‑service obligations and preserve its high‑quality credit ratings (AA‑ from S&P and Aa2 from Moody’s).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67418,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17100,
        "completion_tokens": 118,
        "total_tokens": 17218
      }
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab spent $249 million in 2023 to buy down $5 billion of fixed‑rate obligation amounts under the 2023 IDA agreement, and this amount is recorded as a contract asset (an other‑assets item) on the consolidated balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 44594,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11368,
        "completion_tokens": 56,
        "total_tokens": 11425
      }
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded $483 million in store‑impairment charges in 2024 as part of its enterprise‑wide restructuring plan. The company expects its restructuring initiatives to generate more than $500 million in cost savings beginning in 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36643,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9392,
        "completion_tokens": 58,
        "total_tokens": 9450
      }
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited was $(166) million in 2021, reflecting a loss on its 36.4% stake in the liquefied natural gas project. This indicates Chevron's active involvement in Angola's LNG market through its equity investment in Angola LNG Limited, though the negative earnings suggest operational or market challenges impacting the venture's profitability during that year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 59960,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 15205,
        "completion_tokens": 100,
        "total_tokens": 15305
      }
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources faces an operational risk because its nuclear fuel supply contracts expire in 2033, while the Duane Arnold plant’s decommissioning is not expected to be completed until around 2080; this mismatch means the company must continue to manage spent‑fuel storage and potential regulatory or financial exposure for many years after the contracts end.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42847,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10946,
        "completion_tokens": 92,
        "total_tokens": 11038
      }
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde’s on‑site industrial‑gas contracts are accounted for as performance obligations satisfied over time, with revenue recognized as product is delivered and the company has the right to invoice, typically under long‑term supply agreements that include minimum purchase requirements and price escalations. In contrast, the company records contingent liabilities for projects such as the Amur GPP and the RCA‑related engineering contracts only when a loss is probable and reasonably estimable, and it may suspend or terminate those contracts—leading to recognized contract liabilities (e.g., the $1.0 billion contingent liability for terminated engineering projects and the $0.7 billion for Amur GPP matters). This divergence highlights that while on‑site revenue is earned steadily under long‑term, fixed‑price arrangements, the financial risk from long‑term on‑site agreements is mitigated by the ability to recognize revenue over time and by contractual protections, whereas contingent liabilities tied to suspended or terminated engineering contracts expose Linde to significant potential losses that are recorded only when estimable, underscoring higher risk exposure in those long‑term on‑site agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 46645,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11909,
        "completion_tokens": 302,
        "total_tokens": 12211
      }
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "The expected increase in TAC paid to Google Network partners—driven by shifts toward mobile and emerging‑market device mixes and broader geographic reach—directly reduces the net advertising revenue that Alphabet can recognize, because TAC is recorded as a cost of revenue on a gross basis. Consequently, while total advertising revenue is reported on a gross (gross‑basis) basis, the higher TAC expense lowers the margin and net contribution of advertising revenues in the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 42870,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10953,
        "completion_tokens": 127,
        "total_tokens": 11080
      }
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "The ARO amount recorded for coal‑ash impoundment closure reflects the estimated cost of complying with state and federal regulations, including the EPA’s CCR rule and the North Carolina Coal‑Ash Act. Because the specific closure method and schedule must meet those regulatory requirements, the recorded ARO is directly tied to compliance with the Coal‑Ash Act, and any revisions to the closure plan can materially change the liability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 178,
          "pages": [
            176,
            177,
            178,
            179,
            180
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 66448,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 16863,
        "completion_tokens": 108,
        "total_tokens": 16972
      }
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables is a decrease of $38 million, from $178 million at January 31, 2023 to $236 million at January 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 53102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13482,
        "completion_tokens": 50,
        "total_tokens": 13533
      }
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "Based on the provided document pages, specifically the \"NOTE 5. REVENUE\" section, Danaher's Diagnostics segment sales in 2023 were attributed to \"other developed markets\" at 5% of total Diagnostics sales. The specific geographic regions classified under \"other developed markets\" are defined as Japan, Australia, and New Zealand, as stated in the document: \"The Company defines other developed markets as Japan, Australia and New Zealand.\" This is confirmed by the geographical breakdown showing Diagnostics sales to \"Other developed markets (b)\" totaling $431 million, representing 5% of the total Diagnostics sales ($9,577 million) for 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 41360,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10564,
        "completion_tokens": 160,
        "total_tokens": 10725
      }
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "Based on the provided financial data for 2021, the total revenue contribution from Bulk shipments is $6,656 million. This is derived from the \"Freight Revenues Millions\" table under the \"Bulk\" category, which explicitly states $6,656 for 2021. The document confirms that Bulk includes grain and grain products, fertilizer, food and refrigerated goods, and coal and renewables, and attributes the $6,656 million revenue to a 5% volume increase, core pricing gains, higher fuel surcharge revenue, and positive business mix. The average revenue per car for Bulk ($3,305) and carload volume (2,014 thousand) are also provided, but the total revenue contribution is directly given as $6,656 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39222,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10019,
        "completion_tokens": 173,
        "total_tokens": 10193
      }
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The settlement agreement with NCDEQ reduced Duke Energy’s estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina by roughly $1.5 billion, lowering the total from $9.5 billion‑$10.5 billion to about $8 billion‑$9 billion; approximately $3.1 billion of that total had been spent through 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 67077,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 17019,
        "completion_tokens": 85,
        "total_tokens": 17104
      }
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid $325 million in cash for Dynamic Yield in 2022 and $2.7 billion in cash for Recorded Future in 2024, for a total cash consideration of $3.025 billion across the two acquisitions. This spending reflects the company’s strategy of growing and diversifying its business by acquiring complementary technology firms—such as Dynamic Yield’s personalization platform and Recorded Future’s threat‑intelligence capabilities—to expand its payment‑network and value‑added services portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52102,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13245,
        "completion_tokens": 123,
        "total_tokens": 13369
      }
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "Based on the provided document pages, the total fair value of International bonds held by VZ is $341 million in 2023 and $528 million in 2022. The first table categorizes these bonds as part of the \"International bonds\" line item under Fixed Income securities for the pension plan, while the second table lists them under a separate \"International bonds\" column within the same Fixed Income securities category, but both refer to the same underlying asset class. Thus, the categorization differs only in the presentation format—one groups them as a distinct asset class within Fixed Income, and the other includes them as a sub‑line item under Fixed Income securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 56664,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14381,
        "completion_tokens": 167,
        "total_tokens": 14548
      }
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard’s real‑time, account‑based payments infrastructure—built on a globally integrated, distributed architecture—enables instant, secure ACH‑style transfers and direct account‑to‑account settlements across more than 250 million digital access points in 220 countries. This infrastructure processes roughly 70 % of all Mastercard and Maestro transactions, handling the majority of both domestic and cross‑border payments for the two brands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57012,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14490,
        "completion_tokens": 111,
        "total_tokens": 14602
      }
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. paid $1.9 billion in cash consideration to acquire VIZIO Holding Corp. The acquisition introduces a data‑privacy risk because VIZIO’s digital platforms collect consumer data—including television‑viewing information—and store it on digital systems that may be vulnerable to cyber‑attacks, potentially leading to data‑breach liabilities, regulatory fines and reputational harm.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57241,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14535,
        "completion_tokens": 97,
        "total_tokens": 14632
      }
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "The net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022 was an increase of $35 million in fuel‑related operating expenses, partially offset by a $14 million increase in fuel cost recovery reflected in operating income. Consequently, operating cash flows were reduced by roughly $21 million after accounting for the higher expenses and the modest recovery.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 54953,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13982,
        "completion_tokens": 103,
        "total_tokens": 14086
      }
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021, Intel recorded approximately **$565 million** of additional period charges tied to the ramp‑up of its Intel 4 manufacturing process. These charges are highlighted in the “Operating Income Summary” table under the line “Higher period charges primarily associated with the ramp up of Intel 4,” reflecting the extra costs incurred while scaling production of the new node. The same announcement also noted that Intel was rebranding its process nodes—introducing the “Intel 4” name as part of a broader naming overhaul unveiled in July 2021—so the ramp‑up of Intel 4 directly corresponds to this newly branded manufacturing node.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 50996,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12975,
        "completion_tokens": 158,
        "total_tokens": 13134
      }
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "Based on the provided document pages, 5% of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and the company had approximately 3,000 employees in those same markets as of the end of 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 45583,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 11623,
        "completion_tokens": 55,
        "total_tokens": 11679
      }
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "The total revenue generated from Industrial chemicals & plastics in 2021, combining revenue per car and carloads, is $1,943 million (derived from 606 thousand carloads × $3,207 average revenue per car).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 39222,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10016,
        "completion_tokens": 50,
        "total_tokens": 10066
      }
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "The total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed in the pension plan assets, is $341 million (shown under “International bonds” in the “Fixed income securities” section of the pension plan asset table). This amount represents the fair value of International Bonds within the broader pension asset categories reported for 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 55472,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14078,
        "completion_tokens": 91,
        "total_tokens": 14169
      }
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco’s owned production of private‑label items—supported by its own processing, packaging, and manufacturing facilities—helps the retailer keep merchandise costs lower and maintain tighter control over product quality. By producing these goods internally, Costco can pass savings on to members, boost comparable‑sales growth, and spread its SG&A expenses over a larger sales base, thereby reducing SG&A as a percentage of revenue and enhancing overall profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 80311,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 20297,
        "completion_tokens": 117,
        "total_tokens": 20414
      }
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "Intel's RibbonFET technology, introduced at the Intel 20A node, advances its process and packaging strategy by enabling faster transistor switching and optimized power delivery—key elements of its IDM 2.0 strategy to drive product leadership and manufacturing scale. This innovation supports Intel's broader R&D investments and packaging advancements, such as PowerVia and Foveros Direct, which are central to its roadmap for leadership in process technology and heterogeneous computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 40607,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10391,
        "completion_tokens": 121,
        "total_tokens": 10512
      }
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "Based on the document, in Q4 2023 Meta estimated that roughly 3 percent of its worldwide MAP consisted of violating accounts, and that duplicate and false accounts together made up about 10 percent of worldwide MAUs, with false accounts alone accounting for approximately 4 percent of MAUs. These accounts can distort the stability and accuracy of Meta’s user metrics by inflating the apparent size of its user base, potentially masking underlying trends and making it harder to gauge genuine engagement or the effectiveness of platform health initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 41178,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 10520,
        "completion_tokens": 139,
        "total_tokens": 10659
      }
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31 2023, the crypto‑asset safeguarding liability was $1,241 million and the corresponding safeguarding asset was also $1,241 million. These amounts are recorded at the same fair value because the liability and asset are measured using quoted market prices for the underlying cryptocurrencies on the principal exchange, resulting in identical fair‑value measurements for both.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 52079,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 13245,
        "completion_tokens": 97,
        "total_tokens": 13343
      }
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "The combined total for 2024 of 'Other noncontrolling redeemable interests' ($169,192 k) and '7.50% Cumulative Redeemable Preferred Units' ($15,537 k) is $184,729 k. This is lower than the 2023 combined total of $195,949 k.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 49553,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 12611,
        "completion_tokens": 55,
        "total_tokens": 12666
      }
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "Southern Company Gas' floating‑price natural‑gas purchases through Nicor Gas and SouthStar totaled **$136 million** (39 million mmBtu at floating prices, valued at $136 million) as of December 31 2024. This procurement approach is fully integrated into the company’s regulated cost‑recovery framework, allowing the utilities to recover the wholesale cost of natural gas from customers via rate mechanisms approved by state regulators.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 57797,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 14684,
        "completion_tokens": 108,
        "total_tokens": 14793
      }
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "The net income attributable to ConocoPhillips from the Lower 48 region in 2021 was **$4,932 million**, while the equity in earnings (losses) from that same region for the year was **$(18) million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 36584,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9377,
        "completion_tokens": 49,
        "total_tokens": 9426
      }
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The company's total notional value of unsettled forward foreign‑exchange contracts and variable‑priced commodity contracts used to manage currency and commodity price risks was $1,212 million at the end of 2024 (and $1,068 million in 2023). These contracts, which are not designated as hedge accounting instruments, allow the company to hedge anticipated foreign‑currency expenditures and to lock in fixed prices for certain energy and commodity purchases, thereby reducing exposure to fluctuations in exchange rates and commodity costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 36725,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 9434,
        "completion_tokens": 134,
        "total_tokens": 9568
      }
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft's internal development structure for Microsoft 365—particularly the integration of its cloud‑first services (Azure, Office 365 Commercial, and Microsoft 365 Consumer) into the “More Personal Computing” segment—drives how it reports subscriber growth and revenue trends in its FY 2024 filings. The company ties Microsoft 365 Consumer subscriber counts (now including the Basic tier) and related revenue to the performance of its Windows OEM licensing, Devices, and Gaming businesses, reflecting that the commercial and consumer adoption of Microsoft 365 is closely linked to the underlying hardware ecosystem and ecosystem‑wide engagements such as Xbox Game Pass and Activision Blizzard content. Consequently, FY 2024 financial updates highlight an 82.5 million subscriber base and modest revenue growth for Microsoft 365 Consumer, attributing these results to the synergies created by its unified development and go‑to‑market approach across Windows, Office, and Gaming.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 9,
        "total_chars": 35053,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 8985,
        "completion_tokens": 245,
        "total_tokens": 9230
      }
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "Based on the provided document pages, the total number of shares counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) is calculated as follows:  \n- Each PSA counts as **three shares times the maximum potential payout**.  \n- As of December 31, 2023, **248 million shares** were available for award under the 2019 Stock Plan, which includes the 68 million shares assumed from Seagen's remaining shares.  \n- This 248 million share figure represents the **total shares available for award**, and the calculation of \"three shares per PSA\" is significant because it directly determines how many shares are allocated toward this limit when PSAs are granted.  \n\nThe significance of this calculation is that it ensures the 248 million shares available for award (including the Seagen-assumed shares) are properly accounted for in the plan's share reserve, with PSAs contributing three shares per unit of maximum payout toward this cap. This reserve is distinct from the total shares authorized under the plan and reflects the maximum potential dilution from performance-based awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        }
      },
      "context_stats": {
        "window_size": 5,
        "total_pages": 10,
        "total_chars": 108208,
        "hops_processed": 2
      },
      "token_usage": {
        "prompt_tokens": 27311,
        "completion_tokens": 283,
        "total_tokens": 27594
      }
    }
  ]
}